Akcie AppLovin za měsíc od poslední výsledkové zprávy klesly asi o 6,6 %. Firma ale pro 3. čtvrtletí čeká tržby až 2,085 miliardy USD a upravenou EBITDA až 1,74 miliardy USD.
A month has gone by since the last earnings report for AppLovin (APP - Free Report) . Shares have lost about 6.6% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is AppLovin due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its latest earnings report in order to get a better handle on the important catalysts.
AppLovin Q2 Earnings Beat EstimatesAppLovin reported adjusted earnings of $3.76 per share, surpassing the Zacks Consensus Estimate of $3.72 by 1.08%. Earnings increased 66.4% from $2.26 per share in the year-ago quarter.
The company has now exceeded consensus EPS estimates in each of the past four quarters. However, the magnitude of the latest beat narrowed from the preceding quarter, when earnings of $3.56 per share topped expectations by 4.71%. On a sequential basis, second-quarter EPS increased 5.6%.
Revenues reached $1.92 billion, up approximately 52.4% from $1.26 billion a year earlier. The top line nevertheless missed the Zacks Consensus Estimate by 0.75%. Revenues increased about 4% sequentially, implying first-quarter revenues of roughly $1.85 billion.
The combination of rapid year-over-year expansion and a sequential slowdown in incremental growth helps explain the mixed interpretation of the quarter. AppLovin continues to expand at an exceptional rate for its scale, but elevated expectations leave relatively little room for execution delays.
EBITDA Growth and Margin Remain Major StrengthsAdjusted EBITDA climbed 58% year over year to $1.61 billion, implying approximately $1.02 billion in the prior-year quarter. EBITDA growth therefore exceeded revenue growth by roughly six percentage points.
More importantly, adjusted EBITDA represented approximately 83.9% of second-quarter revenues. That is an exceptionally high profitability level and demonstrates the operating leverage embedded in AppLovin's technology-driven advertising platform.
The quarter also generated $863 million of free cash flow, equivalent to roughly 44.9% of revenues and about 53.6% of adjusted EBITDA. Cash generation was softer than the company's recent earnings profile might suggest, but the weakness primarily reflected timing rather than a deterioration in underlying economics.
Costs increased sequentially as AppLovin directed additional resources toward computing capacity for existing and new artificial-intelligence models. This is worth watching because model training and inference requirements could create some quarter-to-quarter margin variability even if the investments ultimately support higher revenues.
Balance Sheet Supports Continued Capital ReturnsAppLovin ended the quarter with $3.05 billion in cash and $3.7 billion of total debt. The resulting $650 million gap between debt and cash is modest relative to the company's EBITDA generation, with net leverage standing at approximately 0.1 times trailing adjusted EBITDA.
During the quarter, the company repurchased or withheld approximately 1.14 million shares for $551 million. Repurchase activity moderated compared with the first quarter as management balanced capital returns against temporarily softer free cash flow.
The combination of strong profitability, substantial cash holdings and minimal net leverage gives AppLovin flexibility to fund AI infrastructure, pursue product expansion and continue returning capital without placing meaningful stress on the balance sheet.
Q3 Guidance Points to ReaccelerationThird-quarter guidance provides one of the strongest counterarguments to the post-earnings pessimism.
AppLovin expects revenues between $2.055 billion and $2.085 billion. The $2.07 billion midpoint implies approximately 7.8% sequential growth from the second quarter’s $1.92 billion, representing a meaningful acceleration from the second quarter's roughly 4% sequential increase.
Adjusted EBITDA is projected between $1.71 billion and $1.74 billion. At the $1.725 billion midpoint, EBITDA would increase approximately 7.1% sequentially from $1.61 billion.
The company expects an adjusted EBITDA margin of approximately 83% in the third quarter. That would be modestly below the second quarter's roughly 83.9%, reflecting, in part, higher AI-related infrastructure spending. Still, sustaining a margin above 80% while investing aggressively in model development would underline the strength of APP's operating model.
Importantly, the outlook incorporates model enhancements already deployed and does not depend on additional releases that have yet to reach production. That makes the guidance somewhat more tangible than an outlook dependent on future technological breakthroughs.
How Have Estimates Been Moving Since Then?Since the earnings release, investors have witnessed a downward trend in estimates revision.
VGM ScoresAt this time, AppLovin has a great Growth Score of A, though it is lagging a lot on the Momentum Score front with an F. Charting a somewhat similar path, the stock was allocated a score of D on the value side, putting it in the bottom 40% for value investors.
Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, AppLovin has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry PlayerAppLovin belongs to the Zacks Technology Services industry. Another stock from the same industry, SLB (SLB - Free Report) , has gained 11.4% over the past month. More than a month has passed since the company reported results for the quarter ended June 2026.
SLB reported revenues of $8.97 billion in the last reported quarter, representing a year-over-year change of +5%. EPS of $0.55 for the same period compares with $0.74 a year ago.
For the current quarter, SLB is expected to post earnings of $0.62 per share, indicating a change of -10.1% from the year-ago quarter. The Zacks Consensus Estimate has changed +0.3% over the last 30 days.
The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for SLB. Also, the stock has a VGM Score of C.
TransUnion v pátek klesá, protože šéf FHFA Bill Pulte varoval, že úřad zvažuje model bi-merge pro hypotéky podporované vládou. Ten by snížil objem úvěrových zpráv o třetinu.
Shares of TransUnion (NYSE:TRU) are sliding Friday afternoon as investors react to regulatory threats from Federal Housing Finance Agency Director Bill Pulte regarding mortgage credit reporting costs and industry structure.
TransUnion shares are sliding. What’s behind TRU decline? FHFA Director Accuses Credit Bureaus of ‘Cartel-Like’ OverchargingWhile Director Pulte’s Thursday evening directive instructing Fannie Mae and Freddie Mac to approve VantageScore 4.0 for all lenders technically expands the market for a scoring model co-owned by TransUnion, Equifax and Experian, his accompanying comments triggered widespread selling across credit bureau stocks.
In public statements on social media, Pulte accused the three major credit reporting agencies of “overcharging Americans for far too long” and operating with “cartel-like” pricing power. Pulte pledged that the practice “will end soon,” noting that conversations with bureau leadership regarding fee reductions had yielded insufficient progress.
‘Bi-Merge’ Threat Endangers Core Mortgage Data VolumeThe primary catalyst driving TRU stock lower is Pulte’s warning that the FHFA is “seriously considering bi-merge and stronger solutions” for government-backed home loans.
Under the current “tri-merge” framework, mortgage lenders are required to pull credit files from all three national bureaus, TransUnion, Equifax and Experian, for every loan delivered to Fannie Mae or Freddie Mac.
Shifting to a “bi-merge” model would allow lenders to evaluate borrowers using data from only two bureaus, effectively cutting overall industry report volume by a third.
For TransUnion, the potential loss of guaranteed mortgage file volume creates a major structural headwind that overshadows any near-term gains from expanded VantageScore adoption.
TRU Shares Tumble Friday AfternoonTRU Price Action: TransUnion shares were down 7.02% at $78.96 at the time of publication on Friday, according to Benzinga Pro data.
Read Next
Image: Shutterstock
Market News and Data brought to you by Benzinga APIs
Retailové výsledky ukazují rozděleného amerického spotřebitele: Home Depot a Lowe’s těžily ze silné poptávky po větších projektech, zatímco Walmart zaostal.
Looking back on the latest earnings season for retail stocks, an unusual K-shaped pattern emerges: lower-income households appear to be struggling, with some value stores having a difficult time reconciling their low prices against increasingly costly inventory. At the same time, though, a handful of specialized stores, including homeowner and contractor supply chains, have had unexpected strong quarters in numerous respects.
This data helps to support the growing narrative that different groups of consumers are experiencing the economy in vastly different ways, with those with more disposable cash tending to spend freely and those without being forced to tighten belts to even more extreme degrees.
Get Walmart alerts:
The situation means that some companies—like The Home Depot Inc. NYSE: HD and Lowe's Companies Inc. NYSE: LOW—have done better than others, including Walmart NASDAQ: WMT and Five Below Inc. NASDAQ: FIVE, even while the latter have some hidden wins that suggest a more complicated consumer landscape than some may anticipate.
Home Depot Finds Resilience in Pro Demand and Smaller ProjectsHome Depot Today
HD
Home Depot
$320.51 +2.44 (+0.77%)
As of 01:38 PM Eastern
This is a fair market value price provided by Massive. Learn more.
$289.10▼
$426.752.91%
22.43
$375.54
Home Depot's Q2 2026 earnings of $4.92 per share came on the back of revenue of nearly $48 billion, which was up about 6% year over year (YOY).
Both metrics were ahead of analyst predictions, fueled by comparable store sales growth of 1.7%, a notably high figure for the company.
Home improvement projects seem to be fairly robust, particularly among higher-income homeowners with more discretionary income to spend.
The company enjoyed strong demand across many of its departments, supported by its new three-hour express delivery service—this service is also one that may appeal to consumers with more disposable income who are willing to spend extra for the convenience.
To be sure, uncertainty about consumer sentiment in general, as well as concerns about housing affordability, may negatively impact some types of home improvement projects. Still, Wall Street analysts have rallied behind Home Depot stock, calling it a Moderate Buy overall and predicting about 18% in future upside.
This is a fair market value price provided by Massive. Learn more.
$199.34▼
$293.062.45%
17.24
$258.53
On a macro level, Lowe's would seem to benefit from many of the same factors driving Home Depot's growth.
The company is also well-suited to providing for those big-ticket home improvement projects that some consumers are still prepared to spend large amounts of money on.
This is evidenced by Lowe's sales growth of 8.3% YOY in the latest quarter, as well as strong free cash flow and pro sales growth that reflects strong contractor demand.
The issue for Lowe's may be that its overall competitive position is weaker than Home Depot's. Management recently reduced its full-year outlook due to softer DIY demand. Comparable sales increased by just 0.2% YOY—while better than a decline, it's a much slower rate than Home Depot.
In addition, the company decided not to leverage tariff refunds to offer strong summer promotions to the same degree as some of its competitors, and performance suffered as a result.
Five Below and Walmart Show Different Sides of the Value ConsumerFive Below Today
$256.57 +16.61 (+6.92%)
As of 01:38 PM Eastern
This is a fair market value price provided by Massive. Learn more.
$137.77▼
$263.8823.04
$296.20
Five Below faces challenges to its margins as a result of significant increases to fuel costs, and tariff benefits are disappearing fast.
Still, the company has managed to post some crucial wins in key areas: profitability was still up, with merchandise-margin gains and fixed-cost leverage as two important contributing factors.
Where Five Below really succeeded in Q2 2026, though, was in sales growth of 23% YOY, including 14% YOY improvement to comparable sales.
This may suggest that consumers are still be willing to spend on discretionary items when the price point is compelling, even as economic pressures make them more selective about larger purchases. Five Below may have cracked the code to continuing to see robust traffic and transactions, even as economic pressures mount.
Walmart Today
$107.33 -1.09 (-1.01%)
As of 01:38 PM Eastern
This is a fair market value price provided by Massive. Learn more.
$98.88▼
$135.150.92%
38.75
$131.88
Walmart, on the other hand, disappointed investors with its latest earnings, even though it also raised its full-year guidance.
The issue may be that the company posted notably slow sales growth compared to other recent quarters. There also may be a concern that the company's results are artificially benefiting from near-term tariff refunds that are not going to last.
Still, Walmart's digital business appears to be thriving and building its margins.
Advertising remains a high-growth corner of the company's ecosystem, but it is also supported by growth in membership income, e-commerce, and more. This may be why, despite shares falling by about 2.7% year to date (YTD), analysts remain very bullish on WMT stock overall and see the stock gaining 24%.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Should You Invest $1,000 in Walmart Right Now?Before you consider Walmart, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walmart wasn't on the list.
While Walmart currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
NiSource za poslední měsíc klesl asi o 4 % po zveřejnění výsledků, i když za 2. čtvrtletí překonal odhady zisku i tržeb. Firma zároveň potvrdila celoroční výhled zisku na akcii 2,02–2,07 USD.
A month has gone by since the last earnings report for NiSource (NI - Free Report) . Shares have lost about 4% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is NiSource due for a breakout? Well, first let's take a quick look at its latest earnings report in order to get a better handle on the recent catalysts for NiSource, Inc before we dive into how investors and analysts have reacted as of late.
NiSource Q2 Earnings Top Estimates on NIPSCO Gains, Data Center Demand
NiSource Inc. reported second-quarter 2026 adjusted earnings of 16 cents per share, beating the Zacks Consensus Estimate of 15 cents by 6.67%. However, the bottom line declined 27.3% from 22 cents in the year-ago quarter.
Total RevenuesOperating revenues of $1.36 billion topped the consensus estimate of $1.33 billion by 1.98% and increased 5.9% year over year. NIPSCO’s stronger operating performance and higher electric sales partly offset weaker Columbia results and elevated operating costs.
NI Segment DetailsColumbia operations generated revenues of $610.3 million, up 0.8% from $605.6 million a year ago. The segment’s adjusted operating income declined 6.1% to $115.6 million.
NIPSCO operations recorded revenues of $750.4 million, up 10.4% year over year. Adjusted operating income increased 13.6% to $150.9 million, making the segment the primary source of consolidated operating growth.
NI's Operational HighlightsAdjusted operating expenses totaled $1.09 billion, up 6.6% from the prior-year quarter. Operation and maintenance expenses increased 13% to $411.6 million, while depreciation and amortization rose 26.4% to $362 million. The cost of energy declined 26.1% to $193.6 million.
NIPSCO Electric sales volumes, excluding weather, increased 5% to 4,195.3 gigawatt-hours (GWh). Industrial sales rose 10.4% to 2,246.2 GWh, while residential sales declined 5.8% to 757.7 GWh.
Columbia sales and transportation volumes, excluding weather, fell 1.7% to 112.4 million dekatherms. NIPSCO Gas volumes on the same basis decreased 3.5% to 77.5 million dekatherms. The company recorded a $16 million revenue adjustment for weather compared with normal conditions.
Adjusted operating income improved 3.2% to $270.9 million, but net interest expense climbed 43.2% to $199.2 million, pressuring adjusted net income available to common shareholders.
NI's Data Center Strategy AdvancesNiSource advanced its data center strategy with regulatory approvals for special contracts involving Amazon and Alphabet. The agreements are expected to provide $1.4 billion in savings for existing customers.
The company has around 4 GW of signed GenCo capacity, with 3 GW under strategic negotiations and up to 2 GW of developing opportunities. Its data center pipeline could reach up to 9 GW of capacity by 2035. NiSource is also developing a diversified portfolio of generation, battery storage and contracted resources to support the additional load.
NI's Debt and Liquidity ProfileTotal debt was about $17.4 billion as of June 30, 2026, including roughly $16.7 billion of long-term debt. The weighted average maturity was about 11.5 years, with a weighted average interest rate of approximately 4.87%.
Net available liquidity was about $2.1 billion at quarter-end. NiSource also had roughly $2.7 billion of committed facilities, including a $2.5 billion revolving credit facility and about $200 million of accounts receivable securitization facilities.
NiSource Reaffirms 2026 GuidanceNiSource reaffirmed its 2026 consolidated adjusted earnings guidance of $2.02-$2.07 per share. The company also maintained its 2026-2033 consolidated adjusted earnings compound annual growth rate target of 9-10%.
NiSource continues to execute a $28.6 billion capital investment plan for 2026-2030. This includes $21 billion of base plan investments and $7.6 billion of data center-related spending, supporting expected consolidated rate base growth of 9-11% through 2033.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a downward trend in fresh estimates.
VGM ScoresCurrently, NiSource has a average Growth Score of C, though it is lagging a lot on the Momentum Score front with an F. However, the stock was allocated a score of C on the value side, putting it in the middle 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of this revision indicates a downward shift. Interestingly, NiSource has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry PlayerNiSource is part of the Zacks Utility - Electric Power industry. Over the past month, AES (AES - Free Report) , a stock from the same industry, has gained 0.5%. The company reported its results for the quarter ended June 2026 more than a month ago.
AES reported revenues of $3.42 billion in the last reported quarter, representing a year-over-year change of +19.9%. EPS of $0.44 for the same period compares with $0.51 a year ago.
AES is expected to post earnings of $0.60 per share for the current quarter, representing a year-over-year change of -20%. Over the last 30 days, the Zacks Consensus Estimate remained unchanged.
The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for AES. Also, the stock has a VGM Score of B.
Envista za poslední měsíc přidala asi 0,8 % po silných výsledcích za 2. čtvrtletí 2026, kdy upravený zisk na akcii vzrostl na 41 centů a tržby na 730,5 milionu USD.
It has been about a month since the last earnings report for Envista (NVST - Free Report) . Shares have added about 0.8% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Envista due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.
Envista Tops Q2 Earnings and RevenuesEnvista Holdings Corporation reported adjusted earnings per share of 41 cents in the second quarter of 2026, up 57.7% year over year. The bottom line surpassed the Zacks Consensus Estimate by 24.24%.
The adjustments include non-cash charges related to the amortization of acquisition-related and other intangible assets, restructuring costs and asset impairments, fair-value adjustment of acquisition-related inventory and tariff refunds, among others.
The company’s GAAP earnings were 33 cents compared with the year-ago quarter’s earnings of 16 cents per share.
NVST’s Revenues
Revenues totaled $730.5 million in the reported quarter, up 7.1% year over year. The metric topped the Zacks Consensus Estimate by 2.17%.
Segment-wise, Specialty Products & Technologies sales totaled $471 million, up 5.8% year over year. Revenues from Equipment & Consumables rose 9.5% year over year to $259.5 million in the quarter under review.
NVST’s Operational Update
The gross profit in the reported quarter climbed 10% year over year to $407 million. The gross margin expanded 149 basis points (bps) to 55.7% despite cost of sales increasing 3.6%.
Selling, general and administrative expenses were up 0.3% year over year to $296.3 million. Research and development expenses rose 7.4% year over year to $30.4 million. The operating profit of $80.3 million jumped 73.4% year over year. The operating margin expanded 420 bps to 11%.
NVST’s Financial Update
Envista ended the second quarter of 2026 with cash and cash equivalents of $1.13 billion compared with $1.08 billion as of Apr. 3. Long-term debt in the second quarter was $1.44 billion compared with $1.43 billion at the end of first quarter. Cumulative net cash provided by operating activities as of July 3, 2026 was $115.9 million compared with $89 million a year ago.
Envista’s 2026 Guidance
For 2026, the company expects core sales growth between 3.5% and 4.5% (previously, 2%-4%). The Zacks Consensus Estimate projects 2026 sales to be $2.88 billion, representing 6% growth over 2025.
Adjusted EBITDA growth is projected in the range of 11%-14%, previously 7%-13%.
Adjusted diluted earnings per share are projected between $1.50 and $1.55 (earlier, $1.35 to $1.45). The consensus mark for the metric stands at $1.53.
Free cash flow conversion is expected to be approximately 100%.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a upward trend in estimates review.
VGM ScoresAt this time, Envista has a subpar Growth Score of D, a score with the same score on the momentum front. However, the stock has a grade of B on the value side, putting it in the second quintile for value investors.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been trending upward for the stock, and the magnitude of these revisions looks promising. It comes with little surprise Envista has a Zacks Rank #1 (Strong Buy). We expect an above average return from the stock in the next few months.
Performance of an Industry PlayerEnvista belongs to the Zacks Medical - Products industry. Another stock from the same industry, Neogen (NEOG - Free Report) , has gained 3% over the past month. More than a month has passed since the company reported results for the quarter ended May 2026.
Neogen reported revenues of $225.3 million in the last reported quarter, representing a year-over-year change of -0.1%. EPS of $0.09 for the same period compares with $0.05 a year ago.
For the current quarter, Neogen is expected to post earnings of $0.05 per share, indicating a change of +25% from the year-ago quarter. The Zacks Consensus Estimate has changed +4.4% over the last 30 days.
Neogen has a Zacks Rank #2 (Buy) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of B.
Insperity (NSP) za posledních šest měsíců vzrostla o 150,4 % díky obnově marží a lepšímu mixu klientů. Firma zároveň rozšiřuje HRScale a vlastní AI nástroje.
Key Takeaways NSP's margin recovery improved client mix and benefit pricing, supporting stronger profitability in 2026.HRScale entered the third quarter with nearly 8,000 worksite employees sold, including more than 5,000 live.Insperity is expanding proprietary AI tools to improve client service, productivity and access to insights. Insperity (NSP - Free Report) stock has soared 150.4% over the past six months, outpacing the industry and the Zacks S&P 500 Composite's 71.8% and 12.7% gains, respectively.
6-Month Share Price Performance Image Source: Zacks Investment Research
Let us delve deeper into the factors that have contributed to the company’s outperformance.
Margin Recovery Plan Pays OffInsperity’s pricing results progressed in tandem with the margin recovery plan. The company recorded lower profitability from client termination than from retention, resulting in a favorable change in client mix. This strategy improved the price and cost matching in its benefits business during the second quarter of 2026.
Benefits cost per covered employee gained 5.2% year over year, consistent with the first quarter and management expectations, with favorable client mix, design changes and the UnitedHealthcare contract, which offset higher healthcare cost trends.
The lowered pooling threshold led to fixed higher premium costs earlier in 2026, with claims reimbursements significantly weighing in the later half of the year. The company’s historical earnings seasonality is expected to decline, with the favorable claim-cost impact turning vivid in the second half of the year.
Paul Sarvadi, the CEO, stated during the recent earnings call that the company is on track to achieve the goals set for margin recovery in 2026 and is laying the groundwork for regaining growth momentum. Achieving these objectives is expected to lay the foundation for balancing growth and profitability in 2027 and delivering shareholder value in the upcoming years.
HRScale: New Growth AvenueHRScale is a vital growth catalyst deployed by the company at a lower upfront investment, reduced time to value and lower ongoing costs compared with a combination of HCM and HR service vendors. The company onboarded beta clients in March and processed payrolls and invoices in April as per schedule. In the first quarter of 2026, the company signed commitments for approximately 6,000 worksite employees to be onboarded within the next six months.
HRScale’s rollout gained momentum during the second quarter of 2026. The company entered the third quarter with sold HRScale accounts representing nearly 8,000 worksite employees, including more than 5,000 already live and nearly 3,000 undergoing implementations.
Management is bullish on this technology’s ability to expand the company’s addressable market and solidify sales and larger client retention. Following the beta clients going live during the second quarter, HRScale development investment declined to $8 million, suggesting that the offering is moving beyond its initial development stage as the company ramps client implementation and commercial activity.
AI Integration Enhances HR PlatformInsperity is incorporating proprietary AI capabilities into its HR services to improve clients' experiences, raise productivity and accelerate product development. Insperity’s in-house tool is transforming into a scalable enterprise AI platform, laying down a foundation that connects data and business knowledge across the company.
HR360 Agent already assists clients and worksite employees in accessing answers, resources and service support efficiently. The company is expanding its functionality to deliver conversational reporting and swift business insights. Management anticipates that these capabilities will solidify service delivery, enhance productivity and allow clients to access insights at a faster rate.
Zacks Rank & Stocks to ConsiderNSP currently carries a Zacks Rank #3 (Hold).
Better-ranked stocks in the broader Zacks Business Services sector include ScanSource (SCSC - Free Report) and Figure Technology Solutions (FIGR - Free Report) , each currently sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
ScanSource has a long-term earnings growth expectation of 15%. SCSC delivered a trailing four-quarter earnings surprise of 7.8%, on average.
Figure Technology Solutions has a long-term earnings growth expectation of 51.7%. FIGR delivered a trailing four-quarter earnings surprise of 28.2%, on average.
A month has gone by since the last earnings report for Watts Water (WTS - Free Report) . Shares have lost about 5.7% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Watts Water due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its latest earnings report in order to get a better handle on the important drivers.
Watts Water Q2 Earnings Beat Estimates on Data Center Demand
Watts Water reported second-quarter 2026 adjusted earnings of $3.66 per share, up 18.4% from $3.09 a year ago. The bottom line beat the Zacks Consensus Estimate of $3.34 by 9.6%.
Net sales rose 18.6% year over year to $763.2 million and topped the consensus mark of $726 million by 5.1%. Organic sales advanced 12.2%, driven by favorable pricing, higher volumes and data center growth. Year-to-date data center sales represented 8% of total sales.
Data Center Momentum Accelerates
Second-quarter data center sales more than tripled year over year. Demand was concentrated in the Americas and APMEA, while Europe represented an emerging opportunity. Management said project-based demand could create quarter-to-quarter variability.
Watts Water is investing in talent, product innovation and capacity while expanding relationships with contractors, original equipment manufacturers and hyperscalers. The company estimates its served addressable data center market at about $2 billion, with potential content ranging from roughly $25,000 to $100,000 per megawatt.
Americas Demand Supports Growth
Americas sales increased 17.4% year over year to $585 million and rose 11.6% organically. Favorable pricing and higher volumes tied to data center demand supported the increase, while acquisitions added $28 million.
Segment margin fell 150 basis points (bps) to 25.7%. Acquisition dilution, inflation, tariffs and a difficult comparison with a prior-year tariff-related price-cost benefit outweighed gains from pricing, volume leverage and productivity.
Europe and APMEA Results Strengthen
Europe sales rose 12.3% to $124.6 million, including 9.2% organic growth.
Higher volumes and favorable pricing drove the advance, while foreign exchange contributed 3.1%. Segment margin expanded 160 bps to 13.3% as operating gains more than offset inflation.
APMEA sales climbed 56.7% to $53.6 million and advanced 30.7% organically.
Data center growth in China more than offset weaker Middle East activity. Acquisitions contributed 17.3% and foreign exchange added 8.7%, while segment margin improved 100 bps to 19.9%.
Profitability Faces Cost Pressure
Gross profit increased 14.8% to $374.1 million, though gross margin contracted 160 bps to 49.0%. Selling, general and administrative expenses rose 14.6% to $214.5 million.
Adjusted operating income increased 15% to $160 million, while adjusted operating margin declined 60 bps to 21.0%. Adjusted EBITDA rose 15.5% to $176.7 million, but its margin decreased 70 bps to 23.1%. Acquisition dilution, inflation and tariffs pressured profitability, partly offset by price realization, volume leverage and productivity.
Cash Flow Softens as Balance Sheet Holds
For the first six months of 2026, operating cash flow declined to $120.8 million from $124.9 million. Free cash flow decreased to $98.2 million from $105.1 million, reflecting higher working capital and capital expenditures. The cash conversion rate fell to 45.1% from 60.1%.
Watts Water ended June with $347.9 million in cash and $108 million of long-term debt, resulting in net cash of $239.9 million. The company repurchased about 13,000 shares for $4.1 million during the quarter, leaving roughly $121 million under its authorization. Management expects cash flow to improve sequentially in the second half as working capital is monetized.
2026 Outlook
WTS now expects full-year reported sales growth of 14% to 17%, up from its prior 8% to 12% range. Organic growth is projected at 8% to 11% compared with the previous 2% to 6% outlook. Adjusted operating margin is forecast between 19.8% and 20.4%, while adjusted EBITDA margin is expected between 22.1% and 22.7%.
For the third quarter, management expects reported sales growth of 11% to 14% and organic growth of 5% to 8%. Adjusted operating margin is projected between 19.8% and 20.4%, with adjusted EBITDA margin of 22.2% to 22.8%. The outlook assumes no change in the Middle East conflict's impact and includes tariffs announced through Aug. 4, 2026.
On Aug. 3, 2026, WTS also declared a quarterly dividend of 63 cents per share, payable on Sept. 15, 2026, to shareholders of record as of Sept. 1, 2026.
How Have Estimates Been Moving Since Then?Since the earnings release, investors have witnessed a upward trend in fresh estimates.
The consensus estimate has shifted 6.88% due to these changes.
VGM ScoresAt this time, Watts Water has a average Growth Score of C, a score with the same score on the momentum front. However, the stock was allocated a score of F on the value side, putting it in the lowest quintile for this investment strategy.
Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been trending upward for the stock, and the magnitude of these revisions looks promising. It comes with little surprise Watts Water has a Zacks Rank #2 (Buy). We expect an above average return from the stock in the next few months.
Viavi Solutions za poslední měsíc klesla o 17,2 %, přestože poslední čtvrtletní zisk i tržby překonaly odhady. Firma zároveň očekává ve 1. čtvrtletí fiskálního roku 2027 tržby 450–460 milionů USD.
It has been about a month since the last earnings report for Viavi Solutions (VIAV - Free Report) . Shares have lost about 17.2% in that time frame, underperforming the S&P 500.
But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is Viavi Solutions due for a breakout? Well, first let's take a quick look at the latest earnings report in order to get a better handle on the recent drivers for Viavi Solutions Inc. before we dive into how investors and analysts have reacted as of late.
VIAV Q4 Earnings Top Estimates on Data Center, A&D Strength
Viavi reported strong fourth-quarter fiscal 2026 results, with earnings and revenues exceeding the Zacks Consensus Estimate. Non-GAAP earnings of 34 cents per share beat the consensus estimate of 30 cents by 13.33%, while revenues of $443.1 million topped the consensus mark of $433 million by 2.34% and increased 52.5% year over year.
The robust performance was driven by sustained demand from the data center ecosystem and aerospace, and defense markets, along with contributions from acquired Spirent product lines. The Network and Service Enablement (NSE) segment remained the primary growth engine, delivering nearly 70% year-over-year revenue growth.
VIAV Delivers Broad-Based Segment Growth
Network and Service Enablement generated revenues of $353.9 million, up 69.2% year over year and above management's guidance range. Growth reflected continued strength in lab, production and field products serving the data center ecosystem, contributions from Spirent product lines and healthy aerospace and defense demand.
Optical Security and Performance Products (OSP) revenues increased 9.6% year over year to $89.2 million, reaching the high end of guidance. Growth was fueled by stronger demand for 3D sensing products as well as anti-counterfeiting and other optical products, demonstrating continued momentum across the company's second operating segment.
Viavi Expands Margins on Favorable Mix
Profitability improved meaningfully during the quarter as higher revenues and a favorable product mix boosted margins. Non-GAAP gross margin expanded to 62.3% from 60.1% a year earlier, while non-GAAP operating margin climbed 960 basis points year over year to 24.0%, exceeding the high end of management's guidance.
Non-GAAP operating income more than doubled year over year to $106.4 million. Earnings benefited from approximately 2 cents per share from lower interest expense following debt reduction and tariff refunds received during the quarter.
VIAV Strengthens Balance Sheet & Cash Flow
Viavi ended the quarter with $656.7 million in total cash, short-term investments and restricted cash. Cash flow from operating activities reached $66.7 million during the quarter, while capital expenditures totaled $11.1 million.
The company strengthened its balance sheet through capital allocation initiatives. During the quarter, it completed a follow-on equity offering that generated approximately $575 million in gross proceeds. The proceeds were primarily used to retire the remaining $450 million balance of its Term Loan B, while the remaining funds enhanced liquidity. The company did not repurchase shares during the quarter as debt reduction remained the priority, although nearly $170 million remains available under its existing authorization.
Viavi Sees Healthy Demand Across End Markets
Management highlighted that demand from the data center ecosystem remains exceptionally strong, supported by investments in AI infrastructure, high-performance computing, optical networking and hyperscale data center deployments. The recently acquired Spirent high-speed Ethernet product lines continued to perform well and contributed meaningfully to quarterly growth.
The aerospace and defense business delivered another quarter of solid growth, particularly for positioning, navigation and timing products, which management expects to remain a multiyear growth driver. Meanwhile, service provider demand improved seasonally, supported by fiber monitoring deployments and cable network upgrades, although wireless demand remained stable at relatively subdued levels.
VIAV Guides for Another Sequentially Strong Quarter
For the first quarter of fiscal 2027, management projects revenues to be between $450 million and $460 million with non-GAAP earnings of 40-42 cents per share. The outlook implies sequential growth, driven by continued strength in both operating segments.
The company expects NSE revenues to be between $360 million and $368 million, supported by continued momentum across data center and aerospace and defense markets, while OSP revenues are projected to be in the range of $90-$92 million on seasonally stronger demand for 3D sensing products. Management forecasts a non-GAAP operating margin of approximately 27.1%, benefiting from tariff refunds despite additional operating costs associated with the extra week in the fiscal quarter.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a upward trend in estimates revision.
The consensus estimate has shifted 47.67% due to these changes.
VGM ScoresCurrently, Viavi Solutions has a nice Growth Score of B, however its Momentum Score is doing a bit better with an A. However, the stock has a score of D on the value side, putting it in the bottom 40% for value investors.
Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been trending upward for the stock, and the magnitude of these revisions looks promising. It comes with little surprise Viavi Solutions has a Zacks Rank #1 (Strong Buy). We expect an above average return from the stock in the next few months.
Silicon Labs otevřel v Austinu nové R&D centrum pro návrh a testování čipů, podpořené grantem ve výši 23 milionů USD z Texas Semiconductor Innovation Fund. Firma říká, že tím posílí vývoj bezdrátových technologií pro IoT.
New R&D facility expands wireless innovation, engineering collaboration, and advanced testing capabilities
, /PRNewswire/ -- Silicon Labs (NASDAQ: SLAB), the leader in low-power wireless connectivity, today celebrated the opening of its new research and development (R&D) laboratory for advanced chip design and testing in Austin. The new R&D laboratory, made possible in part through a $23 million grant from the Texas Semiconductor Innovation Fund (TSIF) established by the Texas CHIPS Act, was officially opened during a ribbon-cutting ceremony attended by Silicon Labs senior leaders and employees alongside representatives from the State of Texas.
News at a Glance
R&D Lab ribbon-cutting at Silicon Labs’ Austin HQ. From left: Nestor Ho, Chief Legal Officer; Nelda Hunter, HillCo Partners; Cameron Cocke, Committee Director, Texas House Appropriations Committee (Chairman, Greg Bonnen, M.D.); Stephen Davis, Director for Economic Development & Tourism, Texas CHIPS Office in the Office of Governor Greg Abbott; Daniel Cooley, Senior Vice President and Chief Technology Officer; Brian Peterman, Assistant General Counsel; Jacey Zuniga, Director of Communications.
The new R&D lab at Silicon Labs. What: Silicon Labs has opened a new R&D laboratory at its Austin headquarters, featuring advanced research, testing and validation equipment and engineering workspace for advanced chip design and testing. Why it matters: The new facility expands Silicon Labs' R&D capabilities, accelerates wireless semiconductor innovation, and supports the development of next-generation IoT technologies. Texas partnership: The expansion was funded in part through a $23 million grant from the Texas Semiconductor Innovation Fund (TSIF) established by the Texas CHIPS Act. Milestone: Silicon Labs celebrated the facility's opening with a ribbon-cutting ceremony attended by company leaders, employees, and representatives from the State of Texas. "Our new Austin Innovation Center represents an important milestone in the partnership between the State of Texas and Silicon Labs to advance semiconductor innovation and reinforce Texas as the most attractive destination for semiconductor research, design, and development," said Matt Johnson, President and Chief Executive Officer of Silicon Labs. "This new space expands our ability to develop the next generation of wireless technologies that will further extend our leadership and the great impact this technology brings to the way we live and work."
Enabling the Next Generation of Wireless Technologies
The new R&D laboratory expands Silicon Labs' ability to develop, test, and validate the next generation of secure, intelligent wireless technologies that power the Internet of Things.
The facility supports continued innovation across Silicon Labs' wireless portfolio, including the company's Series 3 platform, which delivers advanced security, AI capabilities, and wireless connectivity for smart home, industrial, healthcare, commercial, and smart city applications. The TSIF funding allowed Silicon Labs to upgrade its equipment to work with more advanced wafer process technology nodes, and the expanded lab will enable engineers to accelerate product development, validate new technologies more efficiently, and collaborate across disciplines to bring innovations to market faster.
As demand for intelligent, connected devices continues to grow, the new facility positions Silicon Labs to continue advancing the wireless technologies that help make everyday products smarter, more secure, and more energy-efficient while keeping cutting-edge semiconductor research and development in Texas.
Strengthening Texas' Innovation Ecosystem
The Texas Semiconductor Innovation Fund was established to strengthen domestic semiconductor leadership by supporting strategic research and development investments, reducing barriers to innovation, and addressing increasing global competition in the semiconductor industry.
As one of the world's largest companies dedicated exclusively to wireless IoT connectivity, Silicon Labs is helping advance the U.S. semiconductor industry through its leadership in wireless chip design. Investments in fabless semiconductor innovators like Silicon Labs strengthen Texas' position as a global center for semiconductor research, engineering, and technology development while fostering high-value jobs and long-term economic growth.
Celebrating a Milestone for Austin and Texas
The ribbon-cutting ceremony officially opened the Innovation Center and celebrated the continued partnership between Silicon Labs and the State of Texas to advance semiconductor innovation, strengthen domestic technology leadership, and drive long-term economic growth.
About Silicon Labs
Silicon Labs (NASDAQ: SLAB) is the leading innovator in low-power connectivity, building embedded technology that connects devices and improves lives. Merging cutting-edge technology into the world's most highly integrated SoCs, Silicon Labs provides device makers with the solutions, support, and ecosystems needed to create advanced edge connectivity applications. Headquartered in Austin, Texas, Silicon Labs has operations in over 16 countries and is the trusted partner for innovative solutions in smart home, industrial IoT, and smart cities markets. Learn more at https://www.silabs.com.
Revolution Medicines za poslední měsíc přidala asi 6,6 %, ale ve 2. čtvrtletí roku 2026 vykázala vyšší než očekávanou upravenou ztrátu 2,34 USD na akcii a nulové výnosy.
A month has gone by since the last earnings report for Revolution Medicines, Inc. (RVMD - Free Report) . Shares have added about 6.6% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Revolution Medicines due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.
Q2 Loss Wider Than Expected, Sales NilRevolution Medicines reported an adjusted loss of $2.34 per share in the second quarter of 2026, wider than the Zacks Consensus Estimate of a loss of $1.93.
The adjusted figure excluded a non-cash charge of $151 million tied to a change in the fair value of warrants assumed through the EQRx acquisition, which closed in 2023. Including this item, the reported loss was $3.06 per share. The company had incurred a loss of $1.31 per share in the year-ago quarter.
Currently, the company does not have any approved product in its portfolio. It generated no revenues in the quarter.
Operating Expenses See a Significant IncreaseResearch and development expenses surged 76% year over year to around $395 million. The increase reflected higher costs associated with clinical studies and manufacturing for the company’s pipeline candidates, along with increased employee-related expenses.
General and administrative expenses increased nearly 172% to more than $110 million. The increase was caused by higher personnel and stock-based compensation costs, increased commercial preparation activities and elevated administrative expenses.
2026 Expense Outlook Moves Higher AgainThe company revised its operating expenses guidance for the second time this year. It expects the figure to be between $2.1 billion and $2.2 billion, up from the previous projection of $1.7 billion to $1.8 billion.
The updated forecast includes expected non-cash stock-based compensation expenses of $270 million to $290 million compared with the prior estimate of $260 million to $280 million.
Management intends to increase spending on commercial and clinical manufacturing, expand the company’s development programs and strengthen launch readiness in the United States and international markets.
Improved Cash PositionThe company ended June with cash, cash equivalents and marketable securities of $3.9 billion, up from $1.9 billion as of March 31, 2026.
The increase was primarily driven by $2.225 billion in gross proceeds from concurrent offerings of common stock and convertible senior notes completed in April 2026. The quarter-end balance also included a $250 million payment received from Royalty Pharma in May.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a downward trend in estimates revision.
The consensus estimate has shifted -19.12% due to these changes.
VGM ScoresAt this time, Revolution Medicines has a poor Growth Score of F, however its Momentum Score is doing a bit better with a D. Charting a somewhat similar path, the stock was allocated a score of F on the value side, putting it in the bottom 20% quintile for value investors.
Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, Revolution Medicines has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry PlayerRevolution Medicines is part of the Zacks Medical - Biomedical and Genetics industry. Over the past month, Agios Pharmaceuticals (AGIO - Free Report) , a stock from the same industry, has gained 3.7%. The company reported its results for the quarter ended June 2026 more than a month ago.
Agios Pharmaceuticals reported revenues of $44.74 million in the last reported quarter, representing a year-over-year change of +259.4%. EPS of -$1.69 for the same period compares with -$1.93 a year ago.
Agios Pharmaceuticals is expected to post a loss of $1.32 per share for the current quarter, representing a year-over-year change of +25.8%. Over the last 30 days, the Zacks Consensus Estimate has changed +10.4%.
The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for Agios Pharmaceuticals. Also, the stock has a VGM Score of F.
FDA schválila RASONQUE od Revolution Medicines pro metastatický pankreatický adenokarcinom. Akcie po oznámení téměř nereagovaly, protože dobré zprávy byly už započtené v ceně.
Revolution Medicines NASDAQ: RVMD just landed one of the biggest wins in oncology this year, and the stock barely blinked. On Aug. 26, the FDA approved RASONQUE (daraxonrasib), the first broad RAS-targeted therapy for metastatic pancreatic cancer.
Revolution Medicines Today
RVMD
Revolution Medicines
$208.45 -2.42 (-1.15%)
As of 01:21 PM Eastern
This is a fair market value price provided by Massive. Learn more.
$39.17▼
$224.31$200.74
In the pivotal RASolute 302 trial, patients on RASONQUE nearly doubled their median overall survival compared to standard chemotherapy.
Get Revolution Medicines alerts:
This is a genuinely rare outcome in a disease that has resisted targeted therapy for decades.
By any normal standard, that's the kind of headline that sends a biotech stock soaring. Instead, RVMD shares traded roughly flat on the day of approval. The reason is simple: investors had already bought the rumor.
RASolute 302's data was presented at oncology conferences months earlier, and the stock rallied 41% in a single day.
That gap between medical significance and market reaction is the real story here. It's also a lesson in how markets price information, not just outcomes.
The Science Is the Easy Part to BelieveRAS mutations drive more than 90% of pancreatic cancer cases, and for decades, RAS was considered "undruggable." Revolution Medicines built its entire platform around cracking that problem with its RAS(ON) tri-complex inhibitor technology, which binds the active, "on" state of the RAS protein rather than the inactive state that most earlier compounds targeted.
RASONQUE's approved label reflects just how far that platform has come. The drug is cleared for adults with metastatic pancreatic adenocarcinoma who've had at least one prior therapy, with or without an identified RAS mutation, and without requiring a companion diagnostic test.
That's a notably broad population for a targeted therapy. It's also a meaningful part of why oncologists are calling this a paradigm shift rather than an incremental improvement.
Priced in, Then Priced... Where, Exactly?Here's where the RVMD story gets more interesting than a simple "sell the news" narrative. Looking at the daily chart, RVMD isn't crashing; it's consolidating near all-time highs after an extraordinary run.
Shares recently traded around $210; down about 2% since the Aug. 26 announcement, but that's a rounding error against a stock that's up over 425% over the past 12 months and still trading near its 52-week high of $224.31. The 50-day moving average continues sloping upward, and MACD remains in bullish territory. It's what's known as a beautiful chart.
Analyst behavior tells a similar story. Since the approval, the Revolution Medicines analyst forecasts on MarketBeat show multiple firms have raised price targets, with Evercore having the most bullish target of $320. That kind of response shows that analysts had already modeled approval into estimates and are now recalibrating around what comes next: first-line expansion, additional tumor types, and peak sales assumptions.
The Competitive Picture Favors RVMD—For NowEli Lilly NYSE: LLY is often cited as RVMD's biggest threat in the RAS space, and it's a legitimate long-term competitor. But the comparison requires some precision. Lilly's lead RAS asset, olomorasib, is still in Phase 3 trials and targets only KRAS G12C-mutated tumors — a single mutation subtype. It isn't yet approved for pancreatic cancer at all.
RASONQUE, by contrast, launched with an approved label covering the broader RAS-mutant population, no diagnostic test required. Lilly does have earlier-stage G12D and pan-KRAS programs in development, along with rivals like Amgen NASDAQ: AMGN, Roche OTCMKTS: RHHBY, Merck NYSE: MRK, and Boehringer Ingelheim, all advancing their own RAS-pathway candidates.
The competitive field is real and will intensify. Today, though, Revolution Medicines holds the only broadly approved RAS-targeted therapy in pancreatic cancer, and that head start matters for capturing first-mover share in prescribing patterns.
The Bill for Building a Commercial BiotechThe one note of caution sits in the financials, not the clinical data. Revolution Medicines raised its 2026 GAAP operating expense guidance to a range of $2.1 billion to $2.2 billion as it scales manufacturing, clinical development, and commercial infrastructure simultaneously. Second-quarter net loss widened sharply to $644 million, up from $248 million a year earlier.
That's the cost of transitioning from a clinical-stage biotech to a commercial oncology company in real time. Furthermore, that kind of spending is not unusual for a first launch of this scale.
But it's worth noting that RASONQUE is currently doing the heavy lifting alone. The company's broader pipeline—additional RAS(ON) candidates across lung and colorectal cancer—is expanding, but nothing else appears close to its own approval in the near term. Investors betting on RVMD from here are effectively betting on one drug's commercial execution and label expansion, not a diversified product portfolio.
What Actually Moves This Stock From HereWith approval priced in and the "will it work" question answered, the next re-rating catalysts are execution-based rather than binary: first-line treatment expansion, additional trial readouts in lung and colorectal cancer, insurance reimbursement uptake at RASONQUE's $39,800 monthly list price, and evidence that the company can control spend as it scales commercially.
The medicine itself is a legitimate breakthrough for a disease for which patients have received almost nothing for decades. The stock's next move depends on something less dramatic: whether Revolution Medicines can turn a scientific win into a commercial one before cash burn outruns the launch.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Should You Invest $1,000 in Revolution Medicines Right Now?Before you consider Revolution Medicines, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Revolution Medicines wasn't on the list.
While Revolution Medicines currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Amdocs za poslední měsíc přidal zhruba 7 % po výsledcích, které splnily očekávání: EPS 1,84 USD a tržby 1,175 miliardy USD. Firma zároveň potvrdila výhled na fiskální rok 2026.
It has been about a month since the last earnings report for Amdocs (DOX - Free Report) . Shares have added about 7% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Amdocs due for a pullback? Well, first let's take a quick look at the most recent earnings report in order to get a better handle on the recent catalysts for Amdocs Limited before we dive into how investors and analysts have reacted as of late.
Amdocs Q3 Earnings Match Expectations, Revenues Rise Y/YAmdocs reported third-quarter fiscal 2026 non-GAAP earnings of $1.84 per share, which increased 7% on a year-over-year basis. The figure matched the Zacks Consensus Estimate.
Amdocs’ fiscal third-quarter revenues of $1.175 billion missed the consensus mark by 0.04%. The top line increased 2.7% on a reported basis and 2.2% on a constant-currency basis.
DOX's Managed Services Business Sets a RecordManaged services delivered record revenues and accounted for 67% of total revenues. Managed services revenues rose 2.5% year over year to a record $791 million. The business continued to provide revenue visibility through multiyear agreements and consistently high renewal rates.
Amdocs expanded its managed services relationships during the quarter. The company signed an agreement with a U.S. digital television entertainment provider for a billing migration program and extended its collaboration with Telefonica Vivo to support customer growth and OSS modernization.
The company ended the third quarter of fiscal 2026 with a 12-month backlog of $4.26 billion, up 2.7% year over year. Our model estimates for managed services revenues and backlog were pegged at $769.5 million and $4.29 billion, respectively.
Amdocs’ Q3 in DetailDOX reported growth in revenues across North America, Europe and the Rest of the World (RoW). North America reported revenues of $748.1 million (63.7% of the total revenues), which increased 0.4% year over year. Europe revenues (16.5% of the total revenues) of $193.5 million increased 2.2% year over year.
RoW revenues (19.9% of the total revenues) increased 11.3% year over year to $233.3 million. Our model estimates for North America, Europe and RoW were pinned at $765.9 million, $197.2 million and $212.8 million, respectively.
Non-GAAP operating income increased to $253.4 million from $244.7 million in the year-ago quarter. The non-GAAP operating margin expanded 20 basis points year over year and 10 basis points sequentially to 21.6%.
DOX’s Balance Sheet & Cash FlowAmdocs had cash and cash equivalents of $206.5 million as of June 30, 2026, compared with $214.5 million as of March 31, 2026. Long-term debt was $647.4 million as of June 30, 2026, increasing marginally from the March 31, 2026, level of $647.2 million.
In the fiscal third quarter, the company generated an operating cash flow of $197.2 million and a free cash flow of $171.9 million. During the quarter, it repurchased shares worth $143 million and paid out $60 million in dividends.
DOX Reiterates Key Fiscal 2026 TargetsFor the fourth quarter of fiscal 2026, Amdocs expects revenues between $1.175 billion and $1.215 billion. Amdocs’ Non-GAAP diluted earnings are projected in the range of $1.94-$2 per share.
For fiscal 2026, reported revenue growth is now expected between 3.2% and 4% compared with the previous range of 2.6-4.6%. Constant-currency growth is projected between 2.6% and 3.4%, retaining the prior 3% midpoint.
Non-GAAP earnings growth is expected between 5.5% and 6.5%, with the 6% midpoint unchanged. The company maintained its non-GAAP operating margin forecast of 21.3-21.9% and free cash flow outlook of $710-$730 million.
How Have Estimates Been Moving Since Then?It turns out, estimates review flatlined during the past month.
VGM ScoresAt this time, Amdocs has a average Growth Score of C, though it is lagging a bit on the Momentum Score front with a D. However, the stock has a grade of A on the value side, putting it in the top quintile for value investors.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook Amdocs has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry PlayerAmdocs is part of the Zacks Computers - IT Services industry. Over the past month, Cognizant (CTSH - Free Report) , a stock from the same industry, has gained 13.6%. The company reported its results for the quarter ended June 2026 more than a month ago.
Cognizant reported revenues of $5.48 billion in the last reported quarter, representing a year-over-year change of +4.5%. EPS of $1.37 for the same period compares with $1.31 a year ago.
Cognizant is expected to post earnings of $1.44 per share for the current quarter, representing a year-over-year change of +3.6%. Over the last 30 days, the Zacks Consensus Estimate remained unchanged.
Cognizant has a Zacks Rank #3 (Hold) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of A.
Cencora spustila CGT Enablement, aby zdravotnickým systémům pomohla budovat a škálovat programy buněčné a genové terapie. Služba cílí na finanční, provozní i lékárenské překážky.
Key Takeaways Cencora launched CGT Enablement to help health systems build and scale cell and gene therapy programs.COR targets financial, operational and pharmacy challenges tied to integrating complex CGT treatments.Cencora has completed 170 CGT consulting projects and supported 35 FDA-approved cell and gene therapies. Cencora (COR - Free Report) recently launched Cell and Gene Therapy (CGT) Enablement through its Accelerate Pharmacy Solutions business, offering support to health systems to evaluate, build and scale CGT programs. The new service is designed to improve operational readiness, financial confidence and program scalability while helping reduce barriers to care and expand patient access to advanced therapies.
Per management, cell and gene therapies have the potential to transform care for patients with serious and complex diseases, but delivering these therapies requires close coordination across strategy, finance, clinical operations, pharmacy and patient access. The company is building on its existing capabilities to provide health systems with tailored support, including market landscape and readiness assessments, governance design, implementation and optimization, to help them launch or expand their CGT programs.
Likely Trend of COR Stock Following the NewsShares of COR have inched up 0.3% since the announcement on Wednesday. Year to date, shares of the company have lost 0.2% against the industry’s 3.9% growth. The S&P 500 increased 12.5% in the same time frame.
The launch is likely to support Cencora’s long-term growth prospects by expanding its CGT capabilities and strengthening its relationships with health systems. As the number of approved therapies and clinical trials increases, health systems may require greater financial, operational and pharmacy support to integrate these complex treatments. Cencora’s new offering positions the company to capture the growing demand while complementing its existing CGT commercialization, specialty distribution and provider solutions.
COR currently has a market capitalization of $64.19 billion.
Image Source: Zacks Investment Research
More on the NewsCencora’s new CGT Enablement service comes as health systems face growing challenges in preparing for the increasing adoption of cell and gene therapies. More than 35 CGTs have been approved by the FDA so far, while more than 1,700 clinical trials are underway globally. However, only 4% of health system pharmacy leaders surveyed in a recent report said their organizations were fully prepared to integrate these therapies, highlighting significant gaps in infrastructure, resource allocation and operational alignment.
Cencora’s CGT Enablement team will support health systems across three areas. Financial confidence services will provide insights into the CGT market, therapy-specific financial considerations, reimbursement dynamics and site-of-care factors. Operational readiness support will include readiness assessments, gap analysis, strategic roadmaps, governance design and workflow planning. Scalable growth services will help establish repeatable operating models that support coordinated execution across pharmacy, finance, clinical operations, strategy and patient access teams.
The offering builds on Cencora’s broader CGT expertise across the product lifecycle, including commercialization support, specialty distribution and provider solutions. Cencora has completed 170 upstream CGT consulting projects, delivered more than 29,000 CGT shipments annually and supported 35 FDA-approved CGTs. By combining these capabilities with Accelerate Pharmacy Solutions’ pharmacy and supply chain expertise, the company aims to help health systems expand CGT programs across therapies, sites and indications.
Industry Prospects Favoring the MarketGoing by the data provided by Fortune Business Insights, the global cell and gene therapy market is valued at $16.45 billion in 2026 and is expected to witness a CAGR of 31.1% through 2034.
Factors like the increasing prevalence of rare diseases and cancers, growing number of approved therapies, expanding clinical trial pipelines, rising demand for advanced treatments and increasing focus on operational readiness and patient access are supporting the market’s growth.
Other NewsCencora recently delivered mixed fiscal third-quarter 2026 results, with earnings beating estimates while revenues fell short. Performance was supported by specialty pharmaceutical volumes, GLP-1 demand and growth in international healthcare solutions. OneOncology boosted U.S. Healthcare Solutions, while Profarma and MWI Animal Health added to growth. The company raised its fiscal 2026 adjusted earnings outlook. However, lower-margin GLP-1 sales, higher OneOncology expenses and increased interest costs remain profitability headwinds.
In June, Cencora launched the next-generation Nucleus inventory management solution and initiated a multi-site pilot across more than 20 specialty physician practice locations. The enhanced platform is designed to help providers manage increasingly complex medication workflows with greater efficiency, visibility and control.
Some better-ranked stocks from the broader medical space are Globus Medical (GMED - Free Report) , Veracyte (VCYT - Free Report) and West Pharmaceutical (WST - Free Report) .
Globus Medical, currently sporting a Zacks Rank #1 (Strong Buy), reported a second-quarter 2026 adjusted earnings per share (EPS) of $1.34, which surpassed the Zacks Consensus Estimate by 19.6%. Revenues of $789.6 million beat the Zacks Consensus Estimate by 0.4%. You can see the complete list of today’s Zacks #1 Rank stocks here.
GMED has an estimated long-term earnings growth rate of 12.4%. The company’s earnings beat estimates in each of the trailing four quarters, the average surprise being 27.9%.
Veracyte, currently flaunting a Zacks Rank #1, reported a second-quarter 2026 adjusted EPS of 54 cents, which surpassed the Zacks Consensus Estimate by 25.6%. Revenues of $150.3 million beat the Zacks Consensus Estimate by 4.1%.
VCYT has an estimated earnings growth rate of 8.4% for 2026. The company’s earnings beat estimates in each of the trailing four quarters, the average surprise being 41.8%.
West Pharmaceutical, carrying a Zacks Rank #2 (Buy) at present, reported second-quarter 2026 adjusted EPS of $2.37, which beat the Zacks Consensus Estimate by 13.9%. Revenues of $872.3 million surpassed the Zacks Consensus Estimate by 4.2%.
WST has an estimated long-term earnings growth rate of 16%. WST’s earnings surpassed estimates in the trailing four quarters, the average surprise being 17.4%.
Helmerich & Payne za měsíc od poslední výsledkové zprávy přidala asi 21,5 % a překonala index S&P 500. Tržby za 3. čtvrtletí dosáhly 1 mld. USD, ale upravená ztráta činila 11 centů na akcii.
It has been about a month since the last earnings report for Helmerich & Payne (HP - Free Report) . Shares have added about 21.5% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Helmerich & Payne due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.
Helmerich & Payne Q3 Earnings Miss Estimates, Revenues BeatHelmerich & Payne reported a third-quarter fiscal 2026 adjusted net loss of 11 cents per share, in sharp contrast with the Zacks Consensus Estimate of adjusted net income of 11 cents. Moreover, the bottom line decreased considerably from the year-ago quarter’s reported profit of 22 cents. This was primarily due to an adjustment made for a gain of $115 million related to the sale of Utica Square and lower-than-expected performance of the company's North America Solutions segment.
Operating revenues of $1 billion beat the Zacks Consensus Estimate of $988 million. Sales from Drilling Services beat the consensus mark by 4.4%. However, the figure decreased by $6 million from the year-ago quarter’s level. This was primarily caused by lower year-over-year revenues from the North America Solutions and International Solutions segments.
The company distributed approximately $25 million to its shareholders as part of its ongoing dividend program.
Q3 Segmental PerformanceNorth America Solutions: Operating revenues of $562.9 million were down 5% year over year, with 142 average active rigs. The top line beat our model projection of $546.1 million.
Operating profit totaled $140.3 million compared with $157.6 million in the prior-year period. The reported figure also beat our model estimate of $113.1 million.
International Solutions: Operating revenues of $250.1 million decreased 5.9% from the year-ago quarter’s level of $265.8 million. However, the top line beat our projection of $234.9 million.
Operating loss reached $54.4 million, compared with the prior-year period loss of $166.5 million. The figure was below our projected loss of $93 million.
Offshore Solutions: Revenues of $174.4 million increased 7.8% from the year-ago quarter’s level of $161.8 million. The top line beat our projection of $157.5 million.
Operating profit totaled $16.8 million compared with $8.8 million in the year-ago quarter. The figure beat our estimate of $11 million.
Financial PositionAs of June 30, 2026, the company spent $200.2 million on capital programs. HP had $204.4 million in cash and cash equivalents, while the long-term debt totaled $1.9 billion (debt-to-capitalization of 41%).
Guidance for Q4 & FY26Helmerich & Payne’s fourth-quarter fiscal 2026 outlook points to continued strength in North America, more variable international performance and stable offshore operations. For North America Solutions, the company expects direct margin of $245 million to $255 million, with an average of 145 to 151 active rigs, compared with a fiscal-year average rig range of 140 to 144. International Solutions is expected to generate direct margin of $25 million to $45 million on 60 to 70 average rigs, compared with a fiscal-year average rig range of 60 to 66. Offshore Solutions is projected to deliver direct margin of $26 million to $30 million in the fiscal fourth quarter, while full-year direct margin is expected at $113 million to $117 million, supported by 30 to 35 average rigs/management contracts. The “Other” segment is expected to contribute up to $5 million of direct margin.
For the full fiscal 2026, HP expects gross capital expenditures of $270 million to $310 million, depreciation of approximately $700 million, research and development expense of about $28 million, Selling, general & administrative expenses of $265 million to $285 million, cash taxes of $150 million to $180 million, and interest expense of roughly $100 million. Overall, the outlook implies a relatively constructive finish to fiscal 2026, led by higher North American activity and margins.
How Have Estimates Been Moving Since Then?It turns out, estimates revision have trended upward during the past month.
VGM ScoresCurrently, Helmerich & Payne has a average Growth Score of C, though it is lagging a bit on the Momentum Score front with a D. Charting a somewhat similar path, the stock was allocated a score of C on the value side, putting it in the middle 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending upward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, Helmerich & Payne has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry PlayerHelmerich & Payne belongs to the Zacks Oil and Gas - Drilling industry. Another stock from the same industry, Nabors Industries (NBR - Free Report) , has gained 11.9% over the past month. More than a month has passed since the company reported results for the quarter ended June 2026.
Nabors reported revenues of $814.79 million in the last reported quarter, representing a year-over-year change of -2.2%. EPS of -$2.04 for the same period compares with -$2.71 a year ago.
For the current quarter, Nabors is expected to post a loss of $0.40 per share, indicating a change of +89.1% from the year-ago quarter. The Zacks Consensus Estimate has changed -364.7% over the last 30 days.
Nabors has a Zacks Rank #3 (Hold) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of A.
Choice Hotels po poslední výsledkové zprávě klesly asi o 9,4 % za měsíc, i když ve druhém čtvrtletí překonaly odhady zisku i tržeb. Firma zároveň zvýšila celoroční výhled upravené EBITDA na 635–650 mil. USD.
It has been about a month since the last earnings report for Choice Hotels (CHH - Free Report) . Shares have lost about 9.4% in that time frame, underperforming the S&P 500.
But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is Choice Hotels due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.
CHH Q2 Earnings Beat Estimates as RevPAR and Fees RiseChoice Hotels reported second-quarter 2026 results, with adjusted earnings and revenues beating the Zacks Consensus Estimate and increasing year over year. Adjusted earnings of $2.02 per share beat the consensus estimate of $1.97 by 2.5% and rose 5% year over year. Revenues of $440.76 million surpassed the $431 million consensus mark by 2.3% and increased 3.4% year over year.
Performance benefited from higher U.S. royalties, franchisee programs and services revenues, and partnership revenues. U.S. RevPAR increased 1.3%, while global net rooms grew 2.6%, reflecting improving domestic development trends and continued international growth.
Adjusted EBITDA increased 6% year over year to $175 million. Management attributed the gain primarily to higher U.S. royalties from improving RevPAR and royalty-rate expansion, growth in franchisee programs and services revenues, higher partnership revenues and the continued benefit of the transition to direct franchising in Canada.
Revenues excluding reimbursable revenues from franchised and managed properties increased 7% year over year to $277 million. Choice Hotels reported net income of $64.34 million in the quarter, down 21.3% from $81.73 million a year ago.
Choice Hotels' Cost Profile Pressures Operating ResultsOperating income declined 16.4% year over year to $104.14 million from $124.60 million. Total operating expenses increased 11.5% to $336.62 million, reflecting higher selling, general and administrative expenses, reimbursable expenses and depreciation and amortization.
Selling, general and administrative expenses rose 7.7% to $96.15 million. The increase reflected higher provisions for accounts-receivable credit losses, restructuring and executive severance costs, and expenses related to operating Choice Hotels Canada. Reimbursable expenses from franchised and managed properties totaled $197.67 million versus related reimbursable revenues of $163.32 million.
CHH’s Fee-Led Model Helps Lift RevenuesFranchise and management fees increased 5.9% year over year to $187.54 million, supported by higher international royalty fees, franchise programs and services revenues, and U.S. royalty fees. Partnership services and fees advanced 5.9% to $28.67 million, mainly on higher procurement revenues.
Owned-hotel revenues increased 15.4% to $34.90 million, while other revenues rose 6.5% to $26.33 million. The U.S. average royalty rate expanded 11 basis points. Choice Privileges membership increased 7% to 77 million, while loyalty contribution improved by more than 250 basis points during the quarter.
Choice Hotels' Rooms Growth Improves on ConversionsU.S. gross room openings increased 27% year over year to 6,464 rooms, while exits declined 50% to 5,119 rooms. This resulted in 1,345 net room additions. Management said U.S. net rooms growth improved sequentially for the second consecutive quarter.
U.S. franchise agreements awarded increased 30% year over year, while conversion franchise agreements rose 82%. The U.S. conversion pipeline increased 24% from the prior-year period and 6% sequentially. Conversions are expected to represent approximately 90% of U.S. openings in 2026, while extended stay represents more than 40% of the U.S. pipeline.
CHH’s Cash Flow and Capital Returns Stay ActiveOperating cash flow totaled $67.36 million during the first six months of 2026, down from $116.07 million in the year-ago period. Management attributed the decline primarily to higher franchise agreement acquisition costs as room openings increased and higher marketing and reservation-system reimbursable expenses.
CHH ended the quarter with $42.83 million in cash and cash equivalents and $2 billion of long-term debt. Total liquidity stood at $475 million, while net leverage was 3.1 times adjusted EBITDA. The company returned $139 million to its shareholders through dividends and share repurchases during the first half, while net development outlays declined 80% year over year to $15.1 million.
Choice Hotels Raises 2026 Operating OutlookChoice Hotels raised its full-year 2026 adjusted EBITDA outlook to $635-$650 million from $632-$647 million. U.S. RevPAR growth is now expected at 0-1.25%, global RevPAR growth at 0-1%, U.S. average royalty-rate expansion at 7-9 basis points and global net rooms growth at approximately 1.5%.
Adjusted EPS guidance was updated to $6.86-$7.10 from $6.92-$7.14, primarily reflecting higher expected interest expense and a higher effective tax rate, partly offset by share repurchases. Management continues to expect positive U.S. net rooms growth for 2026 and share repurchases of $175-$225 million.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a downward trend in estimates revision.
The consensus estimate has shifted -5.89% due to these changes.
VGM ScoresAt this time, Choice Hotels has a poor Growth Score of F, a grade with the same score on the momentum front. However, the stock was allocated a grade of C on the value side, putting it in the middle 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Interestingly, Choice Hotels has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
A month has gone by since the last earnings report for Duolingo, Inc. (DUOL - Free Report) . Shares have added about 29.6% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Duolingo due for a pullback? Well, first let's take a quick look at the latest earnings report in order to get a better handle on the recent drivers for Duolingo, Inc. before we dive into how investors and analysts have reacted as of late.
Reported earnings of 66 cents per share beat the Zacks Consensus Estimate of 61 cents by 8.2%. Earnings declined from 91 cents in the year-ago quarter as the company continued investing in product development and user growth.
Revenues increased 18.3% year over year to $298.5 million and topped the consensus estimate of $297.3 million by 0.4%. Daily active users grew 23% to 58.7 million, accelerating from the first quarter, while paid subscribers increased 17% to 12.7 million.
DUOL Gains From Expanding User EngagementMonthly active users rose 10% year over year to 140.6 million. Management attributed the stronger daily active user growth to product improvements, marketing efforts and a one-time Streak Revival campaign conducted in June.
Current User Retention Rate, which measures the proportion of recurring users returning the following day, reached an all-time high of 84%. The metric improved roughly one percentage point from the prior year, reflecting the combined impact of hundreds of product experiments conducted through Duolingo’s Green Machine testing process.
The Streak Revival campaign allowed eligible learners to restore their longest previous streak by completing three lessons. About 15.4 million learners participated, including nearly 8 million who did not have an active streak when the campaign began.
Duolingo’s Subscription Revenues Drive GrowthSubscription revenues increased 22% year over year to $258 million and accounted for the bulk of the company’s top-line expansion. Subscription bookings advanced 10% to $250.3 million.
Total bookings rose 8% to $289.1 million, or 6% on a constant-currency basis. Growth moderated from the first quarter due to a difficult year-ago comparison related to the initial Energy rollout, a price increase and stronger advertising performance.
Advertising revenues grew 2% to $21.1 million, while Duolingo English Test revenues remained nearly flat at $10.1 million. In-app purchase revenues declined 23% to $8 million. Other revenues increased to $1.3 million from $0.5 million.
DUOL Balances Monetization With User GrowthThe company continued testing monetization initiatives designed to avoid adding friction for free users. Longer free trials have increased trial participation and payer conversions while improving the user experience by removing advertisements and Energy restrictions during the trial period.
Duolingo is also testing Super Lite, a lower-priced, advertising-supported subscription tier that provides more Energy than the free product but fewer benefits than Super. The offering remains in an early testing phase and represents only a small portion of subscribers.
Most new Super Duolingo subscribers now have access to Video Call, the company’s AI-powered conversational practice feature. Management plans to extend access to existing Super subscribers later in 2026 after reducing the cost per call to less than 1 cent through greater use of open-source models.
Duolingo’s Costs Rise on Strategic InvestmentsGross profit increased 19% year over year to $216.7 million. Gross margin expanded 20 basis points to 72.6%, exceeding management’s expectation of approximately 71%, supported by AI cost efficiencies and the measured rollout of AI-powered features.
Operating expenses increased to $182.8 million from $149.2 million. Research and development expenses rose to $92.2 million, sales and marketing expenses increased to $40 million, and general and administrative expenses advanced to $50.6 million.
Net income declined 26% to $33.2 million, while net margin contracted to 11.1% from 17.8%. Adjusted EBITDA decreased 2% to $77.3 million, and the corresponding margin narrowed 530 basis points to 25.9% as Duolingo prioritized investments in user acquisition and product improvements.
DUOL Maintains Strong Liquidity and BuybacksNet cash provided by operating activities declined 3% year over year to $88.3 million. Free cash flow decreased 9% to $78.6 million, while free cash flow margin contracted 790 basis points to 26.3%.
Duolingo ended the quarter with approximately $1.3 billion in cash and short-term investments. The company repurchased $44.4 million of shares during the quarter, bringing total repurchases under its $400 million authorization to $71.9 million through Aug. 1, 2026.
Duolingo Raises Profitability OutlookFor the third quarter of 2026, management expects revenues of approximately $302 million, indicating 11.1% year-over-year growth. Bookings are projected at $307 million, while adjusted EBITDA is forecast at $76 million, implying a 25.2% margin.
Duolingo maintained its full-year revenue and bookings targets. Revenues are expected to reach approximately $1.21 billion, up 16.3%. Bookings are projected at $1.29 billion, indicating growth of 10.9%.
The company raised its full-year adjusted EBITDA margin outlook to approximately 26.5% from its earlier expectation of about 25%. Adjusted EBITDA is projected at $320 million, reflecting stronger-than-expected gross margin performance and lower AI costs.
How Have Estimates Been Moving Since Then?It turns out, estimates review have trended downward during the past month.
VGM ScoresAt this time, Duolingo has a subpar Growth Score of D, though it is lagging a bit on the Momentum Score front with an F. Charting a somewhat similar path, the stock was allocated a grade of D on the value side, putting it in the bottom 40% for value investors.
Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Interestingly, Duolingo has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Green Thumb Industries (GTBIF -0.27%) had a rough second quarter. Comparable-store sales for the cannabis purveyer fell 1.1% from a year earlier, while gross margin dropped sharply to 45% from 49.9%.
Earnings before interest, taxes, depreciation, and amortization (EBITDA) also fell to $53.1 million from $69.1 million, as pricing pressure and increased competition continued to weigh on several of Green Thumb's key markets.
Revenue did increase 4.6% to $306.7 million, so the quarter wasn't a complete disaster. But declining comparable sales and shrinking margins aren't exactly what you want to see from one of the largest cannabis companies in the country.
Still, there's reason for optimism. Here's why.
The numbers aren't as bad as they look In Q2, Green Thumb's retail revenue increased 3.6%, while consumer packaged goods gross revenue increased 3.7%. Growth in Minnesota, Connecticut, Florida, Ohio, and New Jersey helped offset price compression and increased competition elsewhere. The bigger weakness showed up in margins.
Today's Change
(
-0.27
%) $
-0.02
Current Price
$
7.46
Gross profit declined to $137.9 million from $146.3 million, while gross margin fell nearly five percentage points. Still, normalized EBITDA reached $84.3 million, up from $82.7 million a year earlier. Green Thumb also produced $29 million in operating cash flow and reported generally accepted accounting principles (GAAP) net income of $4.9 million.
The company finished June with $283.6 million in cash against $283 million in total debt. And during the quarter, management repurchased approximately 7.9 million shares for $48.3 million, at an average price of $6.11. Since beginning its repurchases, Green Thumb has bought back roughly 29.5 million shares for $203.4 million. That's not the balance sheet of a cannabis company fighting for survival.
Virginia could provide the next growth spurt Virginia approved recreational cannabis sales beginning July 1, 2027, with up to 350 retail licenses eventually permitted. Green Thumb already operates in Virginia's medical market, where it holds one of five vertically integrated licenses. It has six dispensaries and cultivation and processing infrastructure already in place.
Management has already expanded capacity in anticipation of adult-use legalization and is evaluating additional investment ahead of next year's launch. To be sure, Virginia won't transform Green Thumb overnight. But it could provide a meaningful new source of revenue at a time when mature cannabis markets are struggling with price compression.
Image source: Getty Images.
And then there's Texas Green Thumb recently received a conditional dispensing organization license under the state's expanding Compassionate Use Program. Texas isn't legalizing recreational cannabis, but expanded medical access allows Green Thumb to establish itself in one of America's largest states before the market potentially opens further.
Texas and Virginia combined represent roughly 12% of the U.S. population. And Green Thumb doesn't need either market to become another California for the opportunity to matter. It simply needs incremental growth while its existing operations continue generating cash.
The setup is getting better The federal government rescheduled marijuana on April 28, ending the application of Section 280E to portions of Green Thumb's business. That provision had prevented cannabis businesses from deducting many ordinary operating expenses, creating an unusually heavy tax burden.
Now combine potential tax relief with moves in Virginia and Texas, continued share repurchases, and a balance sheet carrying nearly as much cash as debt, and Green Thumb starts looking considerably more interesting in the coming years.
Cirrus Logic v 1. fiskálním čtvrtletí 2027 zvýšil upravený zisk na akcii na 1,84 USD a tržby na 460 milionů USD, ale snížil výhled tržeb v PC segmentu.
A month has gone by since the last earnings report for Cirrus Logic (CRUS - Free Report) . Shares have lost about 8.4% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Cirrus Logic due for a breakout? Well, first let's take a quick look at the latest earnings report in order to get a better handle on the recent catalysts for Cirrus Logic, Inc. before we dive into how investors and analysts have reacted as of late.
Cirrus Logic Q1 Earnings Beat Estimates
Cirrus Logic reported first-quarter fiscal 2027 adjusted earnings of $1.84 per share, up 21.9% year over year and above the Zacks Consensus Estimate of $1.45. Strong demand for custom smartphone components supported the record first-quarter results.
Revenue increased 12.9% to $460 million, aligning with the consensus estimate. The strong results were primarily driven by robust shipments of custom components used in premium smartphones, showing that demand from major mobile customers remains healthy despite a competitive consumer electronics market. Quarterly revenues grew 2% sequentially as higher sales of components shipped into smartphones boosted results. Year over year, the gains from increased smartphone component demand were partly offset by previously expected pricing reductions.
Demand continued to be strong for custom boosted amplifiers and smart codecs. Cirrus anticipates these products will ship across multiple future smartphone generations. Development of the next-generation camera controller and a smart power IC for 3D sensing also remained on schedule.
The company’s largest customer accounted for 90% of total revenues in the fiscal first quarter.
Cirrus Logic's HPMS Sales Gain MomentumHigh-Performance Mixed-Signal revenues climbed to $210.7 million from $167.2 million a year earlier and represented 46% of net sales.
Audio revenues increased 3.7% to $249 million and represented 54% of quarterly sales.
Management described the opportunity pipeline across camera, battery and power applications as one of the strongest in the company's history. A power product is already shipping in tablets, while another product for an accessory has yet to reach the market. Additional phone and non-phone programs remain in active development.
Margins Absorb Pricing PressureNon-GAAP gross profit was $242.1 million, with gross margin edging up to 52.7% from 52.6% a year ago. Favorable product mix supported the year-over-year comparison, while higher freight and supply-chain costs limited the improvement. Sequentially, pricing reductions outweighed cost savings.
Non-GAAP operating expenses rose 13.3% year over year to $135.4 million. Higher employee-related costs were the main driver, with variable compensation, product development and professional expenses also contributing.
Non-GAAP operating income reached $106.7 million, while operating margin slipped to 23.2% from 23.3%.
Cirrus Logic's PC Outlook Faces DelaysCirrus lowered its fiscal 2027 PC revenue expectations. Constrained supply of a key industry platform, memory and component shortages and delayed model introductions pushed out expected growth. Management characterized these pressures as timing issues rather than a change in the underlying opportunity.
Customer interest remained strong for the company's low-power smart codec for AI-enabled PCs, with multiple designs targeted for next calendar year. Several customers also announced PCs based on NVIDIA's RTX Spark platform that are expected to ship later this year with Cirrus amplifiers and codecs.
Cirrus Extends Its Mixed-Signal ReachThe company taped out a new high-performance analog front-end family for smart meters and expects to begin sampling during the September quarter. The products combine higher-accuracy voltage and current measurement with on-chip processing for power-quality analysis and fault detection.
Cirrus is targeting a calendar 2028 market launch and sees potential applications in data center DC metrology, energy storage, EV charging and grid monitoring. A new GlobalFoundries agreement secures dedicated wafer capacity and pricing for 2027 and 2028 while supporting progress toward U.S. production.
Cirrus Logic's Cash Position Funds PrioritiesCash and investments totaled $1.2 billion at quarter-end, with no debt outstanding.
Operating cash flow was $64.1 million, and free cash flow totaled $48.6 million, translating into an 11% margin.
It spent $34.5 million to repurchase about 211,000 shares, leaving $239.6 million under its authorization. After quarter-end, it bought roughly 359,000 additional shares for $50.5 million. Management continues to prioritize organic investment, followed by acquisitions and buybacks, and is not considering a near-term dividend.
Guides for a Sequential Revenue IncreaseFor the second quarter of fiscal 2027, Cirrus expects revenues of $510-$570 million. The $540 million midpoint implies growth of 17% sequentially and a decline of 4% year over year.
GAAP gross margin is projected at 52-54%, including a temporary benefit from favorably priced wafers that should largely sell through during the quarter.
Non-GAAP operating expenses are expected at $140-$146 million.
Full-year expenses are expected to increase as Cirrus expands R&D investment, while the non-GAAP tax rate is forecast at 16-18%.
How Have Estimates Been Moving Since Then?It turns out, estimates review have trended downward during the past month.
The consensus estimate has shifted -8.87% due to these changes.
VGM ScoresAt this time, Cirrus Logic has a nice Growth Score of B, though it is lagging a lot on the Momentum Score front with an F. However, the stock was allocated a score of B on the value side, putting it in the second quintile for this investment strategy.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. It's no surprise Cirrus Logic has a Zacks Rank #4 (Sell). We expect a below average return from the stock in the next few months.
Performance of an Industry PlayerCirrus Logic belongs to the Zacks Electronics - Semiconductors industry. Another stock from the same industry, Qualcomm (QCOM - Free Report) , has gained 5.1% over the past month. More than a month has passed since the company reported results for the quarter ended June 2026.
Qualcomm reported revenues of $9.95 billion in the last reported quarter, representing a year-over-year change of -4%. EPS of $2.21 for the same period compares with $2.77 a year ago.
Qualcomm is expected to post earnings of $2.18 per share for the current quarter, representing a year-over-year change of -27.3%. Over the last 30 days, the Zacks Consensus Estimate has changed -2.4%.
The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for Qualcomm. Also, the stock has a VGM Score of F.
BorgWarner za poslední měsíc klesl o 0,1 % po zveřejnění výsledků hospodaření, ale ve 2. čtvrtletí 2026 překonal odhady: upravený EPS činil 1,42 USD a tržby 3,65 miliardy USD.
It has been about a month since the last earnings report for BorgWarner (BWA - Free Report) . Shares have lost about 0.1% in that time frame, underperforming the S&P 500.
But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is BorgWarner due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the latest earnings report in order to get a better handle on the important catalysts.
BWA Tops Q2 Earnings EstimatesBorgWarner reported second-quarter 2026 adjusted earnings of $1.42 per share, which rose 17.4% year over year. The figure beat the Zacks Consensus Estimate of $1.26 by 12.7%. Net sales increased 0.3% to $3.65 billion and surpassed the consensus mark of $3.58 billion by 1.8%.
Strong cost controls supported profitability despite lower industry production and weakness in the Battery Energy Systems business. Adjusted operating margin expanded 100 basis points to 11.3%, while organic sales declined 1.2%.
Gross profit rose to $721 million from $640 million in the year-ago quarter. Gross margin improved to 19.8% from 17.6%, reflecting lower cost of sales and disciplined operating execution. Adjusted operating income increased to $413 million from $373 million.
Segmental PerformanceTurbos & Thermal Technologies sales declined 2.6% year over year to $1.44 billion amid lower industry production. Organic sales fell 4.3%. Segment adjusted operating income slipped to $225 million from $227 million.
Drivetrain & Morse Systems revenues increased 1.8% to $1.5 billion, aided by strong North American transfer-case volumes. Adjusted operating income rose to $277 million from $260 million, supported by higher sales and operating execution.
PowerDrive Systems sales grew 14.5% to $665 million, including organic growth of 11.7%. Its adjusted operating loss narrowed to $29 million from $33 million, driven by higher sales.
Battery Energy Systems revenues plunged 37.1% to $100 million due to weaker European demand and the absence of North American incentives. However, the segment’s adjusted operating loss narrowed to $2 million from $12 million, helped by restructuring actions and savings from the charging-business exit.
New Business PipelineBorgWarner announced seven awards spanning combustion, hybrid and electric-vehicle technologies. These included an eTurbo program for a European automaker, a torque-on-demand transfer case for a Chinese SUV and two variable cam timing programs.
The company also secured an integrated drive module award using its next-generation three-in-one system. Two high-volume inverter program extensions cover plug-in hybrid and 800-volt battery-electric applications. Production for the announced programs is scheduled to begin between late 2026 and 2029.
BorgWarner Advances Industrial ProductsThe company noted progress in data-center and industrial applications. Testing of its turbine generator achieved California Air Resources Board-level emissions standards, while component certification work is expected to begin in September.
BorgWarner continues to target a 2027 launch and had previously outlined roughly $300 million of turbine-generator revenues for that year. Customer interest includes multiple hyperscalers, and management expects to decide during the second half of 2026 whether additional capacity is needed.
BorgWarner is also developing energy-storage systems, microgrid inverters and power-conversion products. Four customers have received inverter samples, and the company is expanding its portfolio from 400 volts to 1,500 volts. It plans to invest an additional $10-$15 million in industrial research and development during the second half.
2026 Earnings View RaisedBWA raised its full-year adjusted earnings guidance to $5.05-$5.30 per share from $5-$5.20. The company maintained its sales outlook of $14-$14.3 billion and adjusted operating margin forecast of 10.7%-10.9%. Organic revenues are expected to decline 1.5%-3.5%, including an anticipated $250 million reduction in Battery Energy Systems sales.
Cash Flow Supports BuybacksSecond-quarter operating cash flow totaled $586 million, while free cash flow was $492 million. For 2026, the company continues to expect operating cash flow of $1.6-$1.7 billion and free cash flow of $900 million-$1.1 billion.
BorgWarner returned about $134 million to shareholders during the quarter through repurchases and dividends. Its board increased the share repurchase authorization by $1 billion, bringing total available authorization to approximately $1.35 billion through 2029. Cash and equivalents were $2.45 billion as of June 30, 2026.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a downward trend in estimates review.
VGM ScoresCurrently, BorgWarner has a nice Growth Score of B, though it is lagging a lot on the Momentum Score front with an F. However, the stock has a grade of A on the value side, putting it in the top 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Interestingly, BorgWarner has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry PlayerBorgWarner is part of the Zacks Automotive - Original Equipment industry. Over the past month, Lear (LEA - Free Report) , a stock from the same industry, has gained 10.1%. The company reported its results for the quarter ended June 2026 more than a month ago.
Lear reported revenues of $6.21 billion in the last reported quarter, representing a year-over-year change of +3%. EPS of $4.28 for the same period compares with $3.47 a year ago.
For the current quarter, Lear is expected to post earnings of $3.28 per share, indicating a change of +17.6% from the year-ago quarter. The Zacks Consensus Estimate has changed -0.7% over the last 30 days.
Lear has a Zacks Rank #3 (Hold) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of A.
A month has gone by since the last earnings report for Owens Corning (OC - Free Report) . Shares have lost about 10.6% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Owens Corning due for a breakout? Well, first let's take a quick look at its latest earnings report in order to get a better handle on the recent catalysts for Owens Corning Inc before we dive into how investors and analysts have reacted as of late.
OC Q2 Earnings Beat Estimates on Strong Commercial ExecutionOwens Corning posted adjusted earnings of $3.93 per share for the second quarter of 2026, down 6.7% year over year but ahead of the Zacks Consensus Estimate of $3.06 by 28.4%. Net sales rose 0.3% to $2.76 billion and beat the $2.67 billion consensus mark by 3.2%.
Results reflected strong commercial execution across Roofing and Insulation, partly offset by inflation and weaker Doors volumes. Roofing sales increased 0.8% year over year, while the business delivered a 34% EBITDA margin.
OC's Profitability Reflects Resilient ExecutionAdjusted EBITDA was $660 million, down 6.1% from $703 million a year ago. The adjusted EBITDA margin contracted to 24% from 26% as inflation weighed on profitability.
Second-quarter EBITDA included $25 million of tariff refunds, about half of which benefited Doors. These refunds partly offset $30 million of net cost inflation tied to the Iran conflict. The company recorded only $3 million of adjusting items during the quarter.
Segmental DiscussionRoofing revenues were $1.31 billion, up 0.8% from $1.30 billion a year earlier. Growth was supported by favorable product mix and solid demand for higher-value products. Shingle and components volumes were slightly ahead of the broader market, while elevated industry restocking supported market shipments.
Roofing EBITDA fell 3.5% to $441 million. Higher inflation, including transportation costs, created negative price-cost pressure amid relatively flat pricing. Management noted solid realization from price increases announced during the quarter.
Insulation revenues increased 4.0% year over year to $971 million, driven mainly by higher volumes and a modest currency benefit. North American residential revenues edged higher, while nonresidential revenues benefited from higher volumes and pockets of strong end-market growth. European operations also posted growth as core markets improved and commercial execution remained strong.
Segment EBITDA declined 5.3% to $213 million because of slightly lower pricing and continued inflation, while the EBITDA margin was 22%.
Doors revenues declined 7.4% to $513 million, mainly because of strategic business exits. The divested distribution business and Oregon components facility reduced second-quarter revenues by a combined $30 million.
Doors EBITDA fell 24.0% to $57 million due to lower volumes and higher transportation costs. The segment's 11% EBITDA margin nevertheless exceeded management's prior guidance, helped by tariff refunds. Owens Corning has achieved $135 million of enterprise run-rate synergies in Doors, above its original $125 million target.
OC Generates Higher Quarterly Free Cash FlowFree cash flow increased 54.3% year over year to $199 million, aided by disciplined working capital management. Capital additions from continuing operations were $194 million, up $18 million from the prior-year quarter, while return on capital for the 12 months ended June 30 was 10%.
Owens Corning ended the quarter with $1.8 billion of liquidity, including $271 million in cash and $1.5 billion available under bank debt facilities. The company returned $264 million to shareholders through $200 million of share repurchases and $64 million of dividends.
Owens Corning Sees Softer Q3 Roofing DemandFor the third quarter of 2026, Owens Corning expects revenues of $2.6 billion to $2.7 billion and an adjusted EBITDA margin of 20% to 22%. The outlook includes about $40 million of incremental inflation costs tied to the Iran conflict.
Roofing revenues are expected to decline by mid- to high-single digits year over year, with an EBITDA margin near 30%, as heavier second-quarter stocking weighs on distributor purchases. Insulation revenues are projected to grow by mid-single digits with a 22% EBITDA margin, while Doors revenues are expected to fall by mid-single digits with a margin of about 10%.
How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a downward trend in estimates revision.
VGM ScoresAt this time, Owens Corning has a average Growth Score of C, however its Momentum Score is doing a bit better with a B. Charting a somewhat similar path, the stock was allocated a grade of A on the value side, putting it in the top 20% for value investors.
Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of this revision indicates a downward shift. Notably, Owens Corning has a Zacks Rank #2 (Buy). We expect an above average return from the stock in the next few months.
Performance of an Industry PlayerOwens Corning belongs to the Zacks Building Products - Miscellaneous industry. Another stock from the same industry, Jacobs Solutions (J - Free Report) , has gained 2.4% over the past month. More than a month has passed since the company reported results for the quarter ended June 2026.
Jacobs Solutions reported revenues of $4.08 billion in the last reported quarter, representing a year-over-year change of +34.5%. EPS of $1.84 for the same period compares with $1.62 a year ago.
Jacobs Solutions is expected to post earnings of $2.17 per share for the current quarter, representing a year-over-year change of +24%. Over the last 30 days, the Zacks Consensus Estimate has changed +0.9%.
Jacobs Solutions has a Zacks Rank #3 (Hold) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of B.
Twilio ve 2. čtvrtletí zvýšila tržby o 22 % meziročně na 1,50 miliardy USD a dosáhla rekordního volného cash flow ve výši 352,6 milionu USD. Zároveň zvýšila výhled tržeb, provozního zisku a volného cash flow pro rok 2026.
Key Takeaways TWLO posted 22% y/y revenue growth in Q2, while organic growth rose to 17% and operating margin hit 19%.TWLO raised 2026 revenue, operating income and free cash flow views after a record quarterly free cash flow.TWLO is gaining AI traction through major deals as businesses use its platform for AI-powered communications. Twilio Inc. (TWLO - Free Report) has emerged as one of the strongest performers in the software space this year. The stock has gained roughly 69% year to date (YTD), sharply outperforming the broader Zacks Internet-Software industry’s fall of 2.4%.
Twilio has also outpaced major industry peers, including Atlassian Corporation (TEAM - Free Report) , DocuSign, Inc. (DOCU - Free Report) and Workiva Inc. (WK - Free Report) . While Workiva has declined 8.9% YTD, Atlassian and DocuSign have gained 19.9% and 1.2%, respectively.
Twilio YTD Price Return Performance
Image Source: Zacks Investment Research
After such a strong rally, investors may wonder whether Twilio’s stock has already priced in its growth opportunity. In our view, the answer is no. Twilio's latest results show that the rally is backed by improving fundamentals, stronger margins, rising cash flow and growing demand for its communications infrastructure as businesses deploy AI applications.
TWLO’s Strong Financial Results Support Further UpsideTwilio's second-quarter 2026 results provide a strong reason to remain bullish on the TWLO stock. Revenues increased 22% year over year to $1.50 billion. Organic revenue growth accelerated to 17% from 16% in the previous quarter and 13% in the year-ago quarter. Non-GAAP gross profit climbed 18% year-over-year to $736 million, marking the fifth consecutive quarter of accelerating non-GAAP gross profit growth.
Image Source: Twilio Inc.
Profitability also continued to improve. Non-GAAP income from operations increased 29% to $285 million, while the operating margin expanded 100 basis points year over year to 19%.
The improvement came despite pressure from higher U.S. carrier fees. Twilio's non-GAAP gross margin contracted 160 basis points year over year to 49.1% in the second quarter. But management noted that excluding the incremental carrier fees, the gross margin would have increased 60 basis points year over year. This highlights the underlying improvement in the business and the benefits of a richer product mix and cost discipline.
In the second quarter, Twilio generated a record free cash flow of $352.6 million compared with $263.5 million in the year-ago period. Twilio's dollar-based net expansion rate also improved to 116% from 108%, indicating stronger spending from existing customers.
The company’s optimistic outlook is also reflected in its raised full-year guidance. Twilio expects 18-18.5% reported revenue growth and 13-13.5% organic revenue growth in 2026, up from previous 14-15% and 9.5-10.5%, respectively. The company also increased its full-year non-GAAP operating income and free cash flow forecasts. Each metric, non-GAAP operating income and free cash flow, is projected at $1.135-$1.155 billion, up from the earlier stated $1.08-$1.10 billion.
This combination of accelerating growth, expanding profitability and upbeat guidance makes the stock an ideal investment case.
AI Adoption Creates Growth Opportunity for TwilioTwilio's biggest long-term opportunity could come from the rapid adoption of AI applications. The company is positioning its communications platform as infrastructure that enables businesses to connect AI agents with customers across voice, messaging and other channels.
Its new Conversations Layer includes Conversation Memory, Conversation Orchestrator, Conversation Intelligence, Conversation Relay and Agent Connect. Early customer results are encouraging. The U.K.-based digital car finance platform and online broker, Car Finance 247, signed a seven-figure deal after testing the platform during the second quarter. Car Finance 247’s AI assistant, Carla, has handled nearly 300,000 customer conversations. Customers interacting with the Carla AI assistant converted to approved leads 1.6 times faster.
Twilio is also seeing strong demand from AI-focused businesses. During the second quarter, it signed an eight-figure deal with a leading AI company. Eltropy, an agentic AI platform, used Twilio's Conversation Relay to build an AI voice agent, while OpenEvidence switched from a competitor to Twilio for voice infrastructure.
The opportunity is significant because growth of AI agents should increase the demand for reliable communication infrastructure. Twilio can potentially benefit from both the development of these applications and the communications activity they generate.
Twilio's Premium Valuation Looks JustifiableTWLO does trade at a premium. Its forward 12-month price-to-earnings (P/E) ratio of 35.20X is well above the industry's 27.89X average.
Twilio Forward 12-Month P/E Ratio
Image Source: Zacks Investment Research
It also trades above industry peers, including Atlassian, Workiva and DocuSign. Currently, Atlassian, Workiva and DocuSign trade at P/E multiples of 32.60X, 20.03X and 13.37X, respectively.
However, the premium appears justified by Twilio's stronger growth profile and improving profitability. The company is growing organically at a healthy pace, expanding margins, generating substantial free cash flow and gaining traction in AI-related communications. Its 116% dollar-based net expansion rate also shows that existing customers are spending more on the platform.
In addition, Twilio is returning capital to shareholders. It repurchased stocks worth $323 million in the first half of 2026 and had approximately $826 million remaining under its authorized repurchase program as of June 30, 2026.
Conclusion: Buy TWLO Stock Right NowTwilio's 69% YTD gain makes the stock more expensive, but its improving fundamentals suggest that the rally is supported by more than investor enthusiasm.
Accelerating organic growth, stronger operating leverage, record free cash flow, raised guidance and increasing AI adoption provide multiple reasons to remain bullish. While the valuation remains stretched, Twilio's growth opportunity and improving financial profile make its premium multiple justifiable for now.
Twilio currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
MKS ve 2. čtvrtletí překonal odhady: zisk na akcii činil 3,30 USD a tržby vzrostly o 28,3 % na 1,25 miliardy USD. Akcie ale za měsíc od poslední výsledkové zprávy klesly asi o 14,3 %.
A month has gone by since the last earnings report for MKS (MKSI - Free Report) . Shares have lost about 14.3% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is MKS due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its latest earnings report in order to get a better handle on the important catalysts.
MKSI Q2 Earnings Beat Estimates, Revenues Increase Year Over YearMKS Inc. reported second-quarter 2026 non-GAAP earnings of $3.30 per share, up 86.4% year over year. The figure beat the Zacks Consensus Estimate by 12.24%.
Revenues rose 28.3% year over year to $1.25 billion and surpassed the consensus mark by 3.06%. Growth was broad-based across all three end markets, led by Electronics & Packaging, while adjusted EBITDA margin expanded to 28.6%.
MKSI's Q2 Revenue Mix StrengthensProduct revenues, which accounted for 88.5% of total revenues, increased 30.2% year over year to $1.10 billion. The performance reflected stronger demand across the company’s semiconductor, electronics and packaging and specialty industrial businesses.
Services revenues totaled $144 million, representing 11.5% of revenues. The figure increased 15.2% from the year-ago quarter, supporting the company’s overall double-digit top-line expansion.
MKS' End Markets Post Broad GrowthSemiconductor revenues increased 28.2% year over year to $554 million and represented 44.4% of total revenues. Management highlighted accelerating AI-driven investment across semiconductor and advanced packaging applications, along with rapidly growing order volumes.
Electronics & Packaging revenues increased 44% to $381 million, contributing 30.5% of revenues. Specialty Industrial revenues rose 13.8% to $313 million and accounted for 25.1% of the quarterly total. The gains across each end market underscored the breadth of demand in the quarter.
MKSI's Operating DetailsGross margin expanded 100 basis points year over year to 47.6%. Non-GAAP operating income totaled $320 million, while the non-GAAP operating margin improved 480 basis points to 25.6%.
Non-GAAP operating expenses were $275 million compared with $251 million a year earlier.
Adjusted EBITDA climbed 49.2% year over year to $358 million. Adjusted EBITDA margin rose 390 basis points to 28.6%, reflecting stronger revenue and improved profitability.
GAAP income from operations increased to $251 million from $135 million in the prior-year quarter. The operating margin expanded 620 basis points to 20.1%, benefiting from the higher revenue base and improved gross margin.
MKSI's Cash Flow and Balance SheetAs of June 30, 2026, MKS had cash and cash equivalents of $611 million compared with $569 million as of March 31, 2026.
As of June 30, 2026, long-term debt totaled $2.54 billion.
Net cash provided by operating activities was $243 million in the second quarter, up 47.3% year over year. Capital expenditures totaled $55 million, resulting in free cash flow of $188 million compared with $136 million in the prior-year quarter.
MKS' Q3 Outlook Signals MomentumFor the third quarter of 2026, MKS expects revenues of $1.35 billion, plus or minus $40 million. Gross margin is projected to be 47%, plus or minus 1 percentage point, while non-GAAP operating expenses are expected to be $280 million, plus or minus $5 million.
The company forecasts non-GAAP earnings of $3.58 per share, plus or minus 31 cents.
Adjusted EBITDA is expected to be $395 million, plus or minus $28 million. Management noted that the outlook reflects the current business environment, including U.S. import tariffs and retaliatory actions by other countries.
How Have Estimates Been Moving Since Then?Since the earnings release, investors have witnessed a upward trend in estimates revision.
The consensus estimate has shifted 8.69% due to these changes.
VGM ScoresAt this time, MKS has a nice Growth Score of B, however its Momentum Score is doing a bit better with an A. However, the stock has a grade of C on the value side, putting it in the middle 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been trending upward for the stock, and the magnitude of these revisions looks promising. It comes with little surprise MKS has a Zacks Rank #2 (Buy). We expect an above average return from the stock in the next few months.
Akcie Exelixis za poslední měsíc vzrostly o 13,3 %, ale společnost snížila výhled tržeb na rok 2026 na 2,50–2,55 miliardy USD kvůli pomalejšímu růstu u NET.
A month has gone by since the last earnings report for Exelixis (EXEL - Free Report) . Shares have added about 13.3% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Exelixis due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.
Exelixis reported adjusted earnings per share (EPS) of 91 cents in the second quarter, which comfortably beat the Zacks Consensus Estimate of 86 cents. The company posted adjusted EPS of 75 cents in the year-ago quarter. Adjusted earnings excluded the impact of stock-based compensation expenses.
Including stock-based compensation expense, EPS was 82 cents compared with 65 cents in the year-ago period.
The bottom-line growth can be attributed to higher operating income and a decrease in shares outstanding due to ongoing buybacks.
Revenues rose 10.6% year over year to $628.7 million but missed the Zacks Consensus Estimate of $635 million.
EXEL's Product Sales Maintain Growth
Net product revenues increased to $573.03 million from $520.01 million in the year-ago quarter, primarily due to higher sales volume.
Cabometyx (cabozantinib) generated revenues of $570.6 million, which missed the Zacks Consensus Estimate of $578 million and our model estimate of $575 million. The drug is approved for advanced renal cell carcinoma (RCC) and previously treated hepatocellular carcinoma.
Cabometyx remained the leading prescribed tyrosine kinase inhibitor (TKI) in RCC. Its total prescription share within the company’s tracked oral TKI market basket increased to 47% from 45% a year earlier, while prescription volume rose 12%, outpacing the market basket’s 6% growth.
In March 2025, Exelixis obtained FDA approval for the label expansion of Cabometyx for the treatment of adult and pediatric patients 12 years of age and older with previously treated, unresectable, locally advanced or metastatic, well-differentiated pancreatic and extra-pancreatic neuroendocrine tumors (pNET). The drug was also approved for adult and pediatric patients 12 years of age and older with previously treated, unresectable, locally advanced or metastatic, well-differentiated extra-pancreatic NET (epNET).
However, the neuroendocrine tumor indication expanded more gradually than management had projected. Exelixis attributed the slower ramp-up to the relatively indolent nature of NET, less frequent patient scans and longer transitions between therapies.
Cometriq (cabozantinib capsules) generated $2.4 million in net product revenues for treating medullary thyroid cancer.
Collaboration revenues rose 15.4% to $55.7 million. The improvement reflected higher royalties on cabozantinib sales outside the United States by partner Ipsen, partly offset by lower development cost reimbursements. Exelixis earned $53.2 million in royalty revenues from partners Ipsen and Takeda during the quarter.
EXEL's Costs Rise as Operating Income Expands
Research and development expenses increased 5.8% year over year to $211.99 million due to higher clinical trial, manufacturing and collaboration costs as Exelixis continued investing in zanzalintinib and other pipeline candidates.
Selling, general and administrative expenses rose 9.5% to $147.63 million, reflecting higher marketing and personnel costs. Despite the increased spending, operating income climbed 16.3% to $248.41 million, and the operating margin expanded to 39.5% from 37.6%.
Exelixis Lowers Its 2026 Revenue Outlook
Management lowered its 2026 total revenue guidance to $2.50-$2.55 billion from $2.525-$2.625 billion. Net product revenue guidance was lowered to $2.30-$2.35 billion from $2.325-$2.425 billion, primarily because of the slower-than-expected NET ramp-up.
The revised outlook excludes potential revenues from zanzalintinib in previously treated metastatic colorectal cancer. Exelixis also lowered its R&D expense forecast to $825-$875 million from $875-$925 million. Its SG&A expense projection remained unchanged at $575-$625 million.
EXEL Advances Share Repurchase Program
Exelixis repurchased $311.6 million of the company’s shares in the second quarter, completing the $750 million share repurchase program (SRP) launched in October 2025.
The company also began repurchases under a new $750 million SRP authorized in May 2026, which runs through Dec. 31, 2027. Since launching its first SRP in March 2023, Exelixis has repurchased $2.9 billion of stock, retiring 93.3 million shares at an average price of $31.12 per share as of the end of the second quarter of 2026.
EXEL Advances Its Zanzalintinib Pipeline
The FDA is reviewing zanzalintinib in combination with Roche’s Tecentriq for previously treated metastatic colorectal cancer, with a target action date of Dec. 3, 2026. Its approval would establish zanzalintinib as Exelixis’ second commercial oncology franchise and broaden its portfolio beyond cabozantinib.
In June 2026, Exelixis reported final phase III STELLAR-303 results showing a non-statistically significant overall survival trend favoring zanzalintinib plus Tecentriq over regorafenib in the non-liver metastases (NLM) subgroup of previously treated non-MSI-high metastatic colorectal cancer. The study had previously met its other dual primary endpoint of overall survival in the intent-to-treat population, which included all randomized patients regardless of the presence of active liver metastases, as reported in June 2025.
Roche’s Tecentriq is a cancer immunotherapy that is approved around the world, either alone or in combination with targeted therapies and/or chemotherapies, for various types of cancer.
EXEL has collaborated with Merck to evaluate zanzalintinib, in combination with subcutaneous Keytruda Qlex in the planned phase III STELLAR-316 study for resected stage II/III colorectal cancer (CRC).
Under the agreement, Exelixis will sponsor the STELLAR-316 study, while Merck will provide Keytruda Qlex for use in the same. Keytruda is approved for several types of cancer.
Exelixis expects to initiate STELLAR-316 shortly, which will evaluate zanzalintinib with and without Keytruda Qlex in patients with resected stage II/III CRC who, following definitive therapy, have tested positive for molecular residual disease (MRD+) and have no radiographic evidence of disease — a high-risk population with substantial unmet need.
Earlier this year, Exelixis partnered with Natera, a global leader in cell-free DNA and precision medicine, for this study.
Natera will supply its Signatera assay to identify eligible MRD-positive patients for enrollment, further integrating precision medicine into the program.
The Merck partnership extends beyond colorectal cancer. In April 2026, Merck initiated the phase III LITESPARK-034 trial evaluating zanzalintinib plus Welireg versus Welireg and placebo in previously treated advanced RCC patients who progressed after PD-1/L1 and VEGFR-TKI therapies.
This marks the second Merck-sponsored phase III study under the collaboration, following LITESPARK-033 (launched in December 2025), which is assessing the combination against cabozantinib in first-line advanced RCC post-adjuvant immunotherapy.
In May 2026, Exelixis announced the initiation of STELLAR-201, a phase II study evaluating zanzalintinib in patients with recurrent Grade I/II/III meningioma with relapse or progression following radiation and/or surgery or those who are not candidates for these therapies.
How Have Estimates Been Moving Since Then?It turns out, estimates revision have trended upward during the past month.
VGM ScoresAt this time, Exelixis has a strong Growth Score of A, though it is lagging a lot on the Momentum Score front with an F. However, the stock has a score of B on the value side, putting it in the second quintile for value investors.
Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending upward for the stock, and the magnitude of these revisions looks promising. Notably, Exelixis has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry PlayerExelixis is part of the Zacks Medical - Biomedical and Genetics industry. Over the past month, Biogen Inc. (BIIB - Free Report) , a stock from the same industry, has gained 8.8%. The company reported its results for the quarter ended June 2026 more than a month ago.
Biogen reported revenues of $2.74 billion in the last reported quarter, representing a year-over-year change of +3.4%. EPS of $3.60 for the same period compares with $5.47 a year ago.
For the current quarter, Biogen is expected to post earnings of $2.31 per share, indicating a change of -52% from the year-ago quarter. The Zacks Consensus Estimate has changed -4.6% over the last 30 days.
The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for Biogen. Also, the stock has a VGM Score of C.
Michael Saylor uvedl, že veřejná podpora Bitcoinu v USA je chráněná svoboda projevu a BTC je podle něj komodita, ne cenný papír. Zároveň zdůraznil, že podvod a manipulace zůstávají nelegální.
Strategy Executive Chairman Michael Saylor has defended public Bitcoin advocacy in the United States as protected free speech. He has also called Bitcoin a commodity rather than a security, while stressing that fraud remains illegal.
Michael Saylor Backs Public Bitcoin Advocacy Saylor has argued that Americans do not need a license to discuss Bitcoin or publicly recommend owning the asset. His comments are drawing attention as Washington continues working on broader rules for the cryptocurrency market.
“In America, you don’t need a license to discuss Bitcoin, advocate for it, or publicly recommend owning it,” Saylor wrote.
He added, “Bitcoin is a commodity, not a security,” while separating Bitcoin advocacy from illegal market conduct. Saylor also stated that fraud and manipulation remain prohibited under existing laws.
The Strategy chairman has repeatedly supported wider Bitcoin adoption through public comments and his company’s treasury strategy. His latest remarks are focusing specifically on public discussion and recommendations involving BTC.
CLARITY Act Debate Continues in Washington Saylor’s comments are arriving as lawmakers continue preparing for a September 15 procedural vote on the CLARITY Act.
The National Sheriffs’ Association has now shifted its position on the legislation from opposition to neutral. The group had previously raised concerns about illicit finance enforcement under the proposed regulatory framework.
Senator Cynthia Lummis has welcomed the change while calling for lawmakers to advance the legislation. She has argued that the bill would provide law enforcement with additional tools against illicit crypto finance.
The CLARITY Act is seeking clearer divisions between federal agencies overseeing digital asset markets. However, lawmakers are still negotiating several provisions before the legislation can complete the Senate process.
However, the September 15 vote is procedural and would allow the Senate to advance consideration of the legislation, but it would not represent final passage of the bill.
MSTR Still Falling Despite Resumed Bitcoin Purchases Saylor’s latest remarks are also following Strategy’s return to Bitcoin purchases after a roughly 10-week buying pause.
As we reported, Strategy has acquired 4,603 BTC for approximately $369.7 million at an average price of $80,318 per Bitcoin, increasing the holdings to 845,050 BTC.
Despite the buys, Strategy shares are trading lower, even as Saylor maintains his public support for Bitcoin and the company resumes BTC purchases.
At press time, the MSTR stock had fallen by about 4.2% to $138.74 as Bitcoin faced renewed volatility following the latest U.S. employment data. Despite recent multi-week momentum fueled by stabilizing macroeconomic updates, the MSTR stock remains down 56% over the last 12 months.
Joby Aviation ve 2. čtvrtletí vykázala ztrátu 25 centů na akcii, ale tržby 38,6 milionu USD překonaly odhady. Firma zároveň zvýšila celoroční výhled tržeb na 115 až 125 milionů USD.
A month has gone by since the last earnings report for Joby Aviation, Inc. (JOBY - Free Report) . Shares have lost about 16.5% in that time frame, underperforming the S&P 500.
But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is Joby Aviation, Inc. due for a breakout? Well, first let's take a quick look at its latest earnings report in order to get a better handle on the recent catalysts for Joby Aviation, Inc. before we dive into how investors and analysts have reacted as of late.
JOBY Incurs Loss in Q2Joby Aviation reported a second-quarter 2026 loss of 25 cents per share, wider than the Zacks Consensus Estimate of a loss of 23 cents per share. In the year-ago quarter, JOBY reported a loss of 41 cents per share.
Quarterly revenues came in at $38.6 million, surpassing the Zacks Consensus Estimate of $29 million. Revenues were up from $15,000 in the prior-year period, with Blade contributing $36.2 million in the reported quarter amid seasonal demand and strong passenger activity.
In the June-end quarter, total operating expenses increased 78.4% year over year to $299.52 million. Research and development expenses rose 42.7% to $194.66 million, while selling, general and administrative expenses climbed 143.2% to $76.56 million as Joby invested in certification, manufacturing and commercial readiness and supported the growth of Blade.
Adjusted EBITDA in the second quarter of 2026 was a loss of approximately $197 million, compared with a loss of approximately $179 million in the first quarter. Management attributed the sequential change to the quarter's revenue and expense dynamics.
JOBY exited the second quarter with cash and cash equivalents of $629.86 million and total cash, cash equivalents and short-term investments of $2.26 billion. Long-term debt was $701.87 million at June 30, 2026.
JOBY's GuidanceThe company raised its full-year 2026 revenue outlook to a range of $115 million to $125 million from $105 million to $115 million, citing Blade's continued strength. For the second half of 2026, Joby expects to use between $385 million and $415 million of cash, cash equivalents and short-term investments.
On the operating front, Joby expects its first flights under the White House-backed eIPP program in Texas in September and continues to target carrying its first passengers in 2026. The company said five aircraft are flying and another 12 are in production, while it recorded its strongest quarterly progress yet in the fifth and final stage of FAA type certification.
How Have Estimates Been Moving Since Then?Since the earnings release, investors have witnessed a downward trend in estimates revision.
The consensus estimate has shifted -13.04% due to these changes.
VGM ScoresCurrently, Joby Aviation, Inc. has a poor Growth Score of F, a score with the same score on the momentum front. Following the exact same course, the stock was allocated a grade of F on the value side, putting it in the lowest quintile for this investment strategy.
Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Interestingly, Joby Aviation, Inc. has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Iron Mountain za poslední měsíc oslabil o 5,7 % po silném výsledku za 2. čtvrtletí. Firma zároveň zvýšila celoroční výhled AFFO na 5,87–5,93 USD na akcii.
It has been about a month since the last earnings report for Iron Mountain (IRM - Free Report) . Shares have lost about 5.7% in that time frame, underperforming the S&P 500.
But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is Iron Mountain due for a breakout? Well, first let's take a quick look at its most recent earnings report in order to get a better handle on the recent drivers for Iron Mountain Incorporated before we dive into how investors and analysts have reacted as of late.
Iron Mountain’s Q2 AFFO Beats Estimates on Data Center and ALM Growth, '26 View UpIron Mountain reported second-quarter 2026 AFFO of $1.44 per share, up 16.1% year over year. The figure surpassed the Zacks Consensus Estimate by 2.9%.
Revenues of $2.03 billion increased 18.5% and beat the consensus mark of $1.97 billion. The upside reflected broad-based strength, with data center revenues advancing 38.8% and asset lifecycle management benefiting from robust enterprise and decommissioning activity.
Iron Mountain’s Revenue Mix Supports Broad GrowthStorage rental revenues rose 12.3% year over year to $1.13 billion. Service revenues increased 27.4% to $894.5 million, underscoring the growing contribution from faster-expanding offerings outside the traditional records storage business.
Organic revenues jumped 16.8% on a constant-currency basis, excluding acquisitions and divestitures. Organic storage rental growth was 11.3%, while organic service growth reached 24.8%, showing that internal execution rather than deal activity drove most of the quarter’s expansion.
Iron Mountain's RIM Business Stays ResilientGlobal Records and Information Management revenues increased 8.3% to $1.43 billion. Storage rental revenues in the segment rose 6.6%, while service revenues advanced 10.9%, supported by revenue management, digital solutions and continued customer activity.
The segment generated adjusted EBITDA of $620.8 million compared with $586.3 million a year earlier. Its adjusted EBITDA margin contracted 100 basis points to 43.3%, as faster service growth carried a different margin profile than the highly recurring storage business.
Global storage volume reached a record 747.9 million cubic feet, up from 735.8 million a year ago. Storage facility utilization improved to 81.6% from 80.6%, while the records management retention rate increased 40 basis points to 93.4%.
Iron Mountain's Data Center Momentum StrengthensGlobal Data Center revenues climbed to $262.9 million from $189.4 million. Storage rental revenues grew 37.5% and the segment’s adjusted EBITDA increased to $137.3 million, with margin expanding 140 basis points to 52.2%.
Iron Mountain signed 13 megawatts of new and expansion leases during the second quarter. Leasing reached 110 megawatts through July after an additional 75 megawatts were signed following quarter-end. The company also cited a backlog supporting $370 million of revenue growth beyond 2026 before including the July leasing.
The operating portfolio had 528.5 leasable megawatts and was 97.1% leased. Management expects roughly 325 megawatts of available-to-lease capacity to become energized over the next 24 months as it works toward total developable capacity of approximately 1.4 gigawatts.
Iron Mountain's ALM and Digital Engines ExpandCorporate and Other revenues surged 67.4% to $332.6 million. Service revenues rose 73.7%, reflecting strong asset lifecycle management performance across enterprise solutions and data center decommissioning.
ALM revenues increased 88% on a reported basis and 82% organically. Management also highlighted record digital revenues and growing traction for Insight DXP, its artificial intelligence-powered platform, including a multi-year managed-services agreement spanning 45 countries.
Iron Mountain's Costs and Balance Sheet Remain ManageableTotal operating expenses increased 14% to $1.66 billion, slower than revenue growth. Operating income advanced 43.7% to $373.5 million, though adjusted EBITDA margin declined 90 basis points to 35.8%, partly reflecting the mix shift toward rapidly growing service businesses.
Net lease-adjusted leverage remained at 4.8 times, within management’s target range of 4.5-5.5 times. Cash and cash equivalents were $204.8 million at quarter-end, while net debt totaled about $17.28 billion.
Iron Mountain Raises 2026 OutlookIron Mountain raised its full-year AFFO per share forecast to $5.87-$5.93 from the earlier guided range of $5.79-$5.86. The midpoint implies approximately 14% growth, supported by continued momentum across records management, data centers, digital solutions and ALM.
How Have Estimates Been Moving Since Then?Analysts were quiet during the last two month period as none of them issued any earnings estimate revisions.
VGM ScoresAt this time, Iron Mountain has a nice Growth Score of B, a score with the same score on the momentum front. However, the stock was allocated a score of D on the value side, putting it in the bottom 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook Iron Mountain has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry PlayerIron Mountain is part of the Zacks Business - Information Services industry. Over the past month, TransUnion (TRU - Free Report) , a stock from the same industry, has gained 7.2%. The company reported its results for the quarter ended June 2026 more than a month ago.
TransUnion reported revenues of $1.31 billion in the last reported quarter, representing a year-over-year change of +14.9%. EPS of $1.23 for the same period compares with $1.08 a year ago.
TransUnion is expected to post earnings of $1.21 per share for the current quarter, representing a year-over-year change of +10%. Over the last 30 days, the Zacks Consensus Estimate remained unchanged.
The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for TransUnion. Also, the stock has a VGM Score of B.
Ripple uzavřel dlouhodobé partnerství s Florida Gators, díky němuž se $XRP stává oficiální kryptoměnovou značkou programu. Logo $XRP se objeví na hřišti v Ben Hill Griffin Stadium během celé fotbalové sezóny 2026.
@Ripple has entered a long-term partnership with @FloridaGators, making $XRP the official crypto brand of one of college sport's most recognisable athletic programmes. The deal marks a significant step in bringing digital asset branding into mainstream American sports.
$XRP Branding at Ben Hill Griffin StadiumUnder the agreement, the $XRP logo will appear on the field at Ben Hill Griffin Stadium throughout the entire 2026 football season. The placement is one of the most prominent in college sports, putting the $XRP brand in front of tens of thousands of fans at every home game and a much wider television audience.
The scope of the deal extends well beyond a single venue or season. Ripple's partnership covers digital and event branding across all 21 Florida Gators sports programmes, giving $XRP consistent visibility across a broad range of athletic events and the millions of fans who follow them worldwide.
Education and Community OutreachRipple is also using the partnership to push beyond logo placement. The company is launching dedicated educational initiatives aimed at 500 student-athletes and the wider University of Florida community. The programmes are designed to introduce students to digital assets and blockchain technology, positioning $XRP and Ripple as more than a sponsor and as a platform with real-world financial relevance.
The move reflects a broader strategy from Ripple to embed $XRP into mainstream culture through sports. College athletics offers direct access to a large and engaged fan base, and a deal of this size, spanning 21 teams and one of the country's most storied football venues, signals a serious long-term commitment to that approach.
For Florida Gators Athletics, the partnership brings both commercial value and a connection to the growing world of digital finance, at a time when sports organisations across the country are exploring new revenue streams and sponsor categories.
AIxCrypto Holdings ukončuje kryptoměnovou treasury strategii a prodává zbytek 33,49 BTC, 497,56 ETH, 6 325,92 SOL i menších pozic v LINK, BNB a ADA po zhruba 50% nerealizované ztrátě portfolia. Firma se chce plně přesunout do robotiky s platformou RoboShare.
AIxCrypto Holdings (AIXC), a US-based technology microcap, has decided to fully liquidate its digital asset portfolio and end its cryptocurrency treasury strategy.
Asset liquidation and SEC filingThe company submitted an amended Form S-1 to the Securities and Exchange Commission on September 4, 2026, revealing plans to sell its remaining cryptocurrency holdings. This decision follows sustained financial losses, including approximately a 50% unrealized decline in the value of its digital asset portfolio.
As of August 31, AIXC reported that it had liquidated 33.49 Bitcoin (BTC), 497.56 Ethereum (ETH), and 6,325.92 Solana (SOL). The firm also sold smaller allocations of Chainlink (LINK), Binance Coin (BNB), and Cardano (ADA).
In a notable detail from its regulatory disclosures, the company classified its XRP position as “immaterial.” By emphasizing this, AIXC’s management appeared to direct shareholders’ attention toward losses centered on major assets like Bitcoin and Ethereum, rather than on XRP.
After disposing of its depreciated assets, the company intends to relaunch and pivot fully to the robotics sector by developing its RoboShare platform, ending its previous focus as a pharmaceutical business.
AIxCrypto Holdings, once primarily focused on pharmaceuticals, is now shifting its strategy to concentrate on robotics, facilitated by the RoboShare platform, after closing out its digital asset exposure.
Mini dictionary: RoboShare, a platform being developed by AIxCrypto Holdings to enter the robotics industry, represents the company’s new direction after exiting its pharmaceutical and crypto treasury activities.
Changing approaches across companiesThis move by AIXC follows similar trends among small-cap companies reevaluating digital asset strategies. Tokyo-based Remixpoint previously cleared its altcoin holdings — including Ethereum, Solana, Dogecoin, and 1.19 million XRP — to fund investment in energy storage systems, yet retained Bitcoin as a treasury asset.
These developments suggest a shift in the approach of small corporates, prioritizing operational stability over speculative crypto investments. Rather than widespread panic, the selloffs point toward a transfer from accidental or opportunistic investors to more pragmatic market participants.
XRP ecosystem sees institutional investment despite small-cap retreatsWhile some companies downplay their exposure to XRP by labeling holdings as immaterial, institutional interest in the XRP ecosystem is evolving. Kinetics funds, a well-known asset management group, disclosed recent direct investments in Ripple Labs’ Class A preferred shares, according to SEC records. This strategy demonstrates that some institutional capital is gaining exposure to XRP through equity positions in Ripple, rather than solely holding tokens traded on exchanges.
Evernorth (XRPN), a leading XRP-focused treasury holding company, currently maintains about 473 million XRP in its reserves and is preparing for a public offering via a special purpose acquisition company (SPAC) structure on Nasdaq.
Mini dictionary: Evernorth (XRPN) is a treasury holding company specializing in XRP, notable for its large balance of XRP and its ongoing preparations for a Nasdaq listing through a SPAC arrangement.
Despite a number of smaller firms exiting the crypto market and labelling certain positions as negligible, other entities are taking calculated steps to strengthen their presence in the sector.
The current pattern reflects not a loss of confidence among corporate players in digital assets, but rather a more selective and strategic approach to managing risk and focusing on core operations.
CompanyCrypto assets soldAssets retainedNew focusRemarksAIxCrypto Holdings (AIXC)BTC, ETH, SOL, LINK, BNB, ADANoneRobotics (RoboShare)50% loss on portfolioRemixpointETH, SOL, DOGE, XRPBTCEnergy storage systemsCleared all but BitcoinEvernorth (XRPN)None~473 million XRPPreparing for Nasdaq via SPACMaintains large XRP holding
XRP testuje zónu 1,45–1,50 USD, přičemž 1,50 USD zůstává klíčovou krátkodobou rezistencí. Zároveň sílí podpora upgradů XRP Ledgeru, včetně native lending a ConfidentialTransfer.
XRP’s recent move toward the $1.50 mark has arrived during a notable phase of protocol upgrades on the XRP Ledger, with the xrpld 3.3.0 release set to introduce changes that extend beyond a single activation date. The update, positioned as one of the ledger’s most consequential in recent periods, reflects a broader shift within its ecosystem.
Institutional trends shape ledger directionAmid these upgrades, network validators are actively debating the addition of native lending features to XRPL, focusing on infrastructure for vaults and lending tailored to institutional credit markets. Ripple, a US-based blockchain company specializing in global payments, is joining forces with firms such as Clearpool and Cicada to develop an institutional credit market centered around RLUSD and native lending protocols.
Ripple participates in supporting protocol amendments; however, it cannot single-handedly activate changes. The governance process on XRPL requires any amendment to secure over 80% backing from trusted validators for two consecutive weeks before integration into the main ledger. If validator support dips below this threshold during the evaluation period, the approval timeline resets.
The first amendment from version 3.3.0 to advance through this process is fixCleanup3_3_0, which is maintenance-focused and impacts multiple components, including automated market makers (AMMs), lending, vaults, Checks, and permissioned trading systems.
Larger upgrades remain under deliberation, reflecting an accelerated but measured approach to protocol development.
One proposed amendment, ConfidentialTransfer, has drawn attention for its approach to privacy. Institutions frequently require transparent settlement processes that do not publicly reveal sensitive transaction amounts. XRPL’s documentation indicates that ConfidentialTransfer uses cryptographic methods to verify the movement of assets while concealing the specific amount transferred.
Mini dictionary: ConfidentialTransfer, an amendment for the XRP Ledger, lets participants confirm the authenticity of transfers without disclosing transaction amounts to the public. This privacy feature is designed for institutional use, balancing regulatory transparency with commercial confidentiality by using advanced cryptography.
In addition, BatchV1_1 aims to enable bundling of several operations into a single, atomic transaction, simplifying complex on-chain actions. The Sponsor amendment, on the other hand, proposes allowing one account to pay certain costs on behalf of another—potentially reducing friction for institutional users managing multiple accounts.
The strategic upgrades and amendments suggest that the primary value proposition for XRPL is shifting toward integrated financial tools, not merely swift transactions. XRPL Commons President David Bchiri also sees institutional design as a growing competitive edge, especially as tokenized finance becomes more widespread.
XRP price prediction: $1.50 remains in focusThe rollout of these protocol initiatives comes as XRP tests the $1.45–$1.50 zone, where $1.50 stands out as a key short-term resistance level for traders.
Separate from technical developments, institutional appetite for XRP has shown significant strength. US-based spot XRP ETFs registered $110.49 million in inflows last week, marking the strongest weekly inflow this year. Overall, net inflows into these funds have reached approximately $1.66 billion.
Notably, XRP’s spot price performance has lagged behind fund inflows, signaling a disconnect between the regulated market and the broader spot market momentum.
MetricLatest ValueXRP ETF weekly inflow (2026)$110.49 millionCumulative XRP ETF net inflows$1.66 billionCurrent resistance level$1.50Next upside target$1.65–$1.70Key support area$1.35–$1.40Analysts point to a sustained break above $1.50 as a possible trigger for a move toward the $1.65–$1.70 range. However, if XRP fails to maintain momentum above resistance, support levels near $1.35 to $1.40 could become significant for short-term price action.
There is an unusual divergence between robust regulated fund demand and the relatively subdued spot price of XRP, with analysts watching closely to see if protocol enhancements and institutional adoption can close that gap.
Kennametal za měsíc po posledních výsledcích odepsal asi 13,1 % a za 4. čtvrtletí fiskálního roku 2026 překonal odhady zisku i tržeb. Firma zároveň pro 1. čtvrtletí fiskálního roku 2027 očekává tržby 745–775 mil. USD a upravený zisk 2,50–2,80 USD na akcii.
A month has gone by since the last earnings report for Kennametal (KMT - Free Report) . Shares have lost about 13.1% in that time frame, underperforming the S&P 500.
But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is Kennametal due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts.
Kennametal Q4 Earnings & Sales Beat Estimates, Rise Y/YKennametal reported adjusted earnings of $2.96 per share for the fourth quarter of fiscal 2026, up 770.6% year over year. The bottom line beat the Zacks Consensus Estimate of $2.31 by 28.1%.
Sales rose 42.6% year over year to $736.6 million and surpassed the consensus estimate of $720 million by 2.3%.
Sales Growth Spans End MarketsReported sales growth reflected a 42% organic increase, a 1% favorable foreign-currency impact and a 1% benefit from business days, partly offset by a 1% divestiture drag. The Americas led constant-currency regional growth at 60%, followed by Asia Pacific at 28% and EMEA at 24%.
Energy sales jumped 101% in constant currency, while Earthworks advanced 76%. Aerospace & Defense rose 43%, General Engineering increased 28% and Transportation grew 7%. Management cited higher pricing, strategic wins and better market activity across several end markets.
Kennametal's Margins Expand SharplyIn the fiscal fourth quarter, Kennametal’s cost of goods sold decreased 18.3% year over year to $303.1 million. Operating expenses were $125.6 million, up 18.7% year over year.
Adjusted operating income was $305.7 million, translating into a 41.5% margin, compared with $38.2 million and 7.4% a year earlier. Adjusted EBITDA reached $345 million, with the margin expanding to 46.8% from 14.8%.
The improvement was driven mainly by about $252 million of favorable timing between raw material-related pricing and costs. Non-raw-material pricing, tariff surcharges, higher sales and production volumes and $5 million of restructuring savings also helped. Compensation costs, tariffs and inflation were offsets.
Metal Cutting Segment AdvancesMetal Cutting revenues increased 24% year over year to $397.8 million. Organic sales rose 22%, supported by a 1% currency benefit and a 1% business-days contribution. Constant-currency sales climbed 29% in the Americas, 20% in Asia Pacific and 16% in EMEA.
Adjusted operating income totaled $108.4 million and adjusted operating margin expanded to 27.3% from 7.9%. Results benefited from roughly $54 million of favorable raw-material pricing timing, non-raw-material pricing, tariff surcharges, higher volume and $4 million of restructuring savings.
Kennametal's Infrastructure Results SurgeInfrastructure revenues rose 73% to $338.8 million, while organic sales increased 74%. A 1% currency benefit and a 1% business-days benefit were partly offset by a 3% divestiture impact. Constant-currency growth reached 103% in the Americas, 46% in EMEA and 40% in Asia Pacific.
Adjusted operating income was $197.9 million, with adjusted margin surging to 58.4% from 6.8%. About $198 million of favorable raw-material pricing timing drove the gain, partly offset by lower volume of sales and production, an increase in compensation costs and general inflation.
Cash Flow Feels Working Capital StrainFiscal 2026 cash used in operating activities was $4.0 million against $208.3 million generated in the prior year. Free operating cash flow was negative $79.1 million against positive $121.2 million, reflecting higher working capital needs tied to tungsten-driven inventory values and supplier advances.
Kennametal ended fiscal 2026 with $95.8 million in cash and cash equivalents, down from $140.5 million a year earlier. Inventories increased to $1.11 billion from $538.2 million, while long-term debt rose to $685.3 million from $596.8 million. The company paid $60.8 million in dividends during the year.
Kennametal's Fiscal 2027 OutlookFor the first quarter of fiscal 2027, it expects sales of $745-$775 million and adjusted earnings of $2.50-$2.80 per share. The outlook assumes 1-4% volume growth, 50-53% price and tariff-surcharge realization and a neutral foreign-exchange impact.
For fiscal 2027, sales are projected at $3.33-$3.45 billion, with adjusted earnings of $4.15-$5.15 per share. Management expects free operating cash flow of about 20% of adjusted net income and capital spending near $85 million. Share repurchases will remain on hold until cash flow becomes positive.
How Have Estimates Been Moving Since Then?Since the earnings release, investors have witnessed a upward trend in estimates review.
The consensus estimate has shifted 107.54% due to these changes.
VGM ScoresCurrently, Kennametal has a poor Growth Score of F, however its Momentum Score is doing a lot better with an A. Following the exact same course, the stock was allocated a grade of A on the value side, putting it in the top quintile for value investors.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been trending upward for the stock, and the magnitude of these revisions looks promising. Notably, Kennametal has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Robinhood Chain na více než 14 minut přestala vytvářet bloky, takže se tokenové převody a chytré kontrakty nepotvrdily. Robinhood neuvedl příčinu výpadku.
Robinhood Chain has stopped producing blocks for more than 14 minutes, preventing the Ethereum layer-2 network from confirming token transfers and smart contract transactions.
Summary
Robinhood Chain stopped producing blocks for more than 14 minutes at around 12:57 p.m. UTC. Transfers and smart contract calls remained pending until block production resumed intermittently. Robinhood has not disclosed the cause or provided a detailed account of the disruption. HOOD shares fell as much as 5.1% from their previous close before recovering part of the loss. Robinhood Chain stopped confirming transactions Robinhood Chain block explorer data showed that the network stopped adding blocks at around 12:57 p.m. UTC on Sept. 4, leaving submitted transactions without confirmation for more than 14 minutes.
Transfers, smart contract calls, and router interactions could not move forward while the chain remained at the same block height. New transactions continued to appear in the explorer, but several stayed pending because the network was not producing blocks to process them.
News aggregator Aggr News was among the first to report the interruption on X.
Block production later restarted, although explorer records showed uneven activity during the first stage of the recovery. Robinhood had not disclosed the cause of the halt or published a technical account of the event at the time of reporting.
The company also had not provided a specific recovery schedule. Its main status page did not list an incident for the chain, leaving the explorer as the main public source for tracking whether blocks were being produced consistently.
No report indicated that balances were lost during the interruption. Transactions submitted while production was paused could not receive on-chain confirmation until the sequencer began creating blocks again.
A sequencer halt froze Robinhood Chain activity As crypto.news explained in July, Robinhood Chain is an Ethereum layer-2 network built with Arbitrum Orbit technology. It runs transactions outside Ethereum’s main execution layer and posts data back to Ethereum.
Robinhood launched the public mainnet on July 1 with 95 tokenized stocks and access through Robinhood Wallet in more than 120 countries. The chain uses ETH for transaction fees and supports Ethereum-compatible wallets, applications, and smart contracts.
According to the network explainer, Robinhood Chain relies on a sequencer to order transactions and produce blocks. When the sequencer stops, users can submit transactions, but the network cannot confirm or settle them until block production returns.
Robinhood Chain normally produces blocks every 100 milliseconds. At that speed, a 14-minute interruption represents approximately 8,400 expected block intervals without normal production.
The halt affected blockchain activity rather than Robinhood’s conventional brokerage system. No evidence showed that customers lost access to U.S. stocks, exchange-traded funds, options, or other assets held in standard Robinhood brokerage accounts because of the chain interruption.
Block production is especially important for decentralized finance users. Without new blocks, traders cannot complete swaps, transfer collateral, repay loans or interact with smart contracts, even when their wallets continue displaying previously recorded balances.
Tokenized stock activity had climbed before the outage The interruption arrived after a sharp increase in trading activity across Robinhood Chain. On Aug. 25, the network recorded approximately $945 million in daily decentralized exchange volume, according to a recent network analysis.
Cumulative DEX volume had surpassed $47 billion since the July 1 launch, while its 30-day total reached approximately $15 billion. The data placed Robinhood Chain fifth among tracked networks by 30-day decentralized exchange volume, behind Solana, BNB Chain, Ethereum, and Base.
A separate Sept. 2 report found that RWA-linked trading volume had reached $390 million. By July 27, Robinhood had accumulated approximately 328,000 tokenized-equity holders, equal to around 44% of the 752,000 holders tracked across five large tokenized-stock platforms at the time.
Robinhood represented about $44 million of the tokenized assets in that comparison. Ondo held approximately $857 million, while xStocks accounted for about $487 million, showing that Robinhood’s holder count did not give it the largest value of tokenized assets.
Uniswap has operated as the chain’s primary public automated market maker since launch. Uniswap founder Hayden Adams said in late August that combined stock-token trading volume on Robinhood Chain had reached $1 billion.
Robinhood Chain had also processed more than $12 billion in DEX volume and over 150 million transactions by the end of July, according to figures cited by Bernstein. The research firm used the figures when maintaining an Outperform rating and a $160 price target for Robinhood Markets.
HOOD shares fell as much as 5.1% During Friday’s U.S. session, Robinhood Markets shares opened at $120.48 after closing at $124.72 on Thursday. HOOD then traded as low as $118.30, representing a decline of approximately 5.1% from the previous close.
Shares later recovered to around $122.81, cutting the daily loss to roughly 1.5%. Robinhood’s market data showed an intraday high of $124.60 and trading volume of 13.96 million shares, compared with an average daily volume of 24.82 million.
Available market data did not establish that the chain outage caused HOOD’s decline. The stock had already traded near $120 in the premarket session when reports of the network interruption appeared.
Friday’s trading also followed a 16.6% rally in HOOD on Thursday, when the stock closed at $124.72. Analyst upgrades and Robinhood’s expanding product range had supported the previous session’s advance.
U.S. investors cannot access Robinhood Stock Tokens Robinhood Stock Tokens remain unavailable to U.S. residents, even though many of the products track U.S.-listed companies. The company offers the tokens in eligible overseas markets as derivative contracts that provide economic exposure to the referenced securities.
Token holders are not shareholders of record and do not receive voting rights attached to the underlying stock. Robinhood has said that a U.S.-licensed institution holds assets supporting the contracts.
In July, two securities transfer groups asked the SEC to distinguish between issuer-approved tokenized securities and products created by unrelated platforms. Continental Stock Transfer & Trust Company and the Securities Transfer Association said third-party tokens may not establish a direct legal relationship between buyers and the company whose shares determine the token’s value.
The groups also raised concerns about custody, shareholder records, voting, dividends, sanctions checks, and claims during insolvency. They asked the SEC to prioritize issuer-backed structures and impose investor safeguards before granting regulatory relief to unaffiliated stock-token products.
Charles River zvýšila výhled ne-GAAP EPS pro rok 2026 na 11,15–11,45 USD z 10,80–11,30 USD. Tržby mají nově klesnout o 3,5 % až 2,5 % místo dřívějších 5,5 % až 4 %.
A month has gone by since the last earnings report for Charles River Laboratories (CRL - Free Report) . Shares have added about 10.5% in that time frame, outperforming the S&P 500.
But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Charles River due for a pullback? Well, first let's take a quick look at the latest earnings report in order to get a better handle on the recent drivers for Charles River Laboratories International, Inc. before we dive into how investors and analysts have reacted as of late.
CRL Q2 Earnings and Revenues Top, '26 View UpCharles River reported second-quarter 2026 company-defined non-GAAP earnings of $3.02 per share, down 3.2% year over year. The reported earnings topped the Zacks Consensus Estimate by 11.0%.
GAAP net loss was 3 cents per share compared to GAAP earnings of $1.06 per share in the year-ago period.
Revenues of $1 billion declined 2.7% (up 0.1% organically) year over year but beat the Zacks Consensus Estimate by 3%.
Charles River's DSA Business Shows Demand GainsDSA revenues totaled $606.5 million, down 1.9% year over year on a reported basis. Organic revenues increased 0.2%, driven mainly by higher study volume for regulated safety assessment services.
The segment's GAAP operating margin rose 60 basis points to 20.5%, aided by lower intangible-asset amortization and reduced third-party legal costs tied to a non-human primate supply matter. The non-GAAP margin fell 180 basis points to 25.6% because of higher study-related direct costs.
CRL's RMS Sales Decline on North America WeaknessRMS revenues totaled $209.5 million, down 1.8% from the year-ago quarter’s level. Organic revenues declined 1.4% primarily due to lower sales of small research models in North America and weaker research model services, partly offset by growth in China.
The segment's GAAP operating margin improved 50 basis points to 17.3%, mainly because of lower amortization following the Cell Solutions divestiture. The non-GAAP margin contracted 80 basis points to 24.5% on lower volume and an unfavorable geographic revenue mix.
Charles River's Manufacturing Margins ExpandManufacturing revenues amounted to $188.1 million, down 6.3% year over year, mainly because of the CDMO divestiture. Organic revenues rose 1.3%, supported by higher revenues in the Microbial Solutions business.
GAAP operating margin surged to 34.9% from 6% a year earlier. The non-GAAP margin expanded 500 basis points to 37.8%, with the CDMO business and the benefit from its divestiture driving the improvement.
CRL's Margin PerformanceThe gross profit in the reported quarter was $363.4 million, up 1.8% from the prior-year quarter’s level. The gross margin of 36.2% expanded approximately 159 basis points (bps) year over year.
Selling, general and administrative expenses increased 19.5% year over year to $228.9 million. Operating profit totaled $119.9 million, up 19.7% from the prior-year quarter’s level. The operating margin expanded approximately 224 bps to 11.9%.
CRL's Cash Flow and Buyback ActivityCash and cash equivalents amounted to $192 million as of June 27, 2026, compared with $191.8 million at the end of the first quarter. Cumulative net cash provided by operating activities at the end of the quarter was $220.8 million compared with $376.3 million a year ago.
CRL repurchased 0.6 million shares for $100 million during the second quarter at an average price of $174 per share. Year-to-date repurchases totaled $300 million, leaving $700 million available under the company's authorization.
Charles River Raises Its 2026 OutlookCharles River now expects reported revenues to decline 3.5% to 2.5% in 2026, compared with its prior projection for a 5.5% to 4% decrease. The Zacks Consensus Estimate for 2026 revenues implies a decline of 3% year over year.
The company raised its non-GAAP earnings guidance to $11.15-$11.45 per share from $10.80-$11.30. The Zacks Consensus Estimate for the metric is pegged at $11.28 per share.
How Have Estimates Been Moving Since Then?Since the earnings release, investors have witnessed a downward trend in estimates revision.
VGM ScoresCurrently, Charles River has a subpar Growth Score of D, though it is lagging a bit on the Momentum Score front with an F. Charting a somewhat similar path, the stock was allocated a score of D on the value side, putting it in the bottom 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Interestingly, Charles River has a Zacks Rank #2 (Buy). We expect an above average return from the stock in the next few months.
Performance of an Industry PlayerCharles River is part of the Zacks Medical Services industry. Over the past month, HCA Healthcare (HCA - Free Report) , a stock from the same industry, has gained 0.1%. The company reported its results for the quarter ended June 2026 more than a month ago.
HCA reported revenues of $20.23 billion in the last reported quarter, representing a year-over-year change of +8.7%. EPS of $7.59 for the same period compares with $6.84 a year ago.
HCA is expected to post earnings of $6.80 per share for the current quarter, representing a year-over-year change of -2.3%. Over the last 30 days, the Zacks Consensus Estimate has changed -2.8%.
The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for HCA. Also, the stock has a VGM Score of B.
HubSpot za poslední měsíc přidal asi 26 % po silných výsledcích za 2. čtvrtletí 2026, když tržby vzrostly o 20 % na 911,7 milionu USD a firma překonala odhady.
A month has gone by since the last earnings report for HubSpot (HUBS - Free Report) . Shares have added about 26% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is HubSpot due for a pullback? Well, first let's take a quick look at its latest earnings report in order to get a better handle on the recent catalysts for HubSpot, Inc. before we dive into how investors and analysts have reacted as of late.
HubSpot Q2 Earnings Beat Estimates on Healthy Top-Line Growth
HubSpot reported solid second-quarter 2026 results, with both top and bottom lines surpassing the Zacks Consensus Estimate.
The company delivered strong 20% year-over-year revenue growth, supported by continued expansion of its subscription business, healthy customer additions, sustained demand for its artificial intelligence (AI)-powered CRM offerings and growth in professional services.
Net Income
On a GAAP basis, the company recorded a net income of $43.3 million or 86 cents per share against a net loss of $3.3 million or a loss of 6 cents per share in the year-ago quarter. Healthy top-line growth boosted the bottom line during the quarter.
Non-GAAP net income was $164.8 million or $3.26 per share, up from $117.3 million or $2.19 per share in the prior-year quarter. The bottom line comfortably beat the Zacks Consensus Estimate of $3.02 per share.
Revenues
Quarterly revenues improved to $911.7 million from $760.9 million reported in the year-ago quarter, supported by robust growth in both the Subscription and Professional services segments. The top line beat the Zacks Consensus Estimate of $897.8 million.
Subscription revenues rose to $894 million, up 20% year over year, driven by continued customer acquisition, expansion within the existing customer base, and increased adoption of the company's AI-powered CRM platform. Average subscription revenues per customer increased 4% year over year to $11,800.
Professional services and other revenues totaled $17.7 million, up 8% year over year, reflecting increased demand for implementation, onboarding and customer success services supporting new customer additions and platform expansion.
HubSpot added more than 6,900 net new customers during the quarter, increasing the total customer count to 306,446, up 14% year over year. Calculated billings in the second quarter of 2026 increased 14% year over year to $929.7 million.
Other Details
Gross profit in the quarter was $750.9 million, up from $638.7 million in the year-ago quarter. Total operating expenses were $707.5 million compared with $663.3 million in the year-ago quarter. Non-GAAP operating income improved to $185.3 million from $129.1 million, with respective margins of 20.3% and 17%.
Cash Flow & Liquidity
In the second quarter of 2026, the company generated $222.8 million of cash from operating activities compared with $164.4 million in the year-earlier quarter. In the first six months of 2026, HubSpot generated $421.6 million in cash compared with $325.9 million in the year-ago period. As of June 30, 2026, the company had $958.3 million in cash and cash equivalents, with $98.8 million in other long-term liabilities.
Outlook
For the third quarter of 2026, HubSpot forecasts revenues in the range of $924 million to $925 million, up 14% year over year. The company expects non-GAAP net income per share in the band of $3.25-$3.27. Non-GAAP operating income is expected to be in the range of $187-$188 million, indicating a 20% operating profit margin.
For 2026, management estimates revenues between $3.68 billion and $3.69 billion, up 18% year over year on a reported basis. Non-GAAP operating income is expected to be in the range of $762-$766 million, representing a 21% operating profit margin. Non-GAAP net income per share is likely to be in the range of $13.23-$13.31.
How Have Estimates Been Moving Since Then?It turns out, estimates review have trended downward during the past month.
The consensus estimate has shifted -22.28% due to these changes.
VGM ScoresAt this time, HubSpot has a great Growth Score of A, though it is lagging a bit on the Momentum Score front with a B. However, the stock was allocated a score of D on the value side, putting it in the bottom 40% for value investors.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, HubSpot has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry PlayerHubSpot is part of the Zacks Internet - Software industry. Over the past month, Reddit Inc. (RDDT - Free Report) , a stock from the same industry, has gained 3.4%. The company reported its results for the quarter ended June 2026 more than a month ago.
Reddit Inc. reported revenues of $804.91 million in the last reported quarter, representing a year-over-year change of +61.1%. EPS of $1.25 for the same period compares with $0.45 a year ago.
For the current quarter, Reddit Inc. is expected to post earnings of $1.33 per share, indicating a change of +66.3% from the year-ago quarter. The Zacks Consensus Estimate has changed +0.8% over the last 30 days.
Reddit Inc. has a Zacks Rank #3 (Hold) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of B.
KKR kupuje Integer Holdings za 5,7 miliardy USD; akcionáři by při uzavření obdrželi 127 USD za akcii v hotovosti. Transakce ještě čeká na souhlas většiny akcionářů i regulační povolení.
Key Takeaways Integer shareholders would receive $127 per share in cash if the $5.7 billion KKR acquisition closes.ITGR's deal requires majority shareholder approval plus antitrust and foreign investment clearances.Integer would become privately held and its shares would be delisted from the NYSE after closing. Integer Holdings Corporation (ITGR - Free Report) entered a definitive agreement on Aug. 2, 2026, to be acquired by affiliates of Kohlberg Kravis Roberts & Co. L.P. in a transaction carrying an enterprise value of $5.7 billion.
The deal has shifted investor focus to the proposed $127-per-share cash payment, closing conditions and the consequences of Integer becoming privately held. Operating trends still matter, but transaction execution is now the more immediate issue.
ITGR's Deal Establishes a Defined Cash ConsiderationUnder the merger agreement, each eligible Integer share outstanding immediately before closing would be converted into the right to receive $127 in cash, without interest. That creates a defined potential cash outcome for shareholders.
The consideration is not guaranteed until the transaction closes. Investors must therefore weigh the stated value against the possibility that closing conditions are delayed or not satisfied.
Integer's Buyout Still Faces Closing ConditionsCompletion requires approval and adoption of the merger agreement by holders of a majority of Integer’s outstanding shares. The transaction also requires applicable antitrust and foreign investment clearances, along with other customary conditions.
The acquisition is not subject to a financing condition. KKR’s affiliates have obtained equity and debt financing commitments, although regulatory, stockholder and other closing requirements remain.
ITGR's $307 Million Fee Adds Deal ProtectionThe agreement provides for a $307 million parent termination fee if Integer ends the deal in specified circumstances involving a buyer breach or failure to complete the transaction when required.
That provision gives Integer contractual protection if the buyer fails to perform under covered conditions. It does not remove completion risk because the merger still depends on required approvals and satisfaction of other terms.
Integer's Outlook Is Now Subordinate to the DealInteger withdrew its previously issued financial outlook after announcing the transaction and canceled its scheduled second-quarter earnings conference call and webcast. Merger progress has therefore become more immediate than management’s prior operating targets.
The business still faces pressure. Second-quarter sales fell 2.6% year over year to $464.1 million and gross margin contracted to 24.3% from 27.1%, reflecting weaker adoption of three new products and lower fixed-cost absorption.
Jabil Inc. (JBL - Free Report) provides advanced manufacturing solutions for medical devices, including cardiovascular and electrophysiology applications. Sanmina Corporation (SANM - Free Report) also designs and manufactures complex medical systems for original equipment manufacturers, underscoring the broader outsourced-manufacturing context.
Image Source: Zacks Investment Research
ITGR Would Exit the Public Market After ClosingIf completed, Integer would survive as a wholly owned subsidiary of the buyer. Its securities would be delisted from the NYSE as soon as practicable after the transaction becomes effective.
That change would end public trading in ITGR and convert the company into a privately held business. Eligible shareholders would receive the agreed cash consideration rather than continue participating in Integer as a listed company.
ITGR's Style Scores Add Context Ahead of ClosingThe bottom line is that the pending KKR transaction now dominates the near-term investment case. The $127 cash consideration offers a defined potential outcome, but shareholders remain exposed to closing risk until required conditions are satisfied.
ITGR currently carries a Zacks Rank #3 (Hold). It has a Value Score of C, a Growth Score of C, a Momentum Score of D and a VGM Score of C. Those readings do not provide strong factor support, particularly on momentum.
Zacks Style Scores complement the Zacks Rank. With a #3 ranking and mostly middle-range Style Scores, a measured stance fits the current setup while investors monitor transaction progress.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
It has been about a month since the last earnings report for Murphy USA (MUSA - Free Report) . Shares have lost about 2.6% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Murphy USA due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts.
Murphy USA Q2 Earnings Beat Estimates on Strong Fuel ContributionMotor fuel retailer Murphy USA reported second-quarter 2026 earnings of $11.27 per share, up 53.1% from $7.36 a year ago and ahead of the Zacks Consensus Estimate of $9.40 by 19.89%. The El Dorado, AR-based company’s total operating revenues surged 36% year over year to $6.81 billion and beat the Zacks Consensus Estimate of $5.90 billion by 15.34%.
Results benefited from stronger fuel economics, higher total retail volumes and merchandise contribution growth. Same-store fuel volumes increased 0.5%, while total retail gallons advanced 3.9%.
Fuel Economics Drive Strong ContributionTotal fuel contribution increased 32% year over year to $518.8 million. Moreover, the reported figure beat our estimate of $447.4 million. Retail fuel contribution climbed 25% to $448.9 million as retail fuel margins expanded to 35.1 cents per gallon from 29.2 cents in the prior-year quarter. Both Retail fuel contribution and margins exceeded our estimates of $362 million and 29 cents per gallon, respectively.
All-in fuel contribution reached 40.6 cents per gallon, up from 32 cents a year earlier. Fuel supply, including RINs, contributed 5.5 cents per gallon compared with 2.8 cents. Management noted that tighter supply conditions supported stronger spot-to-rack spreads, while higher RIN prices aided results, though that timing benefit is not expected to persist through the second half.
Merchandise Growth Remains ResilientTotal merchandise contribution rose 4% to $227.4 million, supported by higher merchandise sales and improved unit margins. Merchandise sales increased to $1.13 billion from $1.09 billion, while unit margin edged up to 20.1% from 20%.
Nicotine remained the main growth engine. Same-store nicotine sales and margins increased 2.4% and 4.6%, respectively. Cigarette sales and margins returned to growth, while nicotine-pouch unit volume more than doubled. Non-nicotine same-store sales declined 1.4%, although margins improved 0.2%.
Store and other operating expenses increased to $308.7 million from $275.2 million. Higher payment fees accounted for roughly two-thirds of the quarterly increase as higher retail fuel prices raised transaction costs. Employee-related expenses and new-store operating costs also contributed to the increase.
Still, store operating expenses excluding payment fees and rent rose only 1.1% on an average-per-store-month basis to $36,500. SG&A increased to $60.5 million from $50.9 million, primarily reflecting employee-related expenses and higher incentive accruals.
MUSA added six new-to-industry stores during the quarter and ended June with 1,806 locations. At quarter-end, 36 stores were under construction, including 32 new-to-industry sites and four raze-and-rebuild projects.
Management expects 2026 new-store additions to be closer to 45, the low end of its 45-55 range, absent tuck-in acquisitions. The company also reduced planned raze-and-rebuild activity to about 10 stores and is directing more resources toward new development, its land pipeline and stores scheduled to open in 2027.
Balance SheetOperating cash flow totaled $235 million in the quarter. Murphy USA ended June with $175.4 million in cash and cash equivalents and roughly $2.17 billion of long-term debt, with a debt-to-total capital of about 73.6%. Its revolving credit facility was undrawn at quarter-end.
This company repurchased about 143,100 shares for $76.8 million at an average price of $536.60 and paid a quarterly dividend of 64 cents per share. Capital expenditures are now expected near the high end of the $475-$525 million range as spending shifts toward growth, land purchases and proactive maintenance.
How Have Estimates Been Moving Since Then?Since the earnings release, investors have witnessed a upward trend in estimates revision.
VGM ScoresAt this time, Murphy USA has a strong Growth Score of A, a score with the same score on the momentum front. Charting a somewhat similar path, the stock has a score of B on the value side, putting it in the top 40% for value investors.
Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.
OutlookEstimates have been trending upward for the stock, and the magnitude of these revisions looks promising. Notably, Murphy USA has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
AST SpaceMobile ve středu posílila téměř o 12 % po zahájení pokrytí ze strany Berenbergu s doporučením Buy a cílovou cenou 92 USD. Firma zároveň čelí regulačním překážkám a slabším výsledkům.
Space-based cellular broadband network provider AST SpaceMobile NASDAQ: ASTS just had its best single-day stock performance since June.
On Wednesday, Sept. 2. ASTS’s nearly 12% gain was welcome news to investors who had endured a brutal slide since shares of the Midland, Texas-based company hit their all-time high (ATH) on May 28.
AST SpaceMobile, Inc. (ASTS) Price Chart for Friday, September, 4, 2026
As the SpaceX NASDAQ: SPCX competitor continues to work its way back toward its ATH, shareholders who have grown accustomed to the ups and downs of the rapidly scaling and highly volatile stock just got a shot in the arm.
Get AST SpaceMobile alerts:
A New Tailwind Ahead of AST SpaceMobile’s Next BlueBird Satellite DeploymentThroughout 2026, AST SpaceMobile’s successful (and less successful) low Earth orbit (LEO) BlueBird satellite launches have served as catalysts.
The next cohort slated to join its LEO constellation is nearing completion. BlueBird 14 is ready for launch, while BlueBirds 15 and 16 are undergoing final preparations.
While no launch date has been announced, based on prior schedules—including the Aug. 5 deployment of Bluebirds 11, 12, and 13—that could happen at some point in October. But the Sept. 2 ASTS rally was not rooted in the company’s launch schedule.
Current Price$63.13High Forecast$108.00Average Forecast$86.58Low Forecast$50.80AST SpaceMobile Stock Forecast Details
Rather, AST SpaceMobile took off on Wednesday thanks to Berenberg’s Michael Filatov initiating coverage, which was extremely bullish.
Filatov not only assigned ASTS a Buy rating, but he also gave the stock a 12-month price target of $92—a roughly 47% potential gain from Wednesday's share price—citing AST SpaceMobile’s hard-to-replicate positions in the space-based telecom industry.
ASTS carries a consensus Hold rating with just six of 13 analysts currently covering the stock assigning it a Buy rating, alongside an average 12-month price target of nearly 39%.
The announcement of initiated coverage and an aggressive price target was enough to make AST SpaceMobile the big winner among space stocks on the day.
Filatov also initiated coverage of Rocket Lab NASDAQ: RKLB and Planet Labs PBC NYSE: PL, assigning both Buy ratings, but neither was able to blast off quite like ASTS did.
This is a fair market value price provided by Massive. Learn more.
$36.08▼
$133.86$86.58
Filatov noted that AST SpaceMobile is "the only company to have demonstrated true cellular broadband from space to unmodified smartphones," adding that its more than 60 mobile network operator partnerships cover roughly three billion subscribers.
Those strategic agreements include pacts with communication services sector mainstays AT&T NYSE: T, Verizon NYSE: VZ, Tokyo-based Rakuten OTCMKTS: RKUNF, as well as a strategic relationship with real estate investment trust American Tower NYSE: AMT and the U.S. federal government.
However, while the firm expects to deploy direct-to-device (D2D) commercial services beginning in the first half of 2027, that goal comes with significant caveats.
AST SpaceMobile still faces regulatory hurdles before it can begin commercial D2D service. In August, the FCC granted the company a 30-day authorization, running through Sept. 12, to test D2D connectivity on up to 100 off-the-shelf devices using 800 MHz spectrum.
Meanwhile, a series of weak earnings continues to be an obstacle. AST SpaceMobile missed Q2 earnings and revenue estimates as spending rose sharply to support its satellite buildout, following a galactic Q1 miss.
Despite reaffirming its 2026 revenue outlook and reporting a backlog of about $1.3 billion, expanding at the scale and speed at which AST SpaceMobile is requires the company to spend its cash reserves at an alarming rate.
Analysts forecast a full-year cash burn rate in the range of $1.5 billion to $1.8 billion, driven primarily by R&D, AST SpaceMobile’s vertically integrated BlueBird satellite production, and costly rocket launch service fees, of which SpaceX charges around $55 million to $65 million per launch.
To address that expense, the company is exploring a partnership or potential acquisition of a launch services provider. In a Form 8-K filing on July 15, AST SpaceMobile noted that its $1 billion private offering of convertible senior notes due in 2034 was intended to “further vertically integrate its business and mitigate risks associated with third-party launch providers.”
However, the offering carries concerns about shareholder dilution. AST SpaceMobile ultimately raised $1.15 billion through the convertible notes, which carry an initial conversion price of $79.57 per share. However, the company also entered into capped call transactions designed to reduce potential dilution, resulting in what AST says is an effective conversion price of $149.20 and effective dilution of less than 2%.
Wall Street Sentiment Remains MixedWhile the stock remains highly volatile with a current beta of 2.74 and short interest at 18.67% of the float, or $4.08 billion worth of ASTS shares, institutional investors are buying the stock in rapid succession.
Over the past 12 months, inflows from 384 institutional buyers have totalled more than $5 billion, while outflows from 111 institutional sellers have been limited to just over $400 million. At 60.95%, institutional ownership is still below average, but AST SpaceMobile has seen buying accelerate since Q2 2025.
AST SpaceMobile continues to work its way toward its target of 45 BlueBird satellites in LEO by early 2027. A company press release confirmed that it is well on its way to achieving that goal, with “production advancing through BlueBird satellite 42” as it continues to scale its constellation.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Should You Invest $1,000 in AST SpaceMobile Right Now?Before you consider AST SpaceMobile, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AST SpaceMobile wasn't on the list.
While AST SpaceMobile currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Domino’s schválila čtvrtletní dividendu 1,99 USD na akcii, což je meziroční zvýšení o 15 %. Firma ale zároveň nese téměř 5 mld. USD dluhu a záporný vlastní kapitál.
Domino's has raised its dividend every year for over a decade and just approved another hefty increase, yet the balance sheet carries nearly $5 billion in debt and a stockholders' deficit that would alarm most retirees. Before you count on…
Income investors who own Domino’s Pizza (NASDAQ:DPZ | DPZ Price Prediction) just got their next check confirmed. The board declared a quarterly cash dividend of $1.99 per share on July 14, 2026, with an ex-dividend date of September 15, 2026 and a payment date of September 30, 2026. That payout sits on top of a trailing twelve month dividend of $7.46 per share, and it caps off one of the more aggressive dividend ramps in the restaurant group.
The tension for a retiree evaluating this stock is right there in the numbers. The dividend is rising quickly, the yield is modest, and the balance sheet carries the kind of leverage that makes conservative income investors nervous. This scorecard works through whether the payout is actually dependable.
A Four-Year Dividend Ramp on Full Display Look at the declared quarterly rate over four years and the pace is unmistakable:
2023: $1.21 per quarter 2024: $1.51 per quarter 2025: $1.74 per quarter 2026: $1.99 per quarter The February 2026 hike from $1.74 to $1.99 represented a 15% year-over-year dividend increase. That is a hefty raise for a mature restaurant chain, and it continues a multi-year growth streak that started when the dividend was initiated in 2013. A fast-rising payout looks great on a screener. It also demands scrutiny on whether cash flow is keeping pace.
Current Yield: Modest Despite the Raises With shares trading at $346.76 as of September 3, 2026, the dividend yield sits at 2.19%. That is not a rich income number. Domino’s has been raising the payout aggressively, but the starting yield is low enough that retirees comparing DPZ to REITs, utilities, or dividend aristocrats with 3.5% to 5% yields will notice the gap. Yield-hungry buyers usually get more elsewhere. What DPZ offers is dividend growth, provided that growth is sustainable.
It’s worth pointing out that DPZ is down 15.8% year to date and 24.2% over the past year, well off a 52-week high of $458.38. The pullback has lifted the yield somewhat but has not turned this into a high-yield name.
Why the Franchise Model Matters for Cash Flow Domino’s does not operate most of its stores. Franchisees do. Domino’s collects royalty streams, supply chain revenue, and franchise fees, then leaves store-level labor, food, rent, and remodel costs on the franchisee’s books. That produces a very asset-light parent company with high margins and consistent cash conversion. Operating margin runs at 19.1% and return on assets at 33.9%.
The upside of that model is what you see in the cash flow statement. In fiscal 2025, Domino’s generated operating cash flow of $792.06 million, spent $120.56 million on capex, and paid out $236.86 million in dividends. Free cash flow of $671.5 million covered the dividend with meaningful room to spare.
Payout Coverage: The Scorecard FY2025 diluted EPS came in at $17.57 against an annualized payout of roughly $7.96 based on the current quarterly rate. Trailing twelve month EPS is $17.96, and Domino’s trades at a 19 PE with a forward PE of 16.
On cash flow, the dividend is also well covered by the roughly $671 million of free cash flow generated last year. The dividend program consumed less than half of free cash flow in 2025.
The catch is that dividends are competing with a very large buyback program. In Q2 2026 alone, Domino’s repurchased 443,917 shares for $156.2 million, and the board authorized an additional $1.0 billion in buybacks in April 2026. Remaining authorization stood at $1.23 billion as of mid-June. Between dividends and buybacks, Domino’s is returning nearly all of its free cash flow to shareholders every year.
Debt on the Books As of the quarter ended June 30, 2026, total liabilities stood at $5.746 billion, long-term debt at $4.876 billion, and total shareholders’ equity at negative $3.98 billion. Domino’s has funded years of buybacks with securitized notes, and the equity account has been in deficit in every annual report from 2006 through 2025.
Cash on hand was $164.8 million at quarter end, down 39.6% year over year. The company carries roughly $4.77 billion in fixed-rate securitized notes. Domino’s regulatory filings have flagged “substantial indebtedness with negative stockholders’ equity” as a repeated risk factor.
For an income investor at or near retirement, that language matters. Negative book value is a byproduct of aggressive share repurchases here, and the interest burden is real. Any material deterioration in same-store sales or franchisee health could tighten the cash flow cushion in a hurry.
Business Behind the Coupon: Comps Decelerate Recent operating results give both bulls and bears something to point at. Q2 2026 revenue rose 4.3% to $1.194 billion, beating the $1.179 billion consensus. Diluted EPS of $4.07 missed the $4.17 consensus. U.S. same-store sales grew a barely visible 0.1%, decelerating from 3.4% in the prior year period. International same-store sales fell 0.1%.
CFO Sandeep Reddy said on the July 20 call: “We had a one-quarter blip on ticket. We’re not going to have another blip.” CEO Russell Weiner, who is transitioning to executive chairman with Joe Jordan taking over as CEO, added: “My conviction in Domino’s long-term growth potential remains as strong as ever.”
Domino’s added 183 international stores during Q2 and expects roughly 800 net international stores for the year, with the U.S. outlook trimmed to approximately 175 net stores.
Risks Retirees Should Weigh Carefully Leverage: roughly $4.9 billion of long-term debt against a stockholders’ deficit means limited balance sheet flexibility if operating results weaken. Same-store sales sensitivity: U.S. comps at +0.1% and international at -0.1% leave very little margin for error. Delivery aggregators: management is pursuing growth on Uber and DoorDash while trying to keep franchisee economics “profit neutral” on those orders. Execution risk is real. Franchisee health: a pressured pipeline and reduced U.S. store outlook reflect franchisee profitability strain. Food and labor inflation: cost pressure at the store level eventually reaches the parent through slower unit growth. Buyback competition: with $1.23 billion in remaining repurchase authorization, buybacks are competing with the dividend and debt service for the same free cash flow. Verdict on Dependability The dividend is dependable in the near and medium term. Free cash flow of $671.5 million comfortably funds the roughly $237 million dividend program, the securitized note structure is fixed rate, and management has an established record of raising the payout. A retiree who owns DPZ for income should expect the check to arrive on September 30, 2026 and expect further raises.
The dividend is less attractive as a primary income vehicle. A 2.19% yield is thin compensation for accepting a stockholders’ deficit, decelerating comps, and buybacks that consume the majority of surplus cash. This is a dividend growth story with balance sheet baggage. It earns a solid dependability grade for the next several years and a cautionary grade for the decade beyond, particularly if same-store sales cannot reaccelerate.
Contact [email protected] for any questions or corrections.
Nuvanté Technologies oznámila v srpnu 2026 prototyp clearingu stablecoinů na síti Stellar, testovaný v Bank of England Synchronisation Lab. Řešení má umožnit vydávání, zpětné odkupy a směnu digitálních peněz přes neutrální clearingovou vrstvu.
Nuvanté Technologies Ltd, a digital money clearing infrastructure company, has announced that in August 2026 it developed a prototype for stablecoin clearing tested in the Bank of England Synchronisation Lab, built on the Stellar network.
The prototype validates how fiat-backed stablecoins and other forms of digital money could be issued, redeemed and exchanged through a neutral clearing layer, with settlement flows tested against the Bank of England’s RTGS RT2 Synchronisation Lab environment.
Nuvanté’s participation in the Lab focused on multi-money issuance and redemption, including stablecoin-to-stablecoin and stablecoin-to-fiat flows. The project used the Stellar network to support the movement and orchestration of digital money.
“Stablecoins are becoming core payment infrastructure, but the market still lacks neutral clearing rails that allow issuers, banks and payment firms to exchange digital money safely and efficiently,” said Michael Chapman, Founder and CEO of Nuvanté. “Through our work in the Bank of England Synchronisation Lab, we demonstrated how regulated stablecoin clearing, interoperability and synchronised settlement could operate in a central-bank settlement environment.”
Denelle Dixon, CEO & Executive Director at the Stellar Development Foundation, added: “As stablecoins continue to scale the market needs safe, trusted and interoperable settlement infrastructure. The Stellar network was built for regulated finance and Nuvanté’s work in the Bank of England Synchronisation Lab is the kind of real-world financial use case the network was designed to support."
The announcement comes as the Bank of England continues to progress its RTGS roadmap, including the development of synchronisation capabilities designed to extend atomic settlement in central bank money to a wider set of asset markets and transaction types.
Nuvanté is also a member of the DTCC Tokenization Industry Working Group, reflecting its focus on interoperable market infrastructure for stablecoins, tokenised assets and digital payments. This follows DTCC and the Stellar Development Foundation’s recent announcement of plans to enable the tokenisation of DTC-custodied assets on the Stellar network as part of DTCC’s multi-chain strategy.
Zcash (ZEC) poprvé v historii prorazil nad 1 000 USD a dosáhl až 1 021 USD. Rally podpořilo spuštění prvního amerického spotového ETF ZCSH od Grayscale.
Key Highlights Zcash reached an unprecedented peak of $1,021 on September 4, marking an 88%+ surge over the previous month The first U.S.-based spot Zcash ETF (ZCSH) from Grayscale began trading on NYSE Arca on August 25 Network hashrate currently operates at 91% of its record peak of 27.9 GSol/s Top-tier Z15 Pro ASIC miners generate approximately $59.09 in daily revenue at present ZEC valuations Derivatives trading volume for ZEC exploded by 113.64% to reach $6.38 billion, while open interest expanded 34.97% to $2.16 billion On September 4, 2026, Zcash (ZEC) achieved a historic milestone by surpassing the $1,021 price level, penetrating the significant $1,000 psychological threshold for the first time in its history. This breakthrough occurred merely 10 days following Grayscale’s introduction of America’s inaugural spot Zcash ETF, trading under the ticker ZCSH on NYSE Arca since August 25.
Zcash (ZEC) Price Just one day earlier, on September 3, ZEC touched an intraday peak of $979, representing a nearly 17% single-day advance. The asset has now accumulated gains exceeding 88% over a 30-day period, while the six-month performance shows an impressive rise of approximately 353% relative to the U.S. dollar.
Prominent cryptocurrency commentary platform Crypto Banter highlighted the $1,000 breakthrough on X, observing that market participants are increasingly viewing Zcash’s confidential transaction capabilities as protection against blockchain monitoring. The platform specifically identified the Grayscale ETF introduction as a primary driver behind the price movement.
🚨ZCASH BREAKS $1,000!$ZEC pushed through $1,000, about 10 days after @Grayscale listed the first U.S. spot Zcash ETF, $ZCSH, on NYSE Arca on Aug. 25.
The move is leading the privacy coin bid as traders treat shielded transfers as a hedge against on-chain surveillance. pic.twitter.com/hMaQb8FlqR
— Crypto Banter (@crypto_banter) September 4, 2026
Zcash’s fundamental value proposition revolves around privacy-centric transactions enabled through zero-knowledge proof technology. The cryptocurrency also features a maximum supply ceiling of 21 million tokens, mirroring Bitcoin’s scarcity characteristics.
Network Hashrate Approaches Historical Peak The dramatic price appreciation has triggered a substantial increase in mining participation. Zcash’s network hashrate achieved a record 27.9 GSol/s on August 28 and presently maintains levels at 91% of that all-time benchmark.
ZEC Jumps 20%, Briefly Hits $1,023 and Enters Crypto Top 10
According to Binance market data, Zcash (ZEC) gained about 20% over the past 24 hours, briefly reaching around $1,023. Its market capitalization now stands at roughly $16.96 billion, ranking it as the 10th-largest… pic.twitter.com/EnqLMx7C29
— Wu Blockchain (@WuBlockchain) September 4, 2026
Currently, Bitmain’s Antminer Z15 Pro stands as the highest-earning ASIC mining device available, producing estimated daily returns of $59.09 at prevailing ZEC valuations, assuming electricity expenses of $0.10 per kWh. The predecessor Z15 model generates approximately $29.25 per day, securing fourth position in profitability rankings.
Inventory for both mining units has been depleted on Bitmain’s official platform. Third-party vendors are offering the Z15 Pro at prices exceeding its $4,999 manufacturer’s suggested retail price.
Futures Trading Activity Surges During Price Rally The derivatives ecosystem surrounding ZEC has experienced significant expansion concurrent with the price rally. Futures trading volume skyrocketed by 113.64% to $6.38 billion. Outstanding open interest increased by 34.97% to reach $2.16 billion. Spot market volume over a 24-hour period currently hovers around $594.6 million.
Market analyst Ali Charts shared a weekly price chart on August 31, projecting $1,800 as a feasible technical objective for ZEC, characterizing the formation as poised to “melt faces.” The analysis designated $1,000 as an initial target, with the $1,200–$1,300 range identified as subsequent resistance zones.
Critical support is established within the $700–$800 range. Maintaining price levels above this zone during potential corrections would preserve the integrity of the current bullish breakout pattern.
The September 4 advance above $1,021 represents ZEC’s inaugural trading session above the four-figure threshold.
Zcash (ZEC) za 24 hodin vyskočil zhruba o 20 % na maximum 1 023 USD a dostal se mezi 10 největších kryptoměn. Likvidace pákových pozic dosáhly 36,6 milionu USD, z toho 34,5 milionu na shortech.
Zcash (ZEC) has soared into cryptocurrency’s top 10 following a powerful rally that briefly pushed its price above $1,000, intensifying trading activity and market risk around the fast-moving asset.
Rally pushes Zcash above $1,000Zcash jumped approximately 20% in the span of 24 hours, climbing to a peak of $1,023 on Friday. This surge boosted ZEC’s market capitalization close to $17 billion, before steadying around $983 with a market cap near $16.6 billion, according to CoinMarketCap.
The strong rally secured Zcash’s place as the 10th-largest cryptocurrency by market value, marking its highest position in years as fresh demand sent volumes soaring.
Leveraged trading intensifies volatilityOpen interest in ZEC futures rose dramatically to about 2.3 million ZEC, equivalent to nearly $2.3 billion at prevailing prices. This amount represents around 14% of Zcash’s total market capitalization, an outsized footprint that analysts say highlights aggressive positioning across derivatives markets.
The spike in leveraged activity led to heavy losses for bearish traders. Within 24 hours, roughly $36.6 million in leveraged ZEC positions were forcibly closed, with $34.5 million of liquidations targeting traders who bet against the asset’s price. Short positions accounted for approximately 94% of the reported liquidations.
A surge in short liquidations can fuel an ongoing rally further, as traders covering their positions must buy back ZEC, creating additional demand pressure.
While leveraged trading has driven sharp gains for bullish participants, analysts warn that the same leverage can amplify downside moves in the event of a reversal, given the scale of current futures positions.
MetricValue24-hour ZEC price high$1,023Current ZEC price$983Market capitalization$16.6 billionOpen interest (futures)2.3 million ZEC / $2.3 billion24-hour liquidations$36.6 millionShort liquidations$34.5 millionETF conversion fuels institutional demandThe latest rally follows a pivotal change for U.S. investors: Grayscale, a leading digital asset manager, completed the conversion of its long-standing Zcash trust into The Zcash ETF. The Securities and Exchange Commission (SEC) approved the ETF structure and new name in late August. Shares now trade under the ZCSH ticker, offering investors regulated brokerage-market access to ZEC.
Momentum had been building for weeks, with ZEC already moving higher after Grayscale filed an amended ETF application that included plans to list on NYSE Arca and a 2.5% management fee. These developments have returned Zcash to price levels last seen during the 2018 bull cycle, highlighting institutional progress as a major catalyst for the current surge.
Grayscale is recognized as one of the world’s largest managers of digital currency investment products, often providing traditional financial channels with access to cryptocurrencies.
Mini dictionary: ETF, or Exchange-Traded Fund, is a regulated investment product that tracks the price of an asset and can be traded like a stock, enabling broader investor access and liquidity for underlying cryptocurrencies like ZEC.
Analysts highlight risks from leverageZcash’s dramatic entry into the upper tier of the crypto market goes beyond short-term speculation. With open interest in ZEC futures now representing nearly one-seventh of the coin’s entire market value, analysts emphasize that the leverage currently propelling sharp gains could just as quickly intensify downside pressure if sentiment shifts.
The interplay of institutional products like ETFs and elevated futures activity places ZEC at the center of a key test for both new and experienced investors, as the asset’s liquidity and price trajectory remain tightly linked to broader trends in cryptocurrency markets.
OKX spouští program DOS „Stake to Earn“ v rámci Flash Earn Lite a účastníci si rozdělí 650 000 DOS z odměnového fondu. Do programu lze přihlásit BTC, OKB nebo DOS. Akce poběží od 10. září 2026 15:00 UTC+8 do 15. září 2026 15:00 UTC+8, předběžná registrace začíná 5. září 2026 15:00 UTC+8.
According to official announcements, OKX’s Flash Earn Lite will launch the DOS "Stake to Earn" program from 15:00 UTC+8 on September 10, 2026 to 15:00 UTC+8 on September 15, 2026. During the event, users who lock BTC, OKB, or DOS to subscribe will share the 650,000 DOS airdrop reward pool. Early subscription is open starting from 15:00 UTC+8 on September 5, 2026, with rewards calculated from the official event start. Additionally, starting with this event, users can directly use assets from their flexible Simple Earn wallets to subscribe to Flash Earn’s Stake to Earn programs. Participation is available via the event link or by selecting "Flash Earn" at the top of the OKX App’s Explore page.
Relevant content
US stocks have maintained low volatility for 25 consecutive days, marking the longest such stretch since May 1992.
According to market data, the CBOE Volatility Index (VIX), the benchmark gauge for U.S. stock market volatility tied to the S&P 500, has closed in the 14 to 17 point range for 25 consecutive trading days — the longest such stretch since May 1992. Over the past 34 years, the only comparable period occurred in 2025, with the streak lasting 24 trading days. Meanwhile, the S&P 500 has not posted a decline of at least -1.0% across 26 consecutive trading days, leaving the market in an unusually calm phase.
35 minutes ago
Hyperliquid will cut the minimum order notional amount for its prediction markets from $10 to $1.
Hyperliquid announced that in its upcoming network upgrade, it will lower the minimum notional amount for outcome orders (prediction market result token orders) from $10 to $1. Meanwhile, deployers will be able to query their remaining quota via the outcomeDeployerLimits information request interface.
35 minutes ago
Anthropic’s strategic deployment of in-house payment technology could erode Stripe’s market share.
Beating AI Express (from Dongcha) reports: Recent job postings reveal that Anthropic is planning to develop more in-house billing, fraud detection, and other financial infrastructure, while evaluating which payment-related services can be built internally instead of relying on external service providers. The postings show Anthropic has not yet finalized decisions on whether to further develop its own tools in areas including payments, billing, and tax processing, or continue procuring solutions from external providers. One senior software engineer position focused on billing requires assisting the company with technical selection: determining which business lines will continue development on external provider platforms, and which scenarios necessitate building their own underlying foundational modules around those external platforms.
35 minutes ago
Analyst: Bitcoin successfully retested the long-term descending trend line, and its monthly chart needs to hold above $76,000.
Prominent crypto analyst Rekt Capital notes that Bitcoin has successfully retested its macro downtrend line as support, with this line aligning closely with the highs from April-May 2026. Current price levels indicate the retest is initially valid. Rekt Capital also states that to avoid a shift into a downtrend, BTC must prevent its monthly closing price from falling below the downtrend line (approximately $761.87 million), as this could form an upper wick and weaken its breakout potential.
35 minutes ago
Tesla’s intraday price fell more than 6% as its Cybercab launch failed to meet expectations.
According to market data from BIT (bit.com), Tesla’s intraday price dropped as much as 6.3%. The highly anticipated Cybercab event held Thursday evening delivered far less substance than Wall Street had expected. Tesla’s stock had risen 5.4% ahead of the Thursday event, with analysts noting that a strong presentation could have reversed the stock’s upward momentum. The electric vehicle maker has staked its future on a shift toward physical AI, including autonomous driving and robotics.
35 minutes ago
Balancer extends a white hat invitation to the hacker, setting a deadline of 5:00 on September 9 for the return of approximately $234,000 in funds.
Balancer announced that its team has sent on-chain messages to wallets linked to the August 31 Balancer V1 exploit attack, proposing a deal: return of stolen funds in exchange for a bounty, with a commitment not to pursue legal liability for the return itself once conditions are met. If the attacker does not respond by 5:00 on September 9, Balancer will take technical, on-chain, and legal measures to track them. The incident resulted in approximately $234,000 in losses.
SpaceX se krátce vrátila na tržní kapitalizaci 2 biliony USD díky optimismu kolem Starlinku, startů a expanze do AI. Firma ale čelí vysokým kapitálovým nárokům, konkurenci a regulační nejistotě.
Key Takeaways SPCX briefly regained a $2 trillion valuation amid optimism over Starlink, launches and AI expansion.Starlink's expansion boosts recurring revenues, while vertical integration lowers satellite launch costs.SpaceX faces high capital needs, execution risks, rising competition and regulatory uncertainty. Space Exploration Technologies Corp. (SPCX - Free Report) has briefly regained the coveted $2 trillion market capitalization mark, reflecting renewed investor optimism surrounding its expanding Starlink business, unmatched launch capabilities, progress on Starship and growing exposure to government and defense spending.
The rebound underscores Wall Street’s confidence in SpaceX’s ability to capitalize on rapidly expanding opportunities across satellite broadband, commercial space launches and next-generation space transportation. Its vertically integrated business model, technological leadership and growing recurring revenue base have also strengthened the investment case.
Starlink: Key Growth EngineStarlink's continued expansion is one of the biggest pillars supporting SpaceX’s valuation. The satellite broadband platform has steadily broadened its reach across residential, enterprise, aviation, maritime and government markets.
Growing adoption increases the proportion of recurring subscription revenues within SpaceX’s overall business mix, reducing its dependence on the comparatively project-driven launch business. The improved revenue visibility can potentially support stronger margins and more predictable cash flows over the long run.
Starlink also benefits from SpaceX’s ability to launch its own satellites at relatively low incremental cost. This vertical integration allows the company to expand its network faster while avoiding the launch expenses that competing satellite operators typically incur. Continued investment in higher-capacity satellites and improved network infrastructure should further strengthen Starlink’s ability to address rising global demand for high-speed connectivity.
Launch Dominance Boosts SpaceX’s Competitive PositionSpaceX’s formidable position in the orbital launch market is another major factor supporting investor confidence. The company’s reusable Falcon 9 platform has transformed launch economics by significantly lowering the cost of accessing orbit. Reusability, high launch frequency and an established operating track record have created formidable competitive advantages that rivals find difficult to replicate.
Higher launch cadence also generates operating efficiencies. SpaceX can spread fixed infrastructure and development costs across a larger number of missions, potentially strengthening profitability as volumes increase. Demand continues to originate from a diverse customer base that includes commercial satellite operators, government agencies, national-security customers and SpaceX’s own Starlink constellation. This diversified launch pipeline provides another layer of revenue visibility.
The ability to serve external customers while simultaneously supporting Starlink deployment gives SpaceX an ecosystem advantage that remains difficult for competing launch providers to match.
AI, Data and Global Connectivity Lend SupportAnother factor supporting the bullish narrative is the increasing importance of global connectivity. Demand for data transmission continues to grow as cloud computing, AI, autonomous systems and connected devices proliferate worldwide. Satellite communications could become an increasingly important component of this infrastructure, particularly in areas where terrestrial broadband remains inadequate. Starlink's global network gives SpaceX exposure to this secular trend.
The company plans to deploy AI compute satellites as early as 2028, effectively creating space-based data centers capable of delivering large-scale computing capacity. This initiative leverages SpaceX's leadership in satellite deployment while addressing the growing demand for AI computing resources. Alongside its satellite ambitions, SpaceX continues to expand its Colossus data center platform, strengthening its position in AI infrastructure. The buyout of Anysphere – a startup firm behind the rapidly growing AI coding assistant Cursor – gives SpaceX exposure to a high-growth software business while strengthening its AI capabilities. It adds a widely adopted developer platform that could complement the company's growing technology portfolio.
Estimate Revision TrendThe Zacks Consensus Estimate for SpaceX’s 2026 loss has narrowed from 53 cents per share to 5 cents over the past 30 days. The same for 2027 earnings has improved from 68 cents to $1.63. The positive estimate revision depicts bullish sentiments about the stock’s growth potential.
Image Source: Zacks Investment Research
Likely PitfallsDespite the strong growth prospects, SPCX is not devoid of challenges. A $2 trillion valuation leaves relatively little room for execution disappointments and implies significant expectations for future revenue and earnings growth. Any slowdown in Starlink subscriber additions, delays in Starship development or deterioration in launch reliability could pressure investor sentiment.
SpaceX also faces substantial capital requirements. Building satellites, developing launch vehicles and expanding communications infrastructure require persistent investment. Meanwhile, competition across the satellite Internet and launch markets is intensifying as governments and private companies invest aggressively in alternative platforms. Regulatory uncertainty surrounding spectrum allocation, orbital congestion and international market access represents another potential headwind.
Price PerformanceSpaceX has declined 6.9% since its IPO against the industry’s growth of 117.4% over the past month. It has lagged peers like Verizon Communications Inc. (VZ - Free Report) and AT&T Inc. (T - Free Report) over this period. While Verizon has jumped 5.2%, AT&T is up 11.1%.
Image Source: Zacks Investment Research
End NoteSpaceX is steadily transforming from a pure-play aerospace company into a diversified AI infrastructure leader. Its aggressive investments in AI computing, expanding enterprise partnerships and plans for space-based data centers underscore management's conviction that AI will be a key driver of future growth.
Although the AI segment is likely to remain under pressure in the near term due to elevated investment levels, the company's long-term growth prospects appear increasingly tied to the rapid expansion of the global AI infrastructure market. While high operating costs and execution risks warrant attention, SpaceX appears well-positioned to benefit from the secular growth of the space economy. Those who already own the stock can hold onto it while new investors may wait for a better entry point.
SpaceX currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Apple se chystá 9. září představit první skládací iPhone na první akci pod vedením Johna Ternuse po jeho nástupu do role CEO 1. září. TrendForce očekává zdražení celé řady o 10 % až 20 %, u iPhonu 18 Pro až na 1 319 USD.
Apple Inc. AAPL fell 0.34% intraday ahead of a September 9 product launch that will be the first under John Ternus, who succeeded Tim Cook as CEO on September 1. The company is expected to introduce its first foldable iPhone at the event, alongside the iPhone 18 Pro and Pro Max.
TrendForce estimates memory costs for the 256-gigabyte iPhone 18 Pro at nearly 400% above where they sat a year ago. Its projection is that Apple raises prices across the lineup by 10% to 20%, putting the Pro at as much as $1,319 against $1,099 for the iPhone 17 Pro. The research firm called that a "moderate pricing approach," while Apple is expected to absorb part of the increase. The first foldable starts between $2,099 and $2,299 on TrendForce's estimate.
KeyBanc reads it as a problem either way. In a note reiterating an Underweight rating and $250 target, the firm argued a large increase eases gross margin pressure but hits unit volumes and risks sticker shock, while a more selective increase leaves the margin question open and invites more hikes later.
Citi označila iPhone 18 za klíčový katalyzátor pro dodavatele Apple a vyzdvihla hlavně Lens Tech, Lingyi, Amphenol, Largan, Sunny, AAC, Alps Alpine, Kioxia, Luxshare a TSMC. První skládací model iPhone Ultra má mít cenu nad 2 000 USD.
Apple Inc (NASDAQ:AAPL, XETRA:APC) was the focus of a supply-chain preview from Citi on Friday, highlighting the upcoming iPhone 18 family as a key catalyst for component suppliers.
With shares trading at $328.21, the iPhone 18 lineup is expected to launch on 9 September, featuring Pro models priced roughly $200 higher than their predecessors.
At the centre of the preview is the tech giant's first foldable device, likely to be called the iPhone Ultra, which the bank expects to have a starting price above $2,000.
That foldable flagship is projected to feature dual front and dual rear cameras alongside an inner foldable display fitted with an ultra-thin glass and OLED cover.
Major hardware upgrades across the range could include A20 chips, an Apple-designed modem, and a variable-aperture main camera for the Pro and Pro Max models.
Following supply-chain underperformance during the June to August restocking period, the note states that the sector is likely to see a rally before launch and potential profit-taking afterwards.
Suppliers tied to the foldable device may face tight initial component supply and extended lead times, particularly for batteries, vapour chamber heatsinks, and structural parts.
Within the production network, Citi highlighted a preference for major share and content gainers such as Lens Tech, Lingyi, Amphenol, Largan, Sunny, AAC, Alps Alpine, Kioxia, Luxshare, and TSMC.
Crucial upcoming catalysts for the sector include initial sales and shipping schedules, as well as subsequent supply chain order adjustments.
Elon Musk po představení Cybercabu řekl, že dalším důležitým krokem je autonomní létání elektrických letadel. Tím podpořil širší vizi Tesly o dopravě řízené umělou inteligencí.
Tesla Inc‘s (NASDAQ:TSLA) Cybercab launch was supposed to be about robotaxis. But less than 24 hours later, CEO Elon Musk shifted the conversation to the skies, calling autonomous flight “an important next step” for electric aircraft. The timing suggests that Tesla’s latest unveiling wasn’t just about a new vehicle—it was about a broader vision for AI-powered transportation.
At the Cybercab launch event, the engineering team didn’t spend most of its presentation talking about battery range, acceleration or even the vehicle itself. Instead, executives devoted much of the launch to explaining the artificial intelligence behind the robotaxi.
AI Before Everything ElseOne theme dominated Tesla’s Cybercab launch: autonomy is an intelligence problem.
“The core issue for self-driving is one of intelligence,” Ashok Elluswamy, Tesla’s vehicle software chief, told attendees, pushing back against the industry’s view that safe autonomous driving requires lidar, radar and high-definition maps.
“You need to understand what is going on. You need to predict what is going to happen in the future,” he said. “No sensor in the world is going to tell you what’s going to happen in the future. It is something an intelligent agent is going to have to figure out.”
Trending
Tesla said that philosophy led it to build an “AI-first, end-to-end driving stack” that relies on camera inputs rather than a suite of expensive sensors. The company argued that humans navigate roads primarily through vision, and that artificial intelligence can learn to do the same by training on vast amounts of real-world driving data.
Executives also revealed that Tesla has now logged more than one million miles of unsupervised robotaxi operation, crediting billions of miles of customer driving data with helping train its autonomous driving models.
The company said the system has accumulated “more than a thousand lifetimes of experience,” allowing it to recognize rare driving scenarios before they happen.
A Clue Beyond CarsAgainst that backdrop, Musk’s latest social media post takes on a different meaning.
Responding to Heart Aerospace’s successful demonstration of its battery-electric X1 aircraft, Musk wrote: “I’m so glad this is being done! An important next step is making it autonomous.”
The remark wasn’t a product announcement, nor did Musk suggest Tesla is building an aircraft. Instead, it echoed the central argument Tesla had spent the previous day making: that once artificial intelligence can reliably understand and predict the physical world, the same autonomy principles could eventually apply beyond cars.
That consistency matters. Rather than describing Cybercab as simply Tesla’s newest electric vehicle, executives repeatedly framed it as the first large-scale deployment of an AI system designed to drive safely without human intervention.
What Investors Should WatchCybercab may be the product investors can see, but Tesla’s messaging suggests the company’s longer-term ambition lies elsewhere.
Throughout the launch, executives emphasized intelligence over hardware, prediction over sensors and AI over traditional automotive engineering. Musk’s comments on autonomous aviation fit neatly into that narrative, hinting that he increasingly views autonomy as a technology platform that can power multiple forms of transportation—not just robotaxis.
Whether that vision ultimately extends beyond roads remains uncertain. But if Cybercab succeeds in proving Tesla’s AI-first approach at scale, investors may come to see the robotaxi not as the destination, but as the first commercial demonstration of a much broader autonomy strategy.
Comprehensive Financial Consultants Institutional Inc. ve 2. čtvrtletí zvýšila podíl v Microsoftu o 11,9 % na 17 184 akcií. Hodnota držby činila 6,41 mil. USD.
Comprehensive Financial Consultants Institutional Inc. raised its position in shares of Microsoft Corporation (NASDAQ:MSFT – Free Report) by 11.9% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 17,184 shares of the software giant’s stock after purchasing an additional 1,821 shares during the quarter. Microsoft accounts for 1.7% of Comprehensive Financial Consultants Institutional Inc.’s portfolio, making the stock its 13th largest position. Comprehensive Financial Consultants Institutional Inc.’s holdings in Microsoft were worth $6,410,000 at the end of the most recent reporting period.
Other hedge funds have also modified their holdings of the company. WFA Asset Management Corp raised its position in Microsoft by 27.0% during the 1st quarter. WFA Asset Management Corp now owns 1,016 shares of the software giant’s stock worth $427,000 after buying an additional 216 shares during the last quarter. Ironwood Wealth Management LLC. boosted its holdings in shares of Microsoft by 0.3% in the 2nd quarter. Ironwood Wealth Management LLC. now owns 12,658 shares of the software giant’s stock valued at $5,658,000 after acquiring an additional 38 shares during the last quarter. Discipline Wealth Solutions LLC increased its stake in shares of Microsoft by 410.4% in the third quarter. Discipline Wealth Solutions LLC now owns 2,659 shares of the software giant’s stock worth $1,144,000 after acquiring an additional 2,138 shares during the period. Wealth Group Ltd. increased its stake in shares of Microsoft by 1.2% in the fourth quarter. Wealth Group Ltd. now owns 2,374 shares of the software giant’s stock worth $1,000,000 after acquiring an additional 28 shares during the period. Finally, Eagle Capital Management LLC raised its holdings in shares of Microsoft by 0.4% during the fourth quarter. Eagle Capital Management LLC now owns 23,097 shares of the software giant’s stock worth $9,735,000 after purchasing an additional 96 shares during the last quarter. 71.13% of the stock is owned by institutional investors and hedge funds.
Microsoft Stock Up 2.7% MSFT stock opened at $510.12 on Friday. Microsoft Corporation has a one year low of $349.20 and a one year high of $553.72. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.22 and a current ratio of 1.23. The firm’s fifty day moving average is $441.99 and its 200 day moving average is $415.21. The firm has a market cap of $3.79 trillion, a PE ratio of 28.40, a P/E/G ratio of 1.60 and a beta of 1.11.
Microsoft (NASDAQ:MSFT – Get Free Report) last issued its quarterly earnings data on Wednesday, July 29th. The software giant reported $4.74 earnings per share for the quarter, topping analysts’ consensus estimates of $4.24 by $0.50. Microsoft had a net margin of 40.31% and a return on equity of 31.98%. The business had revenue of $90.01 billion during the quarter, compared to the consensus estimate of $87.62 billion. During the same quarter in the prior year, the firm posted $3.65 earnings per share. The company’s revenue was up 17.7% compared to the same quarter last year. On average, research analysts forecast that Microsoft Corporation will post 19.59 EPS for the current year. Microsoft Announces Dividend The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 10th. Investors of record on Thursday, August 20th will be issued a $0.91 dividend. The ex-dividend date of this dividend is Thursday, August 20th. This represents a $3.64 dividend on an annualized basis and a yield of 0.7%. Microsoft’s dividend payout ratio is presently 20.27%.
Key Stories Impacting Microsoft Here are the key news stories impacting Microsoft this week:
Positive Sentiment: Microsoft will begin reporting quarterly Azure revenue in fiscal 2027 and reorganize its financial reporting from three segments into two AI-focused categories. Azure generated approximately $29.4 billion in quarterly revenue and $101.9 billion for fiscal 2026, providing investors with more visibility into cloud growth and AI demand. Microsoft to reveal Azure cloud sales in financial reporting shift Positive Sentiment: Citi reaffirmed a Buy rating and $600 price target, while other analysts cited Microsoft’s large AI backlog, Azure’s more than $100 billion annual revenue and the potential for improved AI economics. The company’s latest earnings also showed strong momentum, with revenue up 17.7% year over year and a substantial earnings beat. Analyst reaffirms Buy on Microsoft Positive Sentiment: Microsoft-backed OpenAI launched GPT-6 Astra, potentially strengthening Microsoft’s AI ecosystem and demand for Azure infrastructure. Microsoft is also securing long-term power capacity for data centers and expanding Microsoft 365 Copilot integrations. OpenAI launches GPT-6 Astra Neutral Sentiment: CEO Satya Nadella sold 86,525 shares worth about $43.4 million under a pre-arranged Rule 10b5-1 plan. The scheduled nature of the sale limits its significance, although it reduced his holdings by 15.09% and adds to recent insider selling. Negative Sentiment: Microsoft will impose monthly limits on Xbox cloud-gaming hours for Game Pass subscribers beginning in November as service costs rise. The change may improve economics but could hurt consumer sentiment and gaming engagement. Microsoft to impose time limits on Xbox cloud gaming Negative Sentiment: Investors continue to weigh Microsoft’s roughly $116 billion AI infrastructure spending plan, rising data-center costs and pressure on cloud margins. The key risk is whether the large backlog converts into profitable cash flow rather than simply future revenue. Analyst Upgrades and Downgrades A number of research analysts recently issued reports on the stock. Guggenheim restated a “buy” rating and set a $586.00 target price on shares of Microsoft in a research report on Monday, July 27th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Microsoft in a research report on Monday, July 20th. Royal Bank Of Canada reiterated an “outperform” rating and set a $640.00 price objective on shares of Microsoft in a research note on Thursday, July 30th. Phillip Securities downgraded Microsoft from a “strong-buy” rating to a “moderate buy” rating in a research note on Monday, August 3rd. Finally, CLSA reaffirmed an “outperform” rating on shares of Microsoft in a report on Thursday, July 30th. Forty-two analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $562.49.
Read Our Latest Research Report on Microsoft
Insider Buying and Selling In other news, CEO Judson Althoff sold 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 5th. The stock was sold at an average price of $487.89, for a total value of $4,878,900.00. Following the completion of the sale, the chief executive officer directly owned 100,447 shares in the company, valued at $49,007,086.83. The trade was a 9.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Satya Nadella sold 86,525 shares of the company’s stock in a transaction that occurred on Tuesday, September 1st. The stock was sold at an average price of $501.46, for a total value of $43,388,826.50. Following the transaction, the chief executive officer directly owned 486,763 shares of the company’s stock, valued at approximately $244,092,173.98. The trade was a 15.09% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 108,335 shares of company stock valued at $53,499,700. 0.03% of the stock is owned by company insiders.
Microsoft Company Profile (Free Report)
Microsoft Corporation is a global technology company headquartered in Redmond, Washington. Founded in 1975 by Bill Gates and Paul Allen, Microsoft develops, licenses and supports a broad range of software products, services and devices for consumers, enterprises and governments worldwide. Its operations span personal computing, productivity software, cloud infrastructure, enterprise applications, developer tools and gaming.
Microsoft’s product portfolio includes the Windows operating system and the Microsoft 365 suite of productivity and collaboration tools (Office apps, Outlook, Teams).
See Also Five stocks we like better than Microsoft The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now Dropping the Dough: Yum! Brands Strategically Trims the Fat These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern Want to see what other hedge funds are holding MSFT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Microsoft Corporation (NASDAQ:MSFT – Free Report).
Receive News & Ratings for Microsoft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microsoft and related companies with MarketBeat.com's FREE daily email newsletter.
Goelzer Investment Management Inc. trimmed its stake in Microsoft Corporation (NASDAQ:MSFT – Free Report) by 4.3% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 82,547 shares of the software giant’s stock after selling 3,732 shares during the period. Microsoft comprises approximately 1.3% of Goelzer Investment Management Inc.’s investment portfolio, making the stock its 9th biggest position. Goelzer Investment Management Inc.’s holdings in Microsoft were worth $30,792,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Longfellow Investment Management Co. LLC boosted its holdings in Microsoft by 51.3% in the second quarter. Longfellow Investment Management Co. LLC now owns 59 shares of the software giant’s stock valued at $29,000 after acquiring an additional 20 shares during the last quarter. Bernzott Capital Advisors bought a new position in Microsoft during the 4th quarter worth approximately $34,000. Frankly Finances LLC bought a new position in Microsoft during the 2nd quarter worth approximately $35,000. Timmons Wealth Management LLC acquired a new position in shares of Microsoft in the 4th quarter worth approximately $36,000. Finally, Fairway Wealth LLC lifted its position in shares of Microsoft by 287.0% in the 4th quarter. Fairway Wealth LLC now owns 89 shares of the software giant’s stock worth $43,000 after purchasing an additional 66 shares during the period. 71.13% of the stock is owned by institutional investors and hedge funds.
More Microsoft News Here are the key news stories impacting Microsoft this week:
Positive Sentiment: Microsoft will begin reporting quarterly Azure revenue in fiscal 2027 and reorganize its financial reporting from three segments into two AI-focused categories. Azure generated approximately $29.4 billion in quarterly revenue and $101.9 billion for fiscal 2026, providing investors with more visibility into cloud growth and AI demand. Microsoft to reveal Azure cloud sales in financial reporting shift Positive Sentiment: Citi reaffirmed a Buy rating and $600 price target, while other analysts cited Microsoft’s large AI backlog, Azure’s more than $100 billion annual revenue and the potential for improved AI economics. The company’s latest earnings also showed strong momentum, with revenue up 17.7% year over year and a substantial earnings beat. Analyst reaffirms Buy on Microsoft Positive Sentiment: Microsoft-backed OpenAI launched GPT-6 Astra, potentially strengthening Microsoft’s AI ecosystem and demand for Azure infrastructure. Microsoft is also securing long-term power capacity for data centers and expanding Microsoft 365 Copilot integrations. OpenAI launches GPT-6 Astra Neutral Sentiment: CEO Satya Nadella sold 86,525 shares worth about $43.4 million under a pre-arranged Rule 10b5-1 plan. The scheduled nature of the sale limits its significance, although it reduced his holdings by 15.09% and adds to recent insider selling. Negative Sentiment: Microsoft will impose monthly limits on Xbox cloud-gaming hours for Game Pass subscribers beginning in November as service costs rise. The change may improve economics but could hurt consumer sentiment and gaming engagement. Microsoft to impose time limits on Xbox cloud gaming Negative Sentiment: Investors continue to weigh Microsoft’s roughly $116 billion AI infrastructure spending plan, rising data-center costs and pressure on cloud margins. The key risk is whether the large backlog converts into profitable cash flow rather than simply future revenue. Insider Activity In other Microsoft news, EVP Takeshi Numoto sold 4,810 shares of the stock in a transaction that occurred on Tuesday, August 4th. The stock was sold at an average price of $496.48, for a total value of $2,388,068.80. Following the transaction, the executive vice president owned 42,677 shares in the company, valued at approximately $21,188,276.96. This represents a 10.13% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Judson Althoff sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 5th. The shares were sold at an average price of $487.89, for a total value of $4,878,900.00. Following the completion of the sale, the chief executive officer directly owned 100,447 shares of the company’s stock, valued at $49,007,086.83. This trade represents a 9.05% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 108,335 shares of company stock worth $53,499,700 in the last three months. Company insiders own 0.03% of the company’s stock. Microsoft Stock Up 2.7% Microsoft stock opened at $510.12 on Friday. The company has a market capitalization of $3.79 trillion, a PE ratio of 28.40, a PEG ratio of 1.60 and a beta of 1.11. Microsoft Corporation has a 12-month low of $349.20 and a 12-month high of $553.72. The firm’s fifty day moving average is $441.99 and its 200 day moving average is $415.21. The company has a quick ratio of 1.22, a current ratio of 1.23 and a debt-to-equity ratio of 0.07.
Microsoft (NASDAQ:MSFT – Get Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The software giant reported $4.74 EPS for the quarter, topping analysts’ consensus estimates of $4.24 by $0.50. Microsoft had a net margin of 40.31% and a return on equity of 31.98%. The business had revenue of $90.01 billion during the quarter, compared to analysts’ expectations of $87.62 billion. During the same period last year, the company posted $3.65 earnings per share. The business’s quarterly revenue was up 17.7% on a year-over-year basis. As a group, sell-side analysts predict that Microsoft Corporation will post 19.59 EPS for the current fiscal year.
Microsoft Dividend Announcement The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 10th. Stockholders of record on Thursday, August 20th will be given a dividend of $0.91 per share. This represents a $3.64 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Thursday, August 20th. Microsoft’s dividend payout ratio is 20.27%.
Analyst Upgrades and Downgrades MSFT has been the subject of several recent analyst reports. Citigroup reiterated a “market outperform” rating on shares of Microsoft in a research report on Monday. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Microsoft in a report on Monday, July 20th. CLSA reaffirmed an “outperform” rating on shares of Microsoft in a research report on Thursday, July 30th. Bank of America increased their price target on Microsoft from $500.00 to $600.00 and gave the stock a “buy” rating in a report on Tuesday. Finally, Cantor Fitzgerald boosted their price objective on Microsoft from $502.00 to $522.00 and gave the company an “overweight” rating in a research note on Monday, July 27th. Forty-two research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $562.49.
Get Our Latest Stock Report on MSFT
About Microsoft (Free Report)
Microsoft Corporation is a global technology company headquartered in Redmond, Washington. Founded in 1975 by Bill Gates and Paul Allen, Microsoft develops, licenses and supports a broad range of software products, services and devices for consumers, enterprises and governments worldwide. Its operations span personal computing, productivity software, cloud infrastructure, enterprise applications, developer tools and gaming.
Microsoft’s product portfolio includes the Windows operating system and the Microsoft 365 suite of productivity and collaboration tools (Office apps, Outlook, Teams).
See Also Five stocks we like better than Microsoft The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now Dropping the Dough: Yum! Brands Strategically Trims the Fat These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern
Receive News & Ratings for Microsoft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microsoft and related companies with MarketBeat.com's FREE daily email newsletter.
The growth of Hedera Council’s network of Strategic and Community Partners continues, with the addition of two new partnerships. This partnership program leverages the skills, networks and resources of industry leaders to drive real-world adoption of Hedera.
Hedera Council’s latest collaborations expand Hedera’s capabilities for secure, decentralized infrastructure for real-world use cases, while enhancing Hedera’s technical offerings. Hedera’s latest Strategic Partner is WISeKey, a global expert in cybersecurity, digital identity and IoT solutions. As Hedera’s fourth Strategic Partner, WISeKey joins the Global Blockchain Business Council, Halborn and the Institutes RiskStream Collaborative.
Accelerating Authentication and Digital ID on Hedera
Based in Switzerland, WISeKey is strongly embedded in Web3 infrastructure, offering secure authentication and identification solutions for IoT, blockchain and AI. SEALCOIN AG, one of WISeKey’s established subsidiaries, focuses on the development of the SEALCOIN platform, which enables the autonomous exchange of verified, high value data secured by post-quantum cryptography.
“Becoming a Strategic Partner of the Hedera Council reinforces WISeKey’s commitment to building trusted infrastructure for an increasingly connected and autonomous world,” said Carlos Moreira, Founder and CEO of WISeKey Group.
“By combining WISeKey’s expertise in digital identity, cybersecurity, PQC-secure semiconductors and space-based IoT with Hedera’s enterprise-grade distributed ledger technology, we can accelerate the deployment of trusted digital ecosystems where devices, machines and organizations can identify, authenticate and transact securely at global scale. This partnership is an important step in turning decentralized technologies into real-world infrastructure for the digital economy.”
This strategic partnership builds on an existing use case in the Hedera ecosystem. Earlier this year, the Hashgraph Group launched the QAIT Q-Day Security Assessment Platform on the SEALCOIN Quantum Marketplace. The platform was designed to help enterprises, governments and critical infrastructure operators evaluate, monitor and mitigate cybersecurity risks associated with the emergence of quantum computing.
Jonathan Llamas, Chief Product and Strategy Officer at SEALCOIN AG, added: “SEALCOIN was created around a simple premise: billions of connected devices and autonomous machines will increasingly need to transact with each other without sacrificing identity, security or trust. Hedera has been an active contributor to this vision, with a dedicated team of experts from its ecosystem working alongside us in the development of the SEALCOIN platform. By combining trusted device identity with Hedera’s scalable distributed infrastructure, we are building the foundations for machines to authenticate, exchange value and transact autonomously at global scale. This Strategic Partnership is a natural continuation of that collaboration and an important step toward making trusted machine-to-machine commerce a reality.”
Expanding Reach in Latin America
Hedera Council also proudly welcomes its eighth community partner, SpaceDev. The Council’s Community Partners bring strong ecosystem alignment and active participation, while driving adoption and awareness. SpaceDev is a Latin American software company, which has previously leveraged Hedera for its Blockchain for Energy (B4E) platform. This turned carbon-capture initiatives into auditable on-chain assets, replacing manual, error-prone workflows with a standardized, automated pipeline.
As the Council’s newest Community Partner, SpaceDev brings its expertise in delivering digital products that offer secure, real-world solutions. Previously, SpaceDev has created software for platforms including Tether, WalletConnect, Rarible and UFCStrike, among many others.
Currently ranked No. 2 among Clutch’s top blockchain companies, SpaceDev combines global reach with strong regional roots. Beyond its client work, the company supports the growth of Uruguay and Latin America’s blockchain landscape through educational programs, community events, and social initiatives that broaden access to technology.
Juan Manuel Sobral, CTO and co-founder of SpaceDev and President of the Blockchain Chamber of Uruguay, said: “Joining the Hedera Council Community Partner Program feels like a natural milestone in a story SpaceDev has been writing for years. We grew from Uruguay with the conviction that world-class technology can be created in Latin America, and that technical excellence becomes even more meaningful when it’s shared through education, community, and new opportunities. This recognition belongs to the talented people behind SpaceDev, as well as the clients and partners who have trusted us to bring ambitious ideas to life.”
To learn more about the Hedera Council partnership program, visit hederacouncil.org.
Nvidia zvažuje investici zhruba 2,5 miliardy USD do Thinking Machines Lab Miry Murati. Startup jedná o financování ve výši 5 až 6 miliard USD při valuaci nejméně 40 miliard USD.
Thinking Machines Lab is discussing a funding round at a valuation of at least $40 billion Summary
Nvidia is reportedly considering an investment of about $2.5 billion
Nvidia Corp. (NVDA, Financials), the dominant supplier of artificial intelligence chips, could put roughly $2.5 billion into Mira Murati's Thinking Machines Lab as it expands its reach beyond selling hardware.
Thinking Machines is in talks to raise between $5 billion and $6 billion at a valuation of at least $40 billion before the new investment, according to The Information.
Nvidia is expected to provide roughly half of that capital. The potential deal would deepen an already close relationship.
In March, Nvidia and Thinking Machines announced a multiyear partnership to deploy at least 1 gigawatt of next-generation Vera Rubin systems. The first deployment is targeted for early next year. That makes the investment strategically different from a typical venture bet.
Nvidia would be helping finance an AI company that has already committed to deploying its infrastructure at enormous scale. The arrangement could strengthen future demand for Nvidia systems while giving Thinking Machines access to the computing capacity needed to build and serve advanced AI models.
The talks also come just after Nvidia agreed to acquire open-source AI platform Hugging Face for $12.93 billion, another move that extends the company deeper into the software and developer side of the AI market.
The next catalyst is whether Nvidia and Thinking Machines finalize the funding round and disclose how the investment fits into their existing gigawatt-scale partnership.
Disclosures I/we have no positions in any stocks mentioned, and have no plans to buy any new positions in the stocks mentioned within the next 72 hours.
Nvidia za dva roky vybudovala akciové portfolio téměř za 100 miliard USD; k 26. červenci mělo hodnotu 99 miliard USD. Z toho zhruba 48 miliard USD připadalo na veřejně obchodované akcie a jiné obchodovatelné cenné papíry, 48 miliard USD na podíly v soukromých firmách a jiné neobchodovatelné cenné papíry a 3 miliardy USD na investice účtované metodou ekvivalence.
By You're currently following this author! Want to unfollow? Unsubscribe via the link in your email.
Nvidia CEO Jensen Huang. Tomohiro Ohsumi/Getty Images Nvidia has built a nearly $100 billion equity portfolio from virtually scratch in just two years by investing in other tech companies.
The AI chipmaker, led by CEO Jensen Huang, held $99 billion in equity investments as of July 26, according to its latest earnings report.
That included roughly $48 billion in publicly traded stocks and other marketable securities, $48 billion in shares of private companies and other non-marketable securities, and $3 billion in equity-method investments.
Its equity portfolio surged 14-fold in a year from about $7 billion last summer, and 45-fold from $2.2 billion two summers ago. The company also reported a further $25 billion in equity investment commitments as of July 26.
Nvidia's quarterly portfolio disclosure offered a glimpse at its public US stock portfolio as of June 30. It held a $30 billion stake in Intel, a $21 billion position in SpaceX, and investments in CoreWeave, Coherent, Synopsys, and Nokia, each worth between $2 billion and $5 billion.
The huge increase in Nvidia's equity holdings has vaulted it into the ranks of the biggest tech investors. It still trails the likes of Alphabet, which had a $232 billion equity portfolio at the end of June, including $94 billion of SpaceX shares following its IPO in June.
Nvidia stock has rocketed from below $15 at the start of 2023 to $228 at Thursday's close. That 15-fold increase in under three years has catapulted its market capitalization to $5.5 trillion, making it the world's most valuable company.
The chipmaker has become the premier enabler of the AI boom by providing the types of semiconductors needed to power the nascent technology, financing the AI infrastructure buildout, and investing in its AI peers.
A Nvidia spokesperson pointed Business Insider to finance chief Colette Kress, saying on the company's latest earnings call that frontier AI labs' ability to improve their products, attract more users, and generate more revenue was being "limited by compute," so Nvidia was "needed to help power this flywheel" and had thus invested almost $50 billion in them.
In its latest earnings report, Nvidia said that it makes equity investments to "enhance our growth opportunities, cultivate our ecosystem, and strengthen our competitive position."
However, Michael Burry of "The Big Short" fame has said Nvidia is "overreaching" in its efforts to juice its growth by financing and investing in customers of its chips.
Similarly, former "Shark Tank" investor Mark Cuban has said it's "truly scary" how reliant the AI boom is on Nvidia "funding everyone and anyone."
Read next
Theron Mohamed You're currently following this author! Want to unfollow? Unsubscribe via the link in your email.
Theron Mohamed is a London-based correspondent on the International team at Business Insider. His coverage spans finance, investing, wealth, markets, and the economy.Theron joined BI in 2019 as a reporter at Markets Insider and rose to the rank of correspondent before moving to the Trending team then the broader International team. He previously covered tech, media, and telecom stocks for Investors Chronicle magazine and had a brief stint on the Financial Times' Data team. He interned at the Wall Street Journal in New York where he primarily wrote for Heard on the Street.Theron has freelanced for The Independent, The Telegraph, WIRED, and several smaller publications. He holds an undergraduate degree in geography from the London School of Economics, and a master's degree in journalism from Columbia University.Theron often covers Warren Buffett, Michael Burry, and other elite investors. He also writes about the world's wealthiest people and shares financial advice from all manner of rich and successful people.Email Theron at [email protected] and follow him on X @theron_mohamed.